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Abstract 
Streptococcus agalactiae (Group B Streptococcus; GBS) is a Gram-positive pathogenic 
bacterium that causes disease in a wide range of animals including fish. Outbreaks of GBS 
in farmed fish have substantial economic impacts on the aquaculture industry, especially in 
tilapia production, a staple food product in tropical and subtropical low- and middle-income 
countries and the second most widely farmed fish after carp. Although vaccination can 
effectively prevent disease caused by GBS in fish it often fails after relatively short periods 
of use. Capsular polysaccharide (CPS) is the major protective antigen in GBS vaccines and 
a critical virulence factor. There are currently ten CPS serotypes of GBS and, whilst 
vaccination against one serotype confers protection in fish, it is not cross-protective against 
other serotypes. In addition, under the strong selective pressure of vaccination-driven 
adaptive immunity, evolution of novel serotypes can occur. To improve the serotype cross-
protective efficacy of GBS vaccines for aquaculture, I employed a pan-genome reverse 
vaccinology approach to design candidate serotype-independent protective vaccines based 
on conserved proteins in fish-pathogenic GBS serotypes. Reverse vaccinology exploits 
recent advances in genomics to predict antigens in the genome sequence. Reverse 
vaccinology combined with pan-genome can identify the antigens that are conserved across 
a diversity of strains of a pathogen.  
 
To identify potential vaccine candidate antigens, a pan-genome was constructed for GBS 
comprising 82 genomes including representative isolates from wild marine fish and stingrays, 
farm and companion animals and from human clinical cases in Australia, along with isolates 
from farmed tilapia in Honduras and representative genomes from all current serotypes 
available via the NCBI Genbank database. Core genome single nucleotide polymorphism 
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(SNP) analysis indicated dissemination of the aquatic host-adapted ST-261 lineage in wild 
Australian fish from an ancestral tilapia strain, which is congruent with several introductions 
of tilapia into northern Australia from Israel and Malaysia during the 1970s and 1980s.  
 
Aquatic serotype Ib GBS strains have lost many virulence factors during adaptation, but six 
adhesins, named ST-261 adhesins, were well-conserved across the aquatic isolates and 
might be critical for virulence in fish and good targets for vaccine development. Three of six 
ST-261 adhesins were also conserved across all strains including terrestrial isolates and 
were chosen as vaccine candidates. Expressions of ST-261 adhesin genes were inversely 
co-regulated with CPS expression dependent upon carbon source and metal ions in the 
medium. However, gene transcription was not reflective of surface expression as serum 
antibodies derived in tilapia against recombinant adhesins did not detect similar variation in 
the level of ST-261 adhesins in whole cell ELISA or Western blot. This may be due to post-
transcriptional processing causing a disconnect between gene and protein expression.  
 
To evaluate the efficacies of recombinant ST-261 adhesins as vaccines in tilapia, a 
vaccination and challenge experiment was conducted. All recombinant ST-261 adhesin 
vaccines resulted in strong antibody response detected by ELISA against the recombinant 
adhesins. However, no protection from disease was elicited by any of the recombinant 
vaccines in the challenge model. This may be due to antigenic masking by CPS. It may also 
be that adhesins are not expressed during the critical stages of proliferation in the host and 
are required at the mucosal surfaces during pathogen entry via the gastrointestinal tract. 
Future work should elucidate the role of these ST-261 adhesins in pathogenicity in fish, 
including where and when they are expressed on GBS during the infection.  
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Prevention of disease in aquaculture caused by highly antigenically diverse pathogens such 
as GBS might be achieved through deployment of autogenous (custom-made) vaccines 
supported by careful surveillance to enable incorporation of variants as they arise. Use of 
rapid, low cost genomics as employed in this thesis will aid in accurate surveillance and 
inform vaccine modification as required. Genomics may also aid in defining the 
epidemiological unit over which an autogenous formulation might be employed, increasing 
the cost-effectiveness of custom-made autogenous vaccines. In the era of “one health”, with 
global antimicrobial use in animal production far exceeding use in human medicine, it is 
critical that affordable disease prevention methods are promoted in the world’s fastest 
growing food production sector.  
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Chapter 1: General Introduction 
 
1.1. Background 
1.1.1 Dynamics of the rise in global aquaculture production 
In the last five decades, world fisheries production has been growing rapidly with the 
increase of food fish supply at an average rate of 3.2% per annum and fish consumption per 
capita has been rising almost twice as rapidly with each person consuming an average of 
20.2 kg in 2015 compared to an average of 9.9 kg per capita in the 1960s (FAO, 2018). This 
significant growth in fisheries supply and demand is correlated with population growth, 
increases in average incomes and well developed distribution channels (FAO, 2018). Today, 
fish is considered an important source of protein and nutrients providing a range of essential 
amino acids, fatty acids and some micronutrient and comprising about 17% of the animal 
protein intake of the global population (Blanchard et al., 2017; Merino et al., 2012). 
 
Global fish production, including fisheries and aquaculture, totalled 170.9 million tonnes in 
2016 which was around 14 million tonnes higher than in 2012 (Fig. 1.1) (FAO, 2018). 
According to Food and Agriculture Organization of the United Nations (FAO), the production 
of capture fisheries was 90.9 million tonnes while total aquaculture production was 80 million 
tonnes in 2016 (FAO, 2018). The contribution of farmed food fish to total fish production was 
47% in 2016, and has been steadily growing (FAO, 2018). Aquaculture production in 1990 
represented only 13.4% of total fisheries output and 25.7% in 2000 (FAO, 2016). Although 
productions from capture fisheries still slightly dominated in 2016, it has been decreasing 
92.7 million tonnes to 90.9 million tonnes between 2015 and 2016 and it is estimated to be 
kept dropping (Diggles et al., 2011; FAO, 2018). World fish production in aquaculture has 
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been growing although average annual growth decreased to 5.8% in between 2000 to 2016, 
compared to 10% during 1990s (FAO, 2018). However, fish farming industries are still 
growing dramatically in a number of countries, especially in Africa from 2006 to 2010 (FAO, 
2018). Total aquaculture production increased for 13.2% in Africa, 10.8% in North and Latin 
America and 10.13% in Asia between 2012 to 2014 (FAO, 2016). Europe and Oceania 
regions showed slower aquaculture production growth, which increased only 2.7% in Europe 
and 1.7% in Oceania over the same period (FAO, 2016). In 2014, contribution of aquaculture 
for human consumption exceeded the capture fisheries for the first time (FAO, 2016). In fact, 
the production of cultured fish in Asia has been higher than capture fisheries since 2008, 
and the aquaculture production in Asia, including China accounted 88.91% of world total 
aquaculture production (FAO, 2016). China is one of the largest aquaculture producers and 
has shown dramatic expansion in farmed fish production, with annual growth rate 5.5% in 
2000 to 2012 (Cao et al., 2015; Ponte et al., 2014). The total production in China alone 
reached 45.469 million tonnes in 2014 (FAO, 2016). Aquaculture is now recognised as one 
of the fastest developing food sectors in the world compared to other food production 
industries. For example, cattle production has increased by less than 1%, pig by 0.8% and 
even poultry production has only risen by 3% per year since 2000 (FAO, 2013; Troell et al., 
2014). The estimated global aquaculture harvests value was around USD 160.2 billion 
including food fish and aquatic algae in 2014 (FAO, 2016).  
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Fig. 1.1. The global production of capture fisheries and aquaculture. The figure obtained from FAO 
report 2018: The State of World Fisheries and Aquaculture (FAO, 2018). 
 
The proportion of aquaculture commodity represented by finfish is dominant, comprising 
two-thirds (66.3%) of the total aquaculture production (66.6 million tonnes), with 38.6 million 
tonnes from fresh water finfish aquaculture and 5.6 million tonnes in finfish mariculture 
whereas farmed crustaceans reached 9.7% (6.4 million tonnes) and mollusc production 
accounted 22.8% (15.2 million tonnes) in 2012 (FAO, 2014). In finfish farming, carps 
including silver carp (Hypophthalmichthys molitrix), bighead carp (H. nobilis) and grass carp 
(Ctenopharyngodon idella) are the dominant species which account for about 70% of 
freshwater aquaculture (FAO, 2012). Tilapias, mainly Nile tilapia (Oreochromis niloticus), 
Mozambique tilapia (O. mossambicus), blue tilapia (O. aureus), hybrid tilapia (O. niloticus x 
O. aureus) are the second most important freshwater fish in aquaculture globally and are 
grown in more than 130 countries and territories (FAO, 2014). Tilapia farming in Asia 
contributes to more than 70% of its total finfish production (FAO, 2012). Barramundi or Asian 
sea bass (Lates calcarifer) is widely distributed in the Indo Pacific areas and is farmed mainly 
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in Southeast Asia and Australia (Aji, 2012; FAO, 2012). This fish can inhabit fresh, brackish 
and marine warm water but they are mostly cultured in coastal regions or cage farmed in 
freshwater ponds (Aji, 2012; Bowyer et al., 2013). Although its production remains small, it 
is a commercially important species due to its high value (Aji, 2012; FAO, 2014). Marine 
aquaculture production, including of Atlantic salmon (Salmo salar), ocean trout and groupers 
is much lower than freshwater farming in terms of tonnage (FAO, 2014, 2016). However, 
although marine finfish production contributes only 7.2% of the total production of finfish 
culture, the value is higher than most cultured freshwater finfish, which accounts 16.6% of 
share value (FAO, 2016). Most farmed finfish such as carps and tilapias are warm-water 
fish (temperature above 15°C) so they are cultured in tropical regions like Asia, Africa and 
Latin America, and it is in these warm-water regions where growth in production has been 
most rapid (Bowyer et al., 2013; FAO, 2016). The world population has been estimated to 
reach approximately 9.7 billion by 2050 (Blanchard et al., 2017). The global demand for fish 
products will increase since fish is considered as a key source of protein and essential 
nutrients (Klinger and Naylor, 2012; Merino et al., 2012). However, wild fish catch has been 
dropping and further expansion in capture fisheries will be suppressed because wild fish 
stocks have been declining to biologically unsustainable level (FAO, 2016; Klinger and 
Naylor, 2012). Therefore, aquaculture is one of the solutions to the increase of seafood 
demand in the world and to combat against food issues in the future (Klinger and Naylor, 
2012; Merino et al., 2012).  
 
1.1.2. Diseases in Aquaculture 
In addition to the benefits of employment, poverty alleviation, food security and improved 
nutrition, particularly in developing regions, rapid growth in global aquaculture has also 
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increased problems including environmental impacts, land use conflicts and increased 
incidences of fish diseases (Pretto-Giordano et al., 2010; Troell et al., 2014). Disease has 
been an important constraint on the development of the aquaculture (Bostock et al., 2010; 
Defoirdt et al., 2011). The emergence and development of disease is strongly associated 
with the interactions between infectious agents, host animals and environment (Toranzo et 
al., 2005). In the aquaculture environment, animals are routinely maintained at high 
densities of monospecies populations with low oxygen levels and often poor water quality 
(Murray and Peeler, 2005). High stock densities lead to rapid transmission of infectious 
agents among animals and stressors including low dissolved oxygen and low water quality 
increase hosts’ susceptibility to disease (Defoirdt et al., 2011). Transfer of live fish for 
commercial operational reasons can result in the introduction of pathogens into new 
systems, and has resulted in transboundary distribution of diseases between countries 
(Hedrick, 1996). Whilst quite strict biosecurity legislation applies in some countries, the 
difficulties associated with detection of subclinical infections and limitations in detecting live 
agents in frozen products can results in accidental import and introduction of new pathogens 
into naïve wild stock (Murray and Peeler, 2005). For example, frozen pilchards imported into 
Australia from South America as tuna feed are the most likely explanation of a widespread 
mass mortality of wild native pilchards due to pilchard herpesvirus in the early 2000s 
(Gaughan, 2001). Diseases in fish farming have significant impacts on aquaculture 
economics (Lafferty et al., 2015). There are two ways that diseases in farming can have 
economic impacts, one is the mortality and lower growth rate which reduce biological 
productivity and lead to reduction of harvest (Lafferty et al., 2015). The other way is that 
diseases lower the quality of fish causing decrease in market value (Defoirdt et al., 2011; 
Lafferty et al., 2015). For example in China, diseases caused by Gram-negative bacteria 
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including Aeromonas spp., Yersinia spp. and Vibrio spp., affected freshwater carp farming 
and led to substantial economic losses estimated at more than 120 million USD annually 
(Qi, 2002). The global losses due to disease outbreaks have been estimated as several 
billion USD every year (Defoirdt et al., 2011; Lafferty et al., 2015). The infectious agents 
causing disease in fish include bacteria (34%) viruses (25%), protists (19%) and metazoans 
(18%) although bacterial infections are the most dominant cause of serious disease in 
aquaculture (Lafferty et al., 2015). Whilst many species of bacteria have been documented 
as causative agents in fish mortalities worldwide, many of these are opportunists and can 
be eliminated through improved husbandry. However there are a relatively small number of 
primary fish pathogens that are responsible for the most serious economic losses in global 
aquaculture (Lafferty et al., 2015; Toranzo et al., 2005).  
 
Streptococcus is an emerging pathogen in wild and cultured fish and becoming major 
problem in global aquaculture (Toranzo et al., 2005; Verner-Jeffreys et al., 2017; Yanong 
and Francis-Floyd, 2010). These Gram-positive cocci lead to streptococcosis and are known 
to affect a broad range of hosts including human, terrestrial animal and aquatic animal 
worldwide (Evans et al., 2002; Toranzo et al., 2005). Streptococcal infection in fish was first 
reported in Japan in 1958 that affected commercial rainbow trout (Hoshina et al., 1958). 
After this, large numbers of economically and environmentally important fish species have 
been found to be susceptible to Streptococcus (Li et al., 2016; Verner-Jeffreys et al., 2017; 
Yanong and Francis-Floyd, 2010). Clinical signs of streptococcal infection vary depending 
on the fish species and the type of hosts (Agnew and Barnes, 2007; Woo and Gregory, 
2014). Generally, the infected fish showed lethargic and erratic swimming resulting from 
meningoencephalitis (Yanong and Francis-Floyd, 2010). Other common symptoms of 
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streptococcal infection include exophthalmia and hyphema, petechia, oedema in the 
peritoneal cavity and intestine, pale liver and a darkly coloured spleen (Eldar et al., 1995a). 
There are several species that cause streptococcosis in a diverse array of warm and 
temperate marine and freshwater fish (Toranzo et al., 2005). Streptococcosis is descriptive 
of the disease rather than the genus causing the disease, thus, ‘streptocococcosis’ is caused 
by S. agalactiae, S. iniae, S. parauberis and Lactococcus garvieae in warm water (Toranzo 
et al., 2005; Vendrell et al., 2006; Woo and Gregory, 2014). In cooler temperate water, L. 
piscium and Vagococcus salmoninarum are causative agents of streptococcosis (Ghittino 
et al., 2003). The infectious agents of streptococcosis in warm water are potentially zoonotic 
agents and can induce disease in humans (Toranzo et al., 2005). Streptococcus agalactiae 
and S. iniae are two major pathogens affecting freshwater, brackish and marine cultures in 
warm water and lead to high mortality and consequently economic losses (Li et al., 2016; 
Rodkhum et al., 2011). For example, the global economic impact of disease outbreaks 
caused by S. agalactiae and S. iniae to the aquaculture industry has been estimated to be 
more than 250 million USD annually (Amal and Zamri-Saad, 2011).  
 
1.1.3. Control of bacterial diseases in aquaculture 
The interaction between pathogen, host and environment are important factors in 
development of disease (Toranzo et al., 2005). In the aquatic environment, especially 
farming systems, bacteria can reach high densities and the host animals would be more 
likely to be in contact with pathogens (Defoirdt et al., 2011; Verschuere et al., 2000). 
However, in the aquaculture environment, total eradication of pathogen from the system is 
almost impossible (Millard et al., 2012). Therefore, controlling pathogens is critical for 
developing aquaculture.  
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Antibiotics have been used in aquaculture to control and kill pathogenic bacteria (Defoirdt 
et al., 2011). In the farming environment, fish are exposed to stress and this decreases the 
effectiveness of their immune system (Naylor and Burke, 2005). As a consequence, fish 
cannot avoid bacterial colonization and infection so use of antibiotics to control disease 
became common (Cabello, 2006; Naylor and Burke, 2005). However, frequent use of 
antibiotics increases selective pressure in a bacterial population that can lead to increase of 
antibiotics resistance (Cabello, 2006). Indeed, detected levels of residual antibiotics and 
resistant bacteria have been elevated in the area around farming sites (Kümmerer, 2009). 
In addition, horizontal gene transfer of resistance genes occurs between the tolerant 
bacteria and other potentially more serious pathogens (Barlow, 2009). This could negatively 
affect human health if human pathogens acquire the resistance determinants (Cabello et al., 
2013; Diana et al., 2013). Furthermore, in some cases, antibiotics are not effective to treat 
bacterial infection in fish and antibiotics use has been substantially reduced (Defoirdt et al., 
2011; Verschuere et al., 2000). The decrease of antibiotics use is not only because of its 
ineffectiveness but also routine has been developed to protect fish against bacterial 
pathogens (Håstein et al., 2005; Press and Lillehaug, 1995). In Norway, antibiotics were 
major treatment for diseases caused by bacterial pathogens in salmonids industries in the 
1980s (Midtlyng et al., 2011). 
 
However, since the introduction of functional vaccines, despite use of antibiotics reduced, 
the production of Norwegian salmonids cultures reached more than double in last 10 years 
(Fig. 1.2) (Gudding, 2014; Håstein et al., 2005; Midtlyng et al., 2011). As a vertebrates, fish 
possess an adaptive immune system (Press and Lillehaug, 1995). When vaccine (antigenic 
substance) is injected in fish, this stimulates the hosts immune system to develop adaptive 
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immunity (Gudding and Van Muiswinkel, 2013; Press and Lillehaug, 1995). Today, 
vaccination is the most important and widely used way to prevent and control bacterial 
diseases in cultured fish in developed nations (Gudding, 2014; Håstein et al., 2005). 
However, some bacterial pathogens are particularly hard to control through vaccination.  
 
 
Fig. 1.2. Salmonid fish production and antibiotics use in Norway from 1974 to 2009. The figure obtained 
from Gudding: Vaccination as a Preventive Measure (Gudding, 2014). 
 
1.1.4. Streptococcal infections in fish 
1.1.4.1. Streptococcus iniae 
Streptococcus iniae was first isolated from a skin lesion of diseased Amazon freshwater 
dolphin (Inia geoffrensis) in 1972, although it was potentially isolated from rainbow trout 
earlier in Japan in 1958 (Hoshina et al., 1958), though not identified until later (Pier and 
Madin, 1976). In 1979, large-scale streptococcal infections were observed in farmed 
freshwater fish, tilapia, rainbow trout, and ayu (Plecoglossus altivelis) leading to serious 
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FIGURE 2
Use of antibiotics and production of salmonid fish in Norway from 1974 to 2009
However, there are still challenges, especially related to the relatively small production 
of cod and other marine fish. In 2009, the amount of antibiotics used was similar for the 
production of salmonids and marine fish, whereas the production volume of the marine 
species was less than 2 percent of that for salmonids. The use of antibiotics in the farming 
of cod is a conseque ce of the fact that some bacterial diseases affecting this species are 
difficult to prevent. Francisella is an intracellular bacterium, and it is well known that 
prevention of diseases owing to such intracellular micro-organisms using inactivated 
vaccines is difficult. In other countries, the use of live attenuated vaccines seems to be 
a solution leading to the successful prevention of intracellular micro-organisms based 
on vaccines (Shoemaker et al., 2009). In Canada, a DNA vaccine against infectious 
haematopoietic necrosis was licensed a few years ago (Salonius et al., 2007). In Norway, 
the possible risks associated with DNA vaccines have limited the use of such vaccines in 
aquaculture. However, this issue is now under reconsideration. 
Vaccination is the most important preventive measure in order to maintain 
sustainability in salmonid fish farming. However, there is still a great need for research 
in this area in order to use the potential of the immune system of fish in a beneficial way. 
Here the governmental and private sector have to work together. Among the many areas 
for cooperation are the development of vaccines against intracellular micro-organisms, 
oral vaccines, live vaccines, adjuvants and improved vaccines based on molecular 
biology.
CONCLUSIONS
The conclusion based on 30 to 40 years’ experience with intensive salmonid fish farming in 
Norway is that sustainability should be the basis for developing a successful aquaculture 
industry. The Norwegian experience is that disease prevention is fundamental for 
sustainability. Legislation is the cornerstone in disease prevention, while vaccination is 
the single most important preventive measure. Finally, the authorities and the industry 
must be well organized and have the right competence on all levels.
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economic losses in Japan (Kitao et al., 1981). The pathogen was later identified as S. iniae 
(Nakatsugawa, 1983; Stoffregen et al., 1996). Today, S. iniae infections in fish have been 
reported in multiple countries, including US (North America), Japan, China, Thailand, 
Vietnam, Malaysia, Indonesia, Singapore (Asia), Bahrain and Israel (Middle East), south-
east Caribbean basin (Central America), Brazil (South America) and Australia (Oceania) 
(Bromage et al., 1999; Colorn et al., 2002; Ferguson et al., 2000; Figueiredo et al., 2012; 
Kitao et al., 1981; Mmanda et al., 2014; Nakatsugawa, 1983; Nawawi et al., 2009; Perera 
et al., 1994; Suanyuk et al., 2010; Yuasa et al., 1999). Streptococcus iniae has a wide host 
range, which comprises freshwater, estuary and marine, cultured and wild fish such as 
tilapia, hybrid tilapia, hybrid striped bass, channel catfish, ayu, rainbow trout, barramundi, 
red drum (Sciiaenops ocellatus), European sea bass (Dicentrarchus labrax), striped piggy 
(Pomadasys stridens), lizardfish (Synodus variegatus), snapper (Ocyurus chrysurus), Grey 
mullet (Mugus cephalus), parrot fish (Sparisoma aurofrenatum), silver bream 
(Acanthopagrus australis) and Japanese flounder (Paralichthys olivaces) (Bromage et al., 
1999; Colorn et al., 2002; Ferguson et al., 2000; Kitao et al., 1981; Nakatsugawa, 1983; 
Perera et al., 1994; Shoemaker et al., 2001). In Australia, outbreaks of S. iniae caused 
mortality of 35% in barramundi every winter and early spring that result huge losses in 
barramundi industries (Creeper and Buller, 2006; Nawawi et al., 2008). In addition, S. iniae 
has been isolated from terrestrial animals including flying fox (Puteropus alecto) and causes 
occasional human infections following handling of infected fish (Agnew and Barnes, 2007; 
Facklam et al., 2005).  
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1.1.4.2. Streptococcus agalactiae (Group B Streptococcus; GBS) 
Streptococcus agalactiae is the sole member of the Lancefield group B Streptococcus (GBS) 
(Evans et al., 2002; Lancefield, 1933). Group B Streptococcus has been isolated from 
terrestrial animals including humans, cattle, camels, dogs, cats and frogs and from aquatic 
animals such as fish, seals and dolphins indicating that GBS has broad range of hosts 
(Delannoy et al., 2013; Elliott et al., 1990; Evans et al., 2002). Group B Streptococcus is an 
important pathogens in humans: although commensal in the urogenital tracts of high 
proportion of the human population, GBS is the most frequent cause of meningitis and 
septicaemia in newborns, and is therefore of substantial concern in pregnant women 
(Dangor et al., 2014; Edwards and Gonik, 2013). Streptococcus agalactiae in fish was first 
reported in freshwater fish, golden shiners (Notemigonus crysoleucas) in the US in 1966 
(Robinson and Meyer, 1966). Robinson and Meyer (1966) isolated GBS from diseased fish’s 
kidney (Robinson and Meyer, 1966). They demonstrated transmission of disease between 
diseased and healthy fish in the aquarium causing death within four to five days of infection 
(Robinson and Meyer, 1966). Since the first report, GBS infection in fish has been 
documented in a number of countries in tropical or temperate regions, specifically the US 
(North America), Japan, China, Thailand, Malaysia, Indonesia (Asia), Israel and Kuwait 
(Middle East), Honduras (Central America), Colombia and Brazil (South America) and 
Australia (Oceania) (Abuseliana et al., 2010; Baya et al., 1990; Bowater et al., 2012; Eldar 
et al., 1995b; Evans et al., 2008; Evans et al., 2002; Geng et al., 2012; Kayansamruaj et al., 
2014; Lusiastuti et al., 2014; Najiah et al., 2012; Salvador et al., 2005). A variety of 
commercial and wild fish have been killed by S. agalactiae, including tilapia species, catfish 
species, silver pomfret (Pampus argentes), mullet (Liza klunzingeri), yellowtail and sea 
bream (Amal and Zamri-Saad, 2011; Elliott et al., 1990; Evans et al., 2002; Geng et al., 
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2012). Recently, the first report of natural outbreak of GBS was documented in wild giant 
Queensland groupers (Epinephelus lanceolatus), diamond-scale mullet (L. vaigensis), 
javelin grunter (Pomadasys kaakan), giant sea catfish (Arius thalassinus) and stingray 
species comprising estuary ray (Dasyatis fluviorum), mangrove whipray (Himantura 
granulate) and eastern shovelnose ray (Aptychotrema rostrata) in northern Queensland in 
Australia (Bowater et al., 2018; Bowater et al., 2012; Delamare-Deboutteville et al., 2015). 
The outbreaks of disease caused by S. agalactiae lead to substantial losses in aquaculture, 
with particular impact on tilapia farms (Evans et al., 2004). Both pathogens have caused 
massive disease outbreaks and led to huge economical impacts on global aquaculture every 
year. This research will focus on S. agalactiae, major pathogens in warm water fish.  
 
1.1.5. Streptococcal intraspecific diversity  
1.1.5.1 Serological typing 
Traditionally, intraspecific classification of streptococci have been distinguished by 
serological classification of antigens on the surface and hemolytic activity of bacterium 
(Lancefield, 1933). Streptococcus agalactiae is Lancefield group B, however, S. iniae does 
not fall into any Lancefield group (Agnew and Barnes, 2007; Evans et al., 2002). The typing 
methods have improved with advancing technology and serotyping based on the capsular 
polysaccharides (CPS) has been widely used to discriminate Streptococcus isolates of the 
same species (Amundson et al., 2005; Kong et al., 2002). Molecular serotyping has been 
developed that is based on CPS synthesis (cps) gene clusters (Kong et al., 2002). Currently, 
S. agalactiae can be divided into 10 different CPS serotypes, Ia, Ib and II to IX (Kong et al., 
2002; Slotved et al., 2007). The most infectious GBS in fish are identified as serotype Ia and 
Ib (Delannoy et al., 2013; Evans et al., 2008). There are few strains which are belonging to 
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serotype III-4 isolated from tilapia in Thailand, Vietnam, China and Brazil (Chideroli et al., 
2017; Delannoy et al., 2013; Kayansamruaj et al., 2014; Li et al., 2013).  
 
1.1.5.2. Mutilocus sequence tying (MLST) 
Multilocus sequence typing (MLST) is an unambiguous sequence based typing which 
involves sequencing about 450 to 500 bp of seven housekeeping genes and which 
investigates composition of allele numbers, allelic profile, to determine the sequence type 
(ST) (Jones et al., 2003; Sabat et al., 2013). This method is particularly useful for global 
epidemical research (Sabat et al., 2013). The majority of S. agalactiae strains isolated from 
fish have been typed as ST-260 and ST-261 (Delannoy et al., 2013; Lusiastuti et al., 2014; 
Rosinski-Chupin et al., 2013). Streptococcus agalactiae ST-260 is recognized as part of 
clonal complex (CC) 552, comprising of non-hemolytic S. agalactiae strains (Delannoy et 
al., 2013). These ST-260 strains originate from Honduras, Colombia, Costa Rica and Brazil, 
affecting tilapia and hybrid Amazon catfish (Pseudoplatystoma fasciatum x Leiarius 
marmoratus), and from US infecting hybrid striped bass (Delannoy et al., 2013; Godoy et 
al., 2013b; Rosinski-Chupin et al., 2013). Sequence type 261 strains are a widely distributed 
found in Australia, Belgium, Indonesia, Israel and US affecting wild fish, tilapia and trout 
(Delannoy et al., 2013; Lusiastuti et al., 2014; Rosinski-Chupin et al., 2013). Sequence type 
7 has been isolated in Thailand, Kuwait and China, causing disease in tilapia and mullet 
(Delannoy et al., 2013; Evans et al., 2008; Ye et al., 2011). Sequence type 7 is recognized 
as human pathogen that causes invasive disease in newborn and adults (Jones et al., 2003). 
Human sewage is considered as source of ST-7 outbreaks in fish (Delannoy et al., 2013). 
Other STs have been identified among GBS fish strains including ST-103, 257, 552 and 553 
in Brazil, ST-258 in Israel, ST-259 in Honduras, ST-283 and 500 in Thailand and ST-491 in 
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Vietnam (Evans et al., 2008; Godoy et al., 2013b; Rosinski-Chupin et al., 2013). Sequence 
type 257, 552, 553 and 259 fall into CC-552 and ST-258 has weak connection to CC-552 
(Rosinski-Chupin et al., 2013). Sequence type 261 does not belong to CC-552, but it is 
closely related to this CC (Godoy et al., 2013b). 
 
1.1.6. Control of Streptococcal diseases 
Due to the zoonotic potential of S. agalactiae, controlling infection of S. agalactiae is 
important for both aquaculture development and food safety (Ghittino et al., 2003). There 
are several measures to control streptococcal disease in aquaculture including antibiotic use 
and mass vaccination (Shoemaker et al., 2001). Evans et al. (2002) demonstrated that S. 
agalactiae strains isolated from seabream and mullet in Kuwait were sensitive to 
oxytetracycline, ampicillin, ciprofloxacin, amoxicillin/clavulanic acid, chloramphenicol, 
rifampin and sulphamethoxazole (Evans et al., 2002). Streptococcus agalactiae causing 
mass mortality of tilapia in Malaysia are also sensitive to amoxicillin, ampicillin and 
erythromycin (Abuseliana et al., 2010). Although, antibiotics kill pathogens, some of them 
will still remain and the residual antibiotics in the system increase selective pressure that 
would cause antibiotics resistance in bacteria (Cabello, 2006). Streptococcus agalactiae 
recently, isolated from tilapia in Malaysia indicated low level of resistance to 
amoxicillin/clavulanic acid and ampicillin (Aisyhah et al., 2015). However, antibiotics 
resistance represents a substantial global problem and could be transferred to ecosystems 
around the farm and spread amongst the bacteria so strict regulation of antibiotics and 
monitoring are required (Aisyhah et al., 2015). Several vaccines against streptococcal 
infection have been developed to protect fish (Evans et al., 2004). Eldar et al. (1995b) 
reported that vaccinations with whole-cell and protein extract from S. difficile, later 
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reclassified as S. agalactiae, elicited high protection to hybrid tilapia against challenge with 
S. agalactiae (Eldar et al., 1995b; Kawamura et al., 2005). Whole-cell vaccination gave 
cross-protection against challenge with a heterologous strains of the same species (Eldar 
et al., 1995b). Under field raceway condition, vaccination provided protection to farmed fish 
with 4.5% mortality after four month of vaccination (Eldar et al., 1997). Evans et al. (2004) 
showed the protection to tilapia of 30g injected formalin-killed S. agalactiae resulted 80% of 
survival. These vaccines have been widely used in fish farms in US (Iregui et al., 2014). 
 
1.1.7. Vaccine failures 
The success of vaccination against streptococcal diseases in fish has not reflected the 
success seen against other bacterial infections due to re-emergence of new serotypes 
(Bachrach et al., 2001). In 1997, outbreaks of disease caused by a new serotype (“serotype 
II”) of S. iniae were recorded in rainbow trout in Israel after the vaccination (Bachrach et al., 
2001). In response to the reoccurrence of disease outbreaks, a new vaccine was developed 
containing the serotype II strain (Eyngor et al., 2008). However, vaccination against serotype 
I and II S. iniae led to re-emergence of disease caused by a further novel strain in 2005 
(Eyngor et al., 2008). The new strain differed from vaccine strains (serotype I and II) in the 
capacity to produce larger amount of extracellular polysaccharide (EPS) than vaccine 
strains (Eyngor et al., 2008). Eyngor et al. (2008) suggested that EPS is not only the major 
virulence factors but also it is a major antigenic factor since fish vaccinated with EPS alone 
provided protection (72%) against challenge with new strain (Eyngor et al., 2008). 
Emergence of new strains after vaccinations were also reported from barramundi farms in 
Northern Territory (NT), New South Wales (NSW) and South Australia (SA) in Australia 
(Millard et al., 2012). An autogenous vaccine, which is a vaccine prepared from a strain 
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isolated from the farm directly and only can be used in the same farm, was used to protect 
barramundi against S. iniae in the farms in NT, NSW and SA. In each case, reinfection of 
vaccinated stock occurred and was correlated with variations in at least one of five of the 20 
cps genes in capsular operon (Millard et al., 2012). This corroborated previous studies in 
other streptococcal species that selective pressure induced by vaccination leads to the 
emergence of novel strains which can escape from vaccine-induced adaptive immunity in 
these farmed fish (Bachrach et al., 2001; Eyngor et al., 2008). These vaccine failures were 
due to variability of the antigens that are targeted by the adaptive immune system during 
fish vaccination (Millard et al., 2012).  
 
Fundamental factors for long-term and cross-protective vaccine are the nature of the 
antigens recognised by specific immune response. Therefore, antigens that are highly 
conserved among strains should be ideal vaccine candidates (Millard et al., 2012; Pizza et 
al., 2000). Most streptococci are surrounded by thick wall of polysaccharides (CPS), which 
is one of the major virulence factors and is the dominant antigen targeted by the immune 
system (Lowe et al., 2007). However, due to its antigenicity and immunogenicity, CPS is 
highly polymorphic under immune selective pressure (Barnes et al., 2003; Lowe et al., 
2007). Antibodies raised against vaccine strains did not cross-react with emergent strains 
suggesting that changes in cps genotype correlated with vaccine failure are related to 
antigenic differences amongst streptococcal bacteria (Millard et al., 2012). The variability of 
CPS makes development of vaccines which are able to provide protection against a wide 
range of strains particularly challenging (Lachenauer et al., 1999). For example, S. 
agalactiae can be divided into 10 different CPS serotypes, Ia, Ib and II to IX and each type 
is antigenetically different (Johri et al., 2006; Slotved et al., 2007). Conjugate vaccines that 
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have been made from purified the CPS type, which induce protective antibodies against 
homologous types of US prevalent strains, are not able to provide the protection against 
heterologous strains found in Japan (Johri et al., 2006; Lachenauer et al., 1999; Lindahl et 
al., 2005).  
 
1.1.8. Commercial Streptococcal vaccines in aquaculture 
Currently, commercial vaccines against streptococcal infection are available, AQUAVAC® 
Strep Sa (Merck Animal Health Inc.) against S. agalactia (Locke et al., 2010; Pridgeon and 
Klesius, 2013; Zamri-Saad et al., 2014). The vaccine, AQUAVAC® Strep Sa (Merck Animal 
Health Inc.), has been developed to protect fish against S. agalactiae. It is an inactivated oil-
adjuvant vaccine that can induce active immunity against S. agalactiae biotype II (serotype 
Ib), can be given by injection to fish more than 15 g. This vaccine has been tested in tilapia 
but can be used to other fish which are susceptible to S. agalactiae biotype II (serotype Ib). 
Currently, it has been approved in Brazil, Costa Rica and Indonesia for tilapia (Aftabuddin 
et al., 2016; Brudeseth et al., 2013). Although a number of commercial vaccines against S. 
agalactiae, however it is not available in all countries including Australia where only 
autogenous vaccines can be used to control streptococcal disease (Brudeseth et al., 2013; 
Millard et al., 2012). Moreover, it is killed bacterin, thus reliant on CPS antigens and are 
therefore serotype specific and subject to potential future serotype switching and 
consequent vaccine escape. Consequently, there is a need to identify more highly 
conserved critical surface or secreted protein antigens that can be targeted to give cross 
protection amongst serotypes. 
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1.1.9. Surface protein antigens  
Streptococcal antigenic diversity is not a problem that is unique to development of fish 
vaccines; vaccines against group A and group B Streptococcus and S. pneumoniae in 
humans require coverage for multiple serotypes (Johri et al., 2006; Sharma et al., 2012; 
Talukdar et al., 2014). As a result, many different surface or secreted protein antigens have 
been explored to develop long-term and cross-reactive vaccines as an alternative to CPS 
(Aviles et al., 2013; Brodeur et al., 2000; Cheng et al., 2010; Johri et al., 2006). For instance, 
conserved anchorless surface proteins of S. pyogenes (group A Streptococcus; GAS) 
arginine deiminase and trigger factor have been found to elicit protection in mice against 
challenges with multiple serotypes of GAS (Henningham et al., 2012; Henningham et al., 
2013). In addition, Sip, surface protein of S. agalactiae, has been recognised as 
immunogenic protein which evokes efficient protection in CD-1 mice challenge model 
against six S. agalactiae strains of different capsular serotypes (Brodeur et al., 2000). For 
fish vaccines, Sip11, a putative iron-binding exported protein identified from S. iniae SF1, 
has been showed to elicit protection (69.7%) in Japanese flounder against S. inae SF1 strain 
(Cheng et al., 2010). Although cross-reactivity of Sip11 against heterologous strains has to 
be tested, Sip11 has been considered as a vaccine candidate against S. iniae in aquaculture 
(Cheng et al., 2010). In contrast, highly antigenic proteins are not always protective. M-like 
protein, SiMA, which is a surface expressed protein and contributes to bacteria adherence 
and macrophage resistance (Aviles et al., 2013). SiMA genes, simA, are highly conserved 
among different strains of S. iniae, considered that SiMA has a potential target for cross-
protective vaccine (Aviles et al., 2013; Locke et al., 2008). However, although SiMA induced 
specific antibodies, the recombinant SiMA vaccine did not elicit protective immunity to 
barramundi against challenge with S. iniae (Aviles et al., 2013), although, the antibodies 
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raised against SiMA cross reacted in enzyme-linked immunosorbent assay (ELISA) with the 
heterologous challenge strain which has different capsular serotype but homologous simA 
sequence (Aviles et al., 2013). A similar result was observed when membrane protein, 
fibrinogen-binding protein (FbsA), was tested as a subunit vaccine against S. agalactiae in 
tilapia (Yi et al., 2014): Two protein antigens, FbsA and glycolytic enzyme α-enolase 
identified from S. agalactiae isolated from tilapia, were effective immunogens (Yi et al., 2014). 
However, although recombinant FbsA-specific antibody titer was significantly higher than 
that of recombinant α-enolase, recombinant FbsA provide lower protection (approximately 
40%) in tilapia against S. agalactiae challenge compared to recombinant α-enolase which 
resulted in > 60% protection (Yi et al., 2014). These results indicated that proteins, which 
have high antigenicity, are not always effective as protective immunogens (Yi et al., 2014). 
Therefore, the antigens’ ability to induce protective immunity is critical for successful vaccine 
development.  
 
1.1.10. Reverse vaccinology  
Identification of antigens which are able to elicit protective immunity has predominantly relied 
on extensive biochemical, serological and microbiological experimentation and testing 
putative antigens in a piecemeal manner (Rappuoli, 2001). However, these conventional 
approaches require a long time and usually determine the most abundant or immunogenic 
antigens, therefore often fail if the major antigens are highly variable like CPS in 
Streptococcus (Johri et al., 2006; Rappuoli, 2001). Also, the conventional approach often 
does not address the high potential intraspecific diversity amongst a pathogen species (Johri 
et al., 2006). In the last decade it has become possible to predict all potential vaccine 
candidate antigens in a species complex through rapid inexpensive whole genome 
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sequence technologies, coupled to advances in in silico analysis, and to identify the most 
conserved amongst them in an approach known as reverse vaccinology (Rappuoli, 2001). 
Reverse vaccinology has already demonstrated potential to improve vaccine design in a 
much shorter period and at lower cost (Fig. 1.3) (Adu-Bobie et al., 2003; Rappuoli, 2001). 
Briefly, the identification of potential vaccine candidates by reverse vaccinology starts from 
examining the genome sequence of the pathogens to find open reading frames (ORFs) 
which encode novel protein antigens (generally surface located or secreted) on the 
pathogens (Pizza et al., 2000). After identifying ORFs, the genes are cloned and expressed 
and the recombinant proteins undergo immunogenicity testing in an animal model (Fig. 1.3) 
(Pizza et al., 2000; Rappuoli, 2001). Reverse vaccinology was pioneered by Rappuoli and 
first employed to improve vaccines against Neisseria meningitidis serogroup B, group B 
meningococcus (MenB) which can lead to meningitis and meningococcemia (Pizza et al., 
2000; Rappuoli, 2001). Vaccine development against MenB had been slow taking the 
conventional approach (Rappuoli, 2001): The capsular polysaccharide expressed on the 
surface of MenB was main target antigen, but it is chemically similar to human antigens, 
therefore, it had a potential risk of autoimmunity (Giuliani et al., 2006; Rappuoli, 2001). On 
the other hand, reverse vaccinology successfully identified 29 novel antigens that are 
capable of inducing antibodies against the pathogen (Giuliani et al., 2006). After screening, 
the vaccine comprising three antigens (Neisserial heparin-binding antigen, factor H-binding 
protein and N. meningitidis adhesin A), underwent phase I trials and has been granted a 
marketing authorization in 2012 as the first universal vaccine against MenB (Delany et al., 
2013; Giuliani et al., 2006). Identification of universal antigens, which can induce protective 
immune response against all strains of polymorphic bacteria, is difficult by conventional 
approaches (Rappuoli, 2001). Multigenome or pan-genome reverse vaccinology allows 
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identification of potential protein antigens that are conserved across the most virulent 
serotypes to enable development of vaccines against bacteria with highly variable antigens, 
such as Streptococcus spp. (Adu-Bobie et al., 2003; Maione et al., 2005; Rappuoli, 2001; 
Seib et al., 2012). Maione et al. (2005) compared genome sequences of eight S. agalactiae 
strains that belong to serotype Ia, Ib, II, III and V, which are the most significant serotypes 
causing human disease (Maione et al., 2005). Maione et al. (2005) found 589 surface 
expressed proteins including 396 were in core genes and 193 were in variable genes 
(Maione et al., 2005). After immunogenicity testing, they identified a combination of four 
proteins, including conserved Sip protein and variable surface expressed proteins across 
the strains which were assigned as pili. These induced 59.3% to 100% protection in mice 
against 12 GBS strains in challenge models (Maione et al., 2005; Seib et al., 2012). 
However, although each antigen provides protection against several strains, one antigen 
could not elicit protection against all strains because either their antigen coding gene was 
not present or the antigen was difficult to access in a fraction of GBS (Maione et al., 2005). 
Therefore, screening a genome from a single strain is insufficient to identify the antigen 
combination eliciting protection against all strains (Maione et al., 2005). Since this successful 
identification of universal vaccine candidates in GBS, the multigenome reverse vaccinology 
approach has been employed in other human pathogenic Streptococcus, such as GAS, S. 
pyogenes and S. pneumonia (Sharma et al., 2012; Talukdar et al., 2014). 
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Fig. 1.3. A schematic workflow of the important steps of conventional and pan-genome reverse 
vaccinology approaches for vaccine development in this research.  
 
1.1.11. The Pan-genome concept 
The rapid advance and reduced cost of next generation sequencing technologies and 
bioinformatics have led to extensive whole-genome sequencing efforts with 1000s of draft 
bacterial genomes now publicly available to facilitate understanding of diversity, virulence 
and metabolic pathways (Muzzi et al., 2007; Seib et al., 2012). These are now being 
employed in vaccine research and development approaches such as reverse vaccinology 
(Muzzi et al., 2007; Rappuoli, 2001; Seib et al., 2012). However, looking at the genome of a 
single clonal complex of a bacterial species is not enough to explore a bacterial species 
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(Medini et al., 2005). Recently, Tettelin et al. (2005) analyzed eight genome sequences of 
GBS belonging to different serotype and found out that eight GBS strains contains 2713 
genes, 1806 genes being shared by all strains while any number of the 907 total remaining 
genes are absent in some strains (Tettelin et al., 2005). The group of shared genes is called 
the “core genome” and they are likely to be essential for basic survival, the group of variable 
genes is called the “dispensable” or “accessory” genome and comprises specialisations for 
niche or host adaptation. Genes that are only present in one isolate are called strain-specific 
genes. Together, the core and accessory genomes from multiple representative strains with 
a bacterial species complex make up the “pan-genome” and should describe the complete 
gene set for a particular bacterial species (Medini et al., 2005; Muzzi et al., 2007; Tettelin et 
al., 2005).  
 
Whilst a bacterial species should be fully described by applying the pan-genome (Tettelin et 
al., 2005), according to Tettelin et al. (2005), the pan-genome of GBS will increase by an 
average of 33 new genes each time new genome sequences are introduced, therefore, the 
GBS pan-genome is still an “open” pan-genome (Tettelin et al., 2005). This “open” pan-
genome mode was consistent when whole-genome sequences of five S. pyogenes were 
analyzed which resulted in the addition of about 27 new genes to the pan-genome every 
time the genome of a new strain was sequenced (Tettelin et al., 2005). In contrast, when 
the complete genomes of eight strains of Bacillus anthracis were analyzed, the number of 
novel genes added to the pan-genome decreased to zero after the fourth strain, so the 
species is considered to have a “closed” pan-genome (Muzzi et al., 2007; Tettelin et al., 
2005). It has been suggested that bacterial species which have an open pan-genome can 
colonise variable environments and have several mechanisms to exchange genetic material 
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like transformation (obtained genes from environment), transduction (virus delivers DNA) 
and conjugation exchange of DNA between bacteria (Medini et al., 2005). On the other hand, 
bacteria that live in limited niches and have poor capacity to acquire additional genetic 
material have a closed pan-genome (Medini et al., 2005; Tettelin et al., 2005). Therefore, 
although only four whole-genome sequences are enough to explore B. anthracis, larger 
numbers of complete genome sequences are required to fully describe GBS by pan-genome 
(Medini et al., 2005; Muzzi et al., 2007; Tettelin et al., 2005).  
 
1.1.12. The Pan-genome reveals niche specialisation of aquatic S. agalactiae 
Our previous work on classification of S. agalactiae by MLST revealed that all Australian S. 
agalactiae piscine strains belong to ST-261, which is consistent with previous studies on 
aquatic GBS (Delannoy et al., 2013). In addition, we have sequenced the whole-genomes 
from 23 S. agalactiae including 16 marine and seven terrestrial strains and compared with 
18 other assembled genomes involving human, bovine, camel and frog against virulence 
factors of S. agalactiae (Delamare Deboutteville, 2014). The results indicated that there has 
been substantial virulence factors reduction among ST-261 isolates from Australian fish 
(Fig. 1.4) (Delamare Deboutteville, 2014). Some inactivated genes encode for the proteins 
which contribute to bacterial adherence to host cells, one of the key steps in streptococcal 
pathogenesis (Delamare Deboutteville, 2014). For example, some components of pilus 
(Pilus 1 and 2), FbsA and B and laminin binding protein are not present in ST-261 strains in 
Australia (Fig. 1.4) (Delamare Deboutteville, 2014). On the other hand, six proteins which 
are specific to ST-261 were identified and may contribute to cell adhesion (Delamare 
Deboutteville, 2014). These include two serine-rich proteins anchored to the surface by 
LPXTG C-terminal motif, a membrane protein in the amidase family, a bacterial membrane 
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protein belonging to BibA family and two putative proteins with LPXTG motif (Delamare 
Deboutteville, 2014). Therefore, it has been hypothesised that these six proteins are 
important in pathogenesis of S. agalactiae in fish. These proteins will therefore be key initial 
targets in my current research. 
 
 
Fig. 1.4. Virulence factors of S. agalactiae created by BLAST ring image generator. The innermost ring 
(black) indicates GC content and GC skew (purple/green). The light blue inner rings indicate virulence 
factors of piscine strains belonging to ST-553, ST-260 and ST-261. The next rings with darker blue 
colour represent the strains ST-261 isolated from wild fish in Australia in previous study. Other rings 
show strains from different ST including terrestrial strains and human strains. The novel six adhesins 
are represented on the left side of the figure labeled as “ST-261 adhesins”. The figure obtained from 
93 94
Figure 3. BRIG output image of Streptococcus agalactiae virulence factors. Figure 3 shows a comparison of the total 
virulence factors of 47 GBS isolates (the full list of the isolates is described in Appendix 2). The innermost rings show 
GC content (black) and GC skew (purple/green). The remaining rings show BLAST comparisons of the virulence factors 
of 47 GBS isolates, with the ﬁrst seven innermost light blue rings showing piscine isolates from previous studies (ST-553, 
ST-260, ST-261), the next 16 dark blue rings between the two red circles are the piscine isolates from this study (ST-261), 
and the following 24 rings include terrestrial strains from this study and representative strains of the different sequence-
types retrieved from the database. Labels around the outside of the circular image correspond to the GBS virulence factors 
summarized by their functions with the name of the genes. Gaps within each concentric ring indicate that part or the entire 
gene is absent for this particular strain. The image is scaled to the nucleotide length of the genes. Long tick marks on the 
inner circumference of the ring indicate increments of 10 kilobase-pairs (kbp) and short tick marks indicate 2 kbp. Figure 
produced using BLAST Ring Image Generator (BRIG) (Alikhan et al., 2011).
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Delamare Deboutteville: On the origin of Group B Streptococcus from disease outbreaks in wild marine 
fish in Australia (Delamare Deboutteville, 2014). 
 
1.1.13. Importance of adhesion and adhesins as vaccine candidates 
Bacterial adherence to the host cell surface is the primary and most fundamental step in 
bacterial infection (Wizemann et al., 1999). Adhesins are proteins mediating bacterial 
attachment to the host (Wizemann et al., 1999). The interactions between adhesins and 
host surface receptors are specific and usually involve protein-carbohydrate lectin-like 
reactions, but sometimes involve protein-protein or carbohydrate-carbohydrate reactions 
(Nobbs et al., 2009). Attachment to specific surface receptors on the host cell prevents 
pathogens from being cleared by mucociliary defense mechanisms and determines bacterial 
tissue tropism (Wizemann et al., 1999). Without this step, the pathogen cannot colonise the 
tissue of the host so the infection would not progress, thus the pathogens cannot cause 
disease (Wizemann et al., 1999). Understanding adhesin interaction with the host is 
significant to understanding the pathogenesis of the bacteria since adhesins are contributing 
the adhesion, the first step of bacterial infection. Due to their ability to recognise invariant 
receptor on the host cell, they are highly conserved among all the pathogenic strains 
(Wizemann et al., 1999). Because of this unavoidable structural homology, adhesin have 
been targeted for vaccine development (Langermann et al., 1997; Wizemann et al., 1999). 
For example, antibodies against a Type 1 Fimbrial (FimH) adhesin, which is produced by 
most Escherichia coli and mediates binding to mannose-oligosaccharides, cross react with 
more than 90% of E. coli strains and prevent adhesion to bladder cells in vitro (Langermann 
et al., 1997). 
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Adhesins are key virulence factors in Streptococcus (Nobbs et al., 2009). The antigens I/II 
family of S. mutans were some of the earliest antigens determined to be adhesins in 
streptococci (Nobbs et al., 2009; Wizemann et al., 1999). These adhesins bind to 
glycoproteins in saliva and mediate the attachment to the surface of tooth (Wizemann et al., 
1999). Streptococci are capable of expression of multiple adhesins which allow them to 
adhere to and colonise different tissues (Nobbs et al., 2009).  
 
Although proteins which contribute to bacterial adherence such as M-like protein SiMA and 
FbsA failed to elicit protective immunity in fish, adhesin-based vaccines have continued to 
be developed against Streptococcus and have provided protection in other cases (Aviles et 
al., 2013; Khan and Pichichero, 2012; Margarit et al., 2009; Nobbs et al., 2009; Yi et al., 
2014). Pili are known to mediate attachment to the host cell in both Gram-positive and Gram-
negative pathogens and components of pili can elicit immune response (Margarit et al., 
2009). 
 
Streptococcus agalactiae human isolates from the US and Italy have conserved at least one 
of the three pilus islands and the combination of pilus components from those three islands 
elicited protection against more than 90% of GBS strains in the US and Italy (Margarit et al., 
2009). Margarit et al. (2009) demonstrated that a vaccine prepared from combination of 
recombinant pilus components is can elicit broad protection in mice against challenge with 
multiple S. agalactiae isolates (Margarit et al., 2009). Moreover, two proteins, which are 
components of the universal vaccine against S. agalactiae, showed pilus-like structures 
(Lauer et al., 2005; Maione et al., 2005). Other adhesins have also been shown to induce 
broad protection in mice. These include the Pneumococcal histidine triad protein D (PhtD) 
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and E (PhtE) surface proteins of S. pneumoniae (Khan and Pichichero, 2012), that are, 
characterized by a histidine triad motif, and belong to the highly conserved Pht protein family 
in pneumococci (Khan and Pichichero, 2012; Melin et al., 2010). Khan and Pichichero (2012) 
demonstrated that both PhtD and PhtE play important roles in mediating bacterial 
attachment to the human nasopharyngeal and lung epithelial cells and could elicit functional 
antibodies (Khan and Pichichero, 2012). 
 
Recently, a number of putative proteins, which were predicted to be adhesins, have been 
identified from complete genome sequence of S. iniae isolated from Japanese flounder 
(Zhang et al., 2014). Putative proteins such as fibrinogen-binding-like protein, serine-rich 
protein, alkaline amylopullulanase, agglutinin receptor, collagen-binding protein and 
laminin-binding protein have been predicted as adhesin in the isolate (Zhang et al., 2014). 
However, although these putative adhesins have been predicted to be antigenic, their 
abilities to induce protective immunity have yet to be tested (Zhang et al., 2014). Moreover, 
their universal conservation across the S. iniae pan-genome has not been determined. 
 
1.2. Aims 
This study will employ will generate a pan-genome to investigate into the genomic diversity 
of S. agalactiae and employ the pan-genome and reverse vaccinology approach to explore 
the protein antigens expressed on the surface of fish pathogenic GBS. Six adhesins, which 
have been identified in S. agalactiae piscine strain serotype Ib and ST-261 ND2-22 
(FO393392), were also found from Australian piscine strains. Therefore, it has been 
hypothesised that these six adhesins play important roles in pathogenesis of S. agalactiae 
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in fish. The goal of this research is to determine if these adhesins can be potential 
candidates for a universal vaccine against disease caused by S. agalactiae in fish.  
 
1.2.1. Aim 1: To explore the genomic diversity of S. agalactiae, particular interest in 
piscine strains, by using a pan-genome 
The pan-genome of S. agalactiae is well advanced, but it still lacks geographic coverage, 
from Latin America, Asia and Africa regions. We sequenced more genomes of S. agalactiae 
isolated from tilapia in Honduras and wild fish in Queensland. In addition to the new 
sequences, draft genome of piscine and terrestrial strains from Queensland from previous 
work (Delamare Deboutteville, 2014), Ghanaian piscine strains from public database 
(Verner-Jeffreys et al., 2017) and complete genomes available on NCBI database were 
used to generate the pan-genome. These sequences were also used to investigate the 
phylogenetic relationship. The resulting pan-genome was analysed and major virulence 
factors of S. agalactiae identified.  
 
1.2.2. Aim 2: Characterization of ST-261 adhesins and to determine the level of 
adhesins expression in different conditions  
The six proteins identified in ST-261 strains were predicted as adhesins in previous studies 
(Delamare Deboutteville, 2014; Rosinski-Chupin et al., 2013). Their domain structures were 
analysed by in silico to examine their possible roles in fish pathogenesis. Two types of 
vaccines, whole-cell and recombinant vaccines were prepared to investigate if these 
adhesins can induce antibodies production in tilapia, O. mossambicus, to obtain antibodies. 
To prepare the whole-cell vaccine that express high level of adhesins and low level of CPS, 
bacteria were grown in different conditions and real-time quantitative reverse transcription 
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polymerase chain reaction (qRT-PCR) was employed to determine such condition. The 
antibodies obtained will be used to confirm the expression of adhesins in the determined 
condition.  
 
1.2.3. Aim 3: To investigate if the adhesins are able to elicit a cross-protective immune 
responses against different S. agalactiae serotypes by experimental infection in 
tilapia  
Adhesins have been shown to be highly antigenic as potential vaccine candidates that can 
elicit protection to the host against pathogens (Maione et al., 2005; Margarit et al., 2009; 
Wizemann et al., 1999). However, although the adhesins successfully induce specific 
antibodies, the antibodies might not elicit protection against bacteria (Aviles et al., 2013; Yi 
et al., 2014). Both M-like protein SiMA and FbsA have been demonstrated to evoke antibody 
responses but did not confer protective immunity to fish against challenges (Aviles et al., 
2013; Yi et al., 2014). Therefore, an animal challenge model is required to confirm if the 
adhesin-based vaccines against S. agalactiae are effective to confer broad protection to fish 
against multiple strains of S. agalactiae.  
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Chapter 2: Microevolution of aquatic Streptococcus agalactiae ST-261 from Australia 
indicates dissemination via imported tilapia and ongoing adaptation to marine hosts 
or environment 
 
Abstract 
Streptococcus agalactiae (group B Streptococcus; GBS) causes disease in a wide range of 
animals. The serotype Ib lineage is highly adapted to aquatic hosts, exhibiting substantial 
genome reduction compared with terrestrial conspecifics. Here, we sequence genomes from 
40 GBS isolates, including 25 isolates from wild fish and captive stingrays in Australia, six 
local veterinary or human clinical isolates, and nine isolates from farmed tilapia in Honduras, 
and compared them with 42 genomes from public databases. Phylogenetic analysis based 
on non-recombinant core genome single nucleotide polymorphisms (SNPs) indicated that 
aquatic serotype Ib isolates from Queensland were distantly related to local veterinary and 
human clinical isolates. In contrast, Australian aquatic isolates are most closely related to a 
tilapia isolate from Israel, differing by only 63 core-genome SNPs. A consensus minimum 
spanning tree based on core-genome SNPs indicates the dissemination of sequence type 
261 (ST-261) from an ancestral tilapia strain, which is congruent with several introductions 
of tilapia into Australia from Israel during the 1970s and 1980s. Pan-genome analysis 
identified 1,440 genes as core, with the majority being dispensable or strain specific, with 
non-protein-coding intergenic regions (IGRs) divided among core and strain-specific genes. 
Aquatic serotype Ib strains have lost many virulence factors during adaptation, but six 
adhesins were well conserved across the aquatic isolates and might be critical for virulence 
in fish and for targets in vaccine development. The close relationship among recent ST-261 
isolates from Ghana, the United States, and China with the Israeli tilapia isolate from 1988 
 58 
implicates the global trade in tilapia seed for aquaculture in the widespread dissemination 
of serotype Ib fish-adapted GBS. 
 
2.1. Introduction 
Streptococcus agalactiae, or Lancefield group B Streptococcus (GBS), is a commensal and 
occasionally pathogenic bacterium with a very diverse host range. A common commensal 
in the urogenital tracts of humans, GBS is also a leading cause of morbidity in newborns 
causing meningitis, septicemia, and pneumonia (Brochet et al., 2006; Doumith et al., 2017; 
Edwards and Gonik, 2013; Six et al., 2015). Streptococcus agalactiae can cause septicemic 
infections in cattle, domestic dogs and cats, camels, reptiles, and amphibians (Bowater et 
al., 2012; Delamare-Deboutteville et al., 2015; Elliott et al., 1990; Evans et al., 2002). In fish, 
disease outbreaks caused by S. agalactiae have substantial impact on the aquaculture 
industry, particularly on the production of warm freshwater species, such as tilapia 
(Oreochromis spp.) (Chen et al., 2012; Li et al., 2016; Verner-Jeffreys et al., 2017; Zhang et 
al., 2013). Most outbreaks to date in freshwater farmed fish have resulted from infection by 
highly adapted strains of GBS with genomes that are 10 to 15% smaller than their terrestrial 
conspecifics (Rosinski-Chupin et al., 2013). Unusually, S. agalactiae also causes significant 
mortality in wild aquatic animals, including grouper, stingrays, and mullet (Delamare-
Deboutteville et al., 2015), suggesting further adaptation to marine and freshwater aquatic 
hosts. 
 
Microevolution within a bacterial species can be driven by host or environmental adaptation 
(Brynildsrud et al., 2014; Rosinski-Chupin et al., 2013), permitting an inference of the 
epidemiology of disease outbreaks and how pathogens may have transferred within and 
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between geographic regions (Barnes et al., 2016; Brynildsrud et al., 2014; Sabat et al., 2013). 
This requires an analysis of factors that evolve at a sufficiently rapid pace to be informative 
over relatively short timespans. In GBS, capsular serotyping either with antibodies or by 
molecular serotyping (i.e., sequencing of the capsular operon) has become a widely used 
method of typing for population studies (Carvalho-Castro et al., 2017; Jones et al., 2003; 
Kapatai et al., 2017; Kong et al., 2002), and currently, S. agalactiae can be divided into 10 
capsular serotypes (Ia, Ib, and II to IX) (Carvalho-Castro et al., 2017; Sheppard et al., 2016). 
Determining capsular serotypes is also critical for vaccine formulation, since capsular 
polysaccharide (CPS) is highly immunogenic, and antibodies against CPS can confer 
excellent protection against infections by the homologous CPS serotype (Eldar et al., 1995a; 
Evans et al., 2004; Kapatai et al., 2017). Further typing resolution is provided by multilocus 
sequence typing (MLST), a method that has been employed to great effect to conduct global 
population studies of isolates based on genetic variations among relatively slowly evolving 
housekeeping genes (Jones et al., 2003). Combining molecular serotyping and MLST in the 
analysis of S. agalactiae revealed that the majority of isolates associated with aquatic 
environments and hosts fall within serotypes Ia and Ib, in which Ia isolates belong to 
sequence type 7 (ST-7) in clonal complex 7 (CC-7) and ST-103 in CC-103 (Carvalho-Castro 
et al., 2017; Chong et al., 2017; Evans et al., 2008; Godoy et al., 2013a; Kannika et al., 
2017; Sun et al., 2016; Zhang et al., 2013). Serotype Ib strains isolated in Central and South 
America are ST-260 and ST-552 in CC-552 (Delannoy et al., 2013; Godoy et al., 2013a), 
and strains isolated in Australia, Israel, Belgium, China, Ghana, the United States, and 
Southeast Asia belong to ST-261 (Bowater et al., 2012; Delamare-Deboutteville et al., 2015; 
Delannoy et al., 2013; Lusiastuti et al., 2014; Pridgeon and Zhang, 2014; Rosinski-Chupin 
et al., 2013; Verner-Jeffreys et al., 2017). Serotype III is commonly causative of disease in 
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humans but has also been isolated from fish in Thailand, China, and recently, Brazil 
(Chideroli et al., 2017; Kannika et al., 2017; Li et al., 2013; Suanyuk et al., 2008). 
 
While capsular serotyping and MLST have been useful in inferring the origins and dispersal 
of GBS subtypes, they do not display sufficient resolution to explore the spread and 
evolution within individual sequence types, nor can they reflect the complete genetic 
diversity of S. agalactiae (Tettelin et al., 2005). The rapid fall in the cost of whole genome 
sequencing coupled with multiplexing and rapid development of open-source bioinformatics 
tools has permitted a much deeper analysis of evolution, host adaptation, and 
epidemiological modeling within a single bacterial species (Francis and Tanaka, 2012), 
including those from aquatic hosts (Barnes et al., 2016; Brynildsrud et al., 2014). Bacteria, 
such as S. agalactiae, that can colonize multiple host species often have greater genomic 
intraspecies diversity (Puymège et al., 2015). In GBS, two major evolutionary trends have 
been implicated in rapid adaptation to new hosts, namely, the acquisition of new genes by 
lateral gene transfer and genome reduction via gene loss integral to host specialization 
(Richards et al., 2014; Rosinski-Chupin et al., 2013). For example, S. agalactiae Ia strains 
GD201008-001 and ZQ0910, isolated from tilapia in China, carry a 10-kb genomic island 
(GI) which is absent from their closely related human isolate A909. Moreover, this 10-kb GI 
bears many similarities with the Streptococcus anginosus SK52/DSM 20563 genome 
sequence, suggesting possible transfer from S. anginosus to GBS, with implications for 
virulence in tilapia (Liu et al., 2013; Rosinski-Chupin et al., 2013). During fish host adaptation, 
serotype Ib strains have undergone reductive evolution, resulting in 10 to 25% of their 
genomes being lost compared to terrestrial S. agalactiae isolates and serotype Ia piscine 
strain (Rosinski-Chupin et al., 2013). The evolution of S. agalactiae by genome reduction is 
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an ongoing process, with a high number of pseudogenes present in GBS genomes from 
aquatic sources (Rosinski-Chupin et al., 2013).  
 
The evolution of S. agalactiae and adaptation to aquatic hosts is an incomplete and ongoing 
process; consequently, sequencing the genomes from a few isolates is insufficient to 
understand the full potential genetic diversity of S. agalactiae as a species (Tettelin et al., 
2005). The pan-genome or supragenome of a bacterial species defines the full complement 
of genes, or the union of all the gene sets, within the species (Tettelin et al., 2005). This 
pan-genome is subdivided into its core genome, which includes all the genes that are 
present in all the strains of the same bacterial species and must therefore be responsible 
for essential biological functions to allow the species to survive, and the accessory genome, 
containing species-specific genes that are unique to single strains or constrained to a cohort 
of strains within the species; these genes contribute to the diversity makeup of the species. 
The pan genome of a species resolves the true genomic diversity of that species and permits 
the identification of gene cohorts that are essential to the species as a whole, along with 
gene complements in the accessory genome that permit host or habitat specialization 
(Tettelin et al., 2005). Moreover, by identifying potential antigens within the pan-genome that 
are conserved across all strains that infect a particular host type, vaccine targets can be 
specified that are likely to cross-protect (He et al., 2017; Tettelin et al., 2005). Indeed, the 
first multicomponent protein-containing universal vaccine against human S. agalactiae was 
developed using a pan-genome reverse-vaccinology approach by analysing eight human 
isolates to predict putative antigens that were conserved among those strains (Maione et al., 
2005). Some antigens in this vaccine are in the accessory genome; consequently it is 
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important to analyze the dispensable genome as far as possible for vaccine development 
(Maione et al., 2005; Tettelin et al., 2005).  
 
The S. agalactiae pan-genome is now well advanced but still “open” (i.e., new genes 
continue to be added with more sequenced genomes) and geographically constrained (He 
et al., 2017; Tettelin et al., 2005). In the present study, we sequenced the genomes of new 
aquatic S. agalactiae strains isolated from tilapia in Honduras and from wild and captive 
marine fish in Australia. We infer the potential epidemiological distribution of ST-261 in 
aquatic hosts in Australia and show continuing adaptation to saltwater fish. Moreover, we 
identify conserved surface proteins across ST-260 and ST-261 that may have potential for 
incorporation into vaccines for aquaculture of important food fish species, such as tilapia 
and grouper.  
 
2.2. Materials and Methods 
2.2.1. Bacterial strains and culture conditions 
Forty S. agalactiae isolates comprising strains collected from fish in Honduras and Australia, 
along with reptiles, humans, and other terrestrial mammals from Australia, were chosen for 
sequencing (Table 2.1). Of these 40 isolates, 25 strains were collected from several species 
of fish in Queensland, Australia, two human clinical strains were from Queensland, Australia, 
one strain was isolated from saltwater crocodile (Crocodylus porosus) in the Northern 
Territory, Australia, and three isolates were collected from domestic animals, including cats, 
dogs, and cattle in Australia. Additionally, nine isolates originating from disease in farmed 
tilapia in Honduras were sequenced during this study. All isolates were maintained at -80°C 
in Todd-Hewitt broth (THB) (Oxoid) containing 25% glycerol as frozen stock. The isolates 
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were recovered from stock on Columbia agar containing 5% sheep blood (Oxoid) for 24 h 
at 28°C. For liquid culture, the isolates were grown in THB or 18 h with low agitation at 28°C. 
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Table 2.1. S. agalactiae isolates and sequences used in this study. 
Isolate Origin Year Host Serotype ST Size 
(Mbp) 
Accession 
number 
Assembly 
levels 
QMA0264 QLD, AU 2008 Epinephelus lanceolatus Ib 261 1.8 SAMN07998566 Contig 
QMA0266 QLD, AU 2008 Epinephelus lanceolatus Ib 261 1.8 SAMN07998567 Contig 
QMA0267 QLD, AU 2008 Epinephelus lanceolatus Ib 261 1.8 SAMN07998568 Contig 
QMA0268 QLD, AU 2009 Pomadasys kaaken Ib 261 1.8 SAMN07998569 Contig 
QMA0271 QLD, AU 2009 Arius thalassinus Ib 261 1.8 SAMN07998570 Complete 
QMA0273 QLD, AU 2009 Arius thalassinus Ib 261 1.8 SAMN07998571 Contig 
QMA0274 QLD, AU 2009 Liza vaigensis Ib 261 1.8 SAMN07998572 Contig 
QMA0275 QLD, AU 2009 Aptychotrema rostrata Ib 261 1.8 SAMN07998573 Contig 
QMA0276 QLD, AU 2009 Himantura granulata Ib 261 1.8 SAMN07998574 Contig 
QMA0277 QLD, AU 2009 Dasyatis fluviorum Ib 261 1.8 SAMN07998575 Contig 
QMA0280 QLD, AU 2010 Epinephelus lanceolatus Ib 261 1.8 SAMN07998576 Contig 
QMA0281 QLD, AU 2010 Epinephelus lanceolatus Ib 261 1.8 SAMN07998577 Contig 
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QMA0284 QLD, AU 2010 Epinephelus lanceolatus Ib 261 1.8 SAMN07998578 Contig 
QMA0285 QLD, AU 2010 Epinephelus lanceolatus Ib 261 1.8 SAMN07998579 Contig 
QMA0287 QLD, AU 2010 Pomadasys kaaken Ib 261 1.8 SAMN07998580 Contig 
QMA0290 QLD, AU 2010 Arius thalassinus Ib 261 1.8 SAMN07998581 Contig 
QMA0292 QLD, AU 2010 Aptychotrema rostrata Ib 261 1.8 SAMN07998582 Contig 
QMA0294 QLD, AU 2010 Epinephelus lanceolatus Ib 261 1.8 SAMN07998583 Contig 
QMA0320 QLD, AU 2010 Dasyatis fluviorum Ib 261 1.8 SAMN07998584 Contig 
QMA0321 QLD, AU 2010 Dasyatis fluviorum Ib 261 1.8 SAMN07998585 Contig 
QMA0323 QLD, AU 2010 Dasyatis fluviorum Ib 261 1.8 SAMN07998586 Contig 
QMA0326 QLD, AU 2010 Dasyatis fluviorum Ib 261 1.8 SAMN07998587 Contig 
QMA0347 QLD, AU 2010 Dasyatis fluviorum Ib 261 1.8 SAMN07998588 Contig 
QMA0368 QLD, AU 2010 Epinephelus lanceolatus Ib 261 1.8 SAMN07998589 Contig 
QMA0369 QLD, AU 2011 Epinephelus lanceolatus Ib 261 1.8 SAMN07998590 Contig 
QMA0485 Honduras 2014 Oreochromis niloticus Ib 260 1.8 SAMN07998597 Contig 
QMA0487 Honduras 2014 Oreochromis niloticus Ib 260 1.8 SAMN07998598 Contig 
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QMA0488 Honduras 2014 Oreochromis niloticus Ib 260 1.8 SAMN07998599 Contig 
QMA0489 Honduras 2014 Oreochromis niloticus Ib 260 1.8 SAMN07998600 Contig 
QMA0494 Honduras 2014 Oreochromis niloticus Ib 260 1.8 SAMN07998601 Contig 
QMA0495 Honduras 2014 Oreochromis niloticus Ib 260 1.8 SAMN07998602 Contig 
QMA0496 Honduras 2014 Oreochromis niloticus Ib 260 1.8 SAMN07998603 Contig 
QMA0497 Honduras 2014 Oreochromis niloticus Ib 260 1.8 SAMN07998604 Contig 
QMA0499 Honduras 2014 Oreochromis niloticus Ib 260 1.8 SAMN07998605 Contig 
QMA0355 QLD, AU 2011 Homo sapiens Ia 23 2.0 SAMN07998591 Contig 
QMA0357 QLD, AU 2011 Homo sapiens Ia 23 2.0 SAMN07998592 Contig 
QMA0336 NT, AU 2005 Crocodylus porosus Ia 23 2.0 SAMN07998593 Contig 
QMA0300 QLD, AU 2008 Canis lapis familiaris V 1 2.1 SAMN07998594 Contig 
QMA0303 QLD, AU 2009 Felis catus V 1 2.1 SAMN07998595 Contig 
QMA0306 QLD, AU 2005 Bos taurus V 1 2.2 SAMN07998596 Contig 
GS16-0008 Ghana 2016 Oreochromis niloticus Ib 261 1.8 SRX2698682 Contig 
GS16-0031 Ghana 2016 Oreochromis niloticus Ib 261 1.8 SRX2698681 Contig 
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GS16-0035 Ghana 2016 Oreochromis niloticus Ib 261 1.8 SRX2698680 Contig 
GS16-0046 Ghana 2016 Oreochromis niloticus Ib 261 1.8 SRX2698679 Contig 
ND2-22 Israel 1988  Oreochromis niloticus Ib 261 1.8 FO393392 Complete  
138P USA 2007 Oreochromis niloticus Ib 261 1.8 CP007482 Complete  
138spar USA 2011 Oreochromis niloticus Ib 261 1.8 CP007565.1 Complete  
GX026 China 2011 Oreochromis niloticus Ib 261 1.8 CP011328.1 Complete  
S13 Brazil 2015 Oreochromis niloticus Ib 552 1.8 CP018623.1 Complete  
S25 Brazil 2015 Oreochromis niloticus Ib 552 1.8 CP015976.1 Complete  
SA20 Brazil   Oreochromis niloticus Ib 552*** 1.8 CP003919.2 Complete  
GD201008-001 China 2010 Oreochromis niloticus Ia 7 2.1  NC_018646.1 Complete  
HN016 China 2011 Oreochromis niloticus Ia 7 2.1 NZ_CP011325.1 Complete  
WC1535 China 2015 Oreochromis niloticus Ia 7 2.2 NZ_CP016501.1 Complete  
A909 USA   Homo sapiens Ia 7 2.1 NC_007432.1 Complete  
GBS85147 Brazil   Homo sapiens Ia 103 2.0 NZ_CP010319.1 Complete  
Sag37 China 2014 Homo sapiens Ib* 12 2.2 NZ_CP019978.1 Complete  
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GBS1-NY USA 2012 Homo sapiens II 22 2.2  NZ_CP007570.1 Complete  
GBS2_NM USA 2012 Homo sapiens II 22 2.2 NZ_CP007571.1 Complete  
GBS6 USA 2009 Homo sapiens II 22 2.2 NZ_CP007572.1 Complete  
FDAARGOS_254 USA 2014 Homo sapiens II* 22 2.2 CP020449.1 Complete  
COH1 USA   Homo sapiens III 17 2.1 NZ_HG939456.1 Complete  
NEM316 France   Homo sapiens III 23 2.2 NC_004368.1 Complete  
CU_GBS_08 Hong Kong 2008 Homo sapiens III 283 2.1 NZ_CP010874.1 Complete  
CU_GBS_98 Hong Kong 1998 Homo sapiens III 283 2.0 NZ_CP010875.1 Complete  
NGBS128 Canada 2010 Homo sapiens III 17 2.1 NZ_CP012480.1 Complete  
SG-M1 Singapore 2015 Homo sapiens III 283 2.1 NZ_CP012419.2 Complete  
H002 China 2011 Homo sapiens III 736 2.1  NZ_CP011329.1 Complete  
Sag158 China 2014 Homo sapiens III* 19 2.1 NZ_CP019979.1 Complete  
NGBS061 Canada 2010 Homo sapiens IV 459 2.2 NZ_CP007631.1 Complete  
NGBS572 Canada 2012 Homo sapiens IV 452 2.1 NZ_CP007632.1 Complete  
2603V/R USA   Homo sapiens V 110 2.2  NC_004116.1 Complete  
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CNCTC10/84 USA   Homo sapiens V 26 2.0 NZ_CP006910.1 Complete  
NGBS357 Canada 2011 Homo sapiens V 1 2.2 NZ_CP012503.1 Complete  
SS1 USA 1992 Homo sapiens V 1 2.1 NZ_CP010867.1 Complete  
GBS-M002 China 2014 Homo sapiens VI* 1 2.1 NZ_CP013908.1 Complete  
SA111 Portugal 2013 Homo sapiens II* 61** 2.3 NZ_LT545678.1 Complete  
FWL1402 China 2014 
Hoplobatrachus 
chinensis 
III* 739** 2.1 NZ_CP016391.1 Complete 
09mas018883 Sweden   Bos taurus V* 1 2.1 NC_021485.1 Complete  
GBS ST-1 USA 2015 Canis lupus familiaris V 1 2.2 NZ_CP013202.1 Complete  
ILRI005 Kenya   Camelus dromedarius V* 609 2.1  NC_021486.1 Complete  
ILRI112 Kenya   Camelus dromedarius VI* 617 2.0 HF952106.1 Complete  
AU, Australia; QLD, Queensland; NT, Northern Territory; ST, Sequence Type.  
*Serotype was detected with Kaptive.  
** ST was determined via Center for Genomic Epidemiology.  
*** Gap in glcK. 
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Table 2.2. Genome assembly statistics. 
Strain BioSample no. Sequence yield 
(bp) 
No. of 
contigs 
Genome size 
(bp) 
GC content 
(%) 
N50 (bp) Coverage (x) 
QMA0264 SAMN07998566 383,903,016 26 1,800,255 35.27 181,173 213 
QMA0266 SAMN07998567 383,903,016 23 1,799,604 35.26 181,173 213 
QMA0267 SAMN07998568 822,647,364 22 1,805,121 35.33 181,785 456 
QMA0268 SAMN07998569 541,821,504 22 1,796,834 35.25 130,961 302 
QMA0271 SAMN07998570 488,654,460 1 1,802,470 35.28 1,802,470 271 
QMA0273 SAMN07998571 488,596,752 26 1,799,223 35.26 181,173272 272 
QMA0274 SAMN07998572 666,932,868 33 1,795,949 35.23 91,064 371 
QMA0275 SAMN07998573 444,271,968 28 1,798,598 35.26 129,867 247 
QMA0276 SAMN07998574 595,443,828 30 1,801,706 35.28 101,410 330 
QMA0277 SAMN07998575 532,021,392 30 1,794,975 35.23 125,723 296 
QMA0280 SAMN07998576 507,086,244 26 1,798,991 35.26 130,981 282 
QMA0281 SAMN07998577 947,517,396 28 1,795,694 35.26 130,961 528 
 71 
QMA0284 SAMN07998578 870,597,252 27 1,804,787 35.3 129,871 482 
QMA0285 SAMN07998579 946,715,952 25 1,798,637 35.26 181,149 526 
QMA0287 SAMN07998580 744,380,280 27 1,799,347 35.27 130,969 414 
QMA0290 SAMN07998581 1,059,786,168 24 1,804,000 35.3 181,153 587 
QMA0292 SAMN07998582 383,835,312 22 1,800,208 35.26 181,172 213 
QMA0294 SAMN07998583 807,742,572 24 1,800,272 35.26 181,172 449 
QMA0300 SAMN07998584 703,661,784 33 2,109,161 35.25 115,466 334 
QMA0303 SAMN07998585 949,167,156 42 2,123,226 35.05 94,602 447 
QMA0306 SAMN07998586 745,047,660 106 2,165,975 35.52 40,135 344 
QMA0320 SAMN07998587 445,338,936 30 1,804,060 35.3 181,347 247 
QMA0321 SAMN07998588 406,041,552 22 1,800,073 35.26 181,173 226 
QMA0323 SAMN07998589 487,351,368 22 1,800,031 35.26 181,173 271 
QMA0326 SAMN07998590 847,046,508 22 1,800,125 35.26 181,173 471 
QMA0336 SAMN07998591 437,035,536 37 2,022,886 35.26 87,595 216 
QMA0347 SAMN07998592 942,292,680 21 1,795,434 35.23 181,173 525 
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QMA0355 SAMN07998593 903,514,248 66 1,996,200 35.31 63,524 453 
QMA0357 SAMN07998594 564,675,720 35 2,004,249 35.23 92,563 282 
QMA0368 SAMN07998595 506,471,448 26 1,803,560 35.3 104,282 281 
QMA0369 SAMN07998596 1,056,496,560 28 1,804,404 35.3 130,985 586 
QMA0485 SAMN07998597 490,192,752 28 1,803,278 35.27 109,741 272 
QMA0487 SAMN07998598 467,765,088 28 1,800,682 35.25 109,741 260 
QMA0488 SAMN07998599 356,791,512 29 1,800,616 35.25 109,741 198 
QMA0489 SAMN07998600 432,449,472 28 1,801,015 35.25 109,741 240 
QMA0494 SAMN07998601 363,434,736 37 1,792,992 35.28 71,935 203 
QMA0495 SAMN07998602 412,230,672 28 1,803,007 35.27 109,741 229 
QMA0496 SAMN07998603 499,707,096 29 1,801,879 35.27 109,737 277 
QMA0497 SAMN07998604 364,009,464 28 1,800,976 35.25 109,741 202 
QMA0499 SAMN07998605 428,636,208 28 1,799,426 35.24 109,741 238 
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2.2.2. DNA extraction and sequencing 
Genomic DNA (gDNA) was extracted from 10-ml early stationary phase THB cultures with 
the DNeasy minikit (Qiagen), according to the manufacturer’s instructions. The quantity of 
extracted DNA was measured by Qubit fluorimetry (Invitrogen), and the quality was checked 
by agarose gel electrophoresis. To confirm the purity of the gDNA, the 16S rRNA gene was 
amplified by PCR using universal primers 27F and 1492R (Amann et al., 1995), and the 
PCR products were sent to Australian Genome Research Facility (AGRF, Brisbane, 
Australia) for Sanger sequencing. The 16S amplicon sequences were assembled in 
Sequencher version 5.2.2 and analyzed by BLAST. Once identity and purity were confirmed, 
Nextera XT paired-end libraries were generated using gDNA from each isolate and 
sequenced on the Illumina HiSeq 2000 platform system (AGRF, Melbourne, Australia). 
 
2.2.3. De novo assembly and annotation 
Illumina sequencing yielded between 5,288,952 and 12,577,340 read pairs for each strain. 
Read quality control and contaminant screening were performed using FastQC (Andrews, 
2010). Reads were trimmed using the clip function in Nesoni (https://github.com/Victorian-
Bioinformatics-Consortium/nesoni) and then assembled de novo with SPAdes assembler 
version 3.11 (Bankevich et al., 2012). Assemblies were quality checked using Quast version 
4.6 (Bankevich et al., 2012). The assemblies of fish isolates in Queensland comprised about 
1.8 million base pair (Mbp) of assembled sequence, while terrestrial strains comprised 2 
Mbp. The assembled contigs for all Queensland strains were reordered against an internal 
curated reference genome from S. agalactiae strain QMA0271, using the Mauve contig 
ordering tool (Rissman et al., 2009). Automated annotation was performed using Prokka 
1.12 (Seemann, 2014).  
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2.2.4. Molecular serotyping and multilocus sequence typing (MLST) 
Reference sequences for the nine CPS serotypes Table 2.3 (Sheppard et al., 2016) were 
retrieved from GenBank to generate a database for prediction of capsular serotype from the 
draft genomes with Kaptive, using default settings (Wyres et al., 2016). To determine 
multilocus sequence types (MLST), all draft assemblies were analysed using the Center for 
Genomic Epidemiology web-tools MLST ver. 1.8, using S. agalactiae configuration (see 
https://cge.cbs.dtu.dk//services/MLST/ ) (Larsen et al., 2012).  
 
Table 2.3. Reference sequences used for molecular capsular serotyping.  
Serotype Accession 
Number 
Size 
(bp) 
Reference 
Ia AB028896.2 25021 (Yamamoto et al., 1999) 
Ib AB050723.1 9987 (Watanabe et al., 2002) 
II EF990365.1 12864 (Martins et al., 2007) 
III AF163833.1 17276 (Chaffin et al., 2000) 
IV AF355776.1 17596 (Chaffin et al., 2002) 
V AF349539.1 18239 (Chaffin et al., 2002) 
VI AF337958.1 16448 (Chaffin et al., 2002) 
VII AY376403.1 14202 (Cieslewicz et al., 2005) 
VIII AY375363.1 12637 (Cieslewicz et al., 2005) 
 
2.2.5. Phylogenetic analysis 
To estimate approximate phylogenetic relationships among our strains and other isolates 
with whole genome sequences available in GenBank (Table 2.1), a core genome single 
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nucleotide polymorphism SNP-based phylogenetic tree was constructed. Whole genome 
sequences of Queensland and Honduras tilapia isolates, terrestrial isolates and the 
genomes obtained from GenBank were aligned with Parsnp in the Harvest Tools suite 
version 1.2 (Treangen et al., 2014). The genome of Streptococcus pyogenes M1 (Group A 
Streptococcus; GAS) (RefDeq accession number NC_002737.2) was also included as an 
outgroup for tree rooting. Hypothetical recombination sites in the core genome alignment 
were detected and filtered out with Gubbins (Croucher et al., 2015). Maximum likelihood 
phylogenetic trees were inferred with RAxML version 8.2.9 (Stamatakis, 2014) based on 
non-recombinant core genome SNPs under general time-reversible (GTR) nucleotides 
substitution model, with 1000 bootstrap replicates. Ascertainment bias associated with 
analysis of only variable sites was accounted for using Felsenstein’s correction implemented 
in RAxML (Stamatakis, 2014). The resulting tree was exported and rooted, nodes with low 
bootstrap supported collapsed with Dendroscope, and the resulting tree/cladogram 
annotated with Evolview version 2 (He et al., 2016).  
 
In order to infer possible phylogenetic relationships within the aquatic ST-261 clade of GBS, 
minimum spanning trees were constructed in MSTGold 2.4 (Salipante and Hall, 2011) from 
a distance matrix based on core genome SNPs derived by alignment of 27 ST-261 genomes 
in Geneious V9.1 (Biomatters Inc.). A consensus tree was constructed based on inference 
of 2400 trees and only those edges occurring in greater than 50% of trees were included in 
the consensus. 
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2.2.6. Pan-genome analysis 
A reference pan-genome was built with GView server (Petkau et al., 2010) using our 
curated genome of Queensland ST-261 serotype Ib grouper isolate, QMA0271 as a seed 
and 38 complete genomes from public databases added sequentially (Table 2.1). Only 
complete genomes were included into the reference pan-genome to avoid incomplete 
genes associated with the high fragmentation of draft sequences. For visualisation, draft 
and complete genomes were compared with the reference pan-genome using BLAST ring 
image generator (BRIG) 0.95 (Alikhan et al., 2011). To investigate core and accessory 
protein-coding genes, sequences from all strains were analysed with Roary (Page et al., 
2015) using default settings. Since Roary only considers protein-coding sequences, we 
used Piggy (Thorpe et al., 2017) to identify non protein-coding intergenic regions (IGRs) in 
each strain, which comprise about 15% of the GBS genomes. The 1,539 strain-specific 
IGR sequences identified in Piggy were then extracted from the representative merged 
clusters of IGR sequences and used as query sequences in a local BLASTn analysis (E 
value 1e_10) against all the coding sequences in the pan-genome. The output from the 
BLAST search was tabulated and analyzed further in Microsoft Excel.  
 
2.2.7. Identification and comparison of virulence factors 
Virulence factor screening was performed using SeqFindr (Stanton-Cook et al., 2013) by 
comparing the assembled genomes of all strains in this study along with the genomes 
available through GenBank (Table 2.1) against a list of 51 S. agalactiae-specific virulence 
factors sequences collected from the Virulence Factors Database (VFDB) (Chen et al., 
2005), complemented by six additional sequences identified in the sequenced ST-261 S. 
agalactiae strain ND2-22 (Table 2.1). 
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2.2.8. Analysis of effects of SNPs in ST-261 clade 
Putative effects of SNPs amongst and between the ST-261 clade were determined using 
SNPeff version 4.3p (Cingolani et al., 2012). First, a new S. agalactiae database was 
constructed from the Genbank-formatted curated reference genome for QMA0271, in 
accordance with the manual (http://snpeff.sourceforge.net/SnpEff_manual.html#databases). 
Then a VCF file, generated from curated SNPs generated by alignment of complete 
genomes of 27 ST-261 isolates in Geneious version 9.1, was annotated for SNP effect with 
SNPeff using the database from QMA0271 as reference. 
 
2.2.9. Accession numbers 
The accession numbers for genome assemblies used in this study are presented with strain 
metadata in Table 2.1. The assembly statistics and BioSample numbers are in Table 2.2.  
 
2.3. Results and Discussion 
2.3.1. Group B Streptococcus isolates from marine fish and rays in Queensland and tilapia 
in Honduras belong to differing host-adapted lineages 
The average size of draft genomes of isolates from fish and rays in Queensland was 
1,801,022 bp, containing 1,881 genes on average, while the mean genome size of strains 
from Honduran tilapia was 1,801,133 bp with an average of 1,869 genes, consistent with 
the small genomes associated with the host-adapted aquatic lineage (Rosinski-Chupin et 
al., 2013) (Table 2.1 and 2.2). Molecular serotyping indicated that all Queensland and 
Honduras aquatic strains belong to serotype Ib, but Queensland isolates belong to ST-261 
while Honduras strains are ST-260. Both ST-260 and ST-261 have been identified infecting 
aquatic animals. Sequence type 261 isolates have been isolated from tilapia in Brazil and 
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Costa Rica occupy CC-552, along with ST-552 and ST-553 strains also isolated from tilapia 
in Latin America (Godoy et al., 2013a), whilst ST-261 has been isolated from tilapia in USA, 
China, Ghana and Israel (Pridgeon and Zhang, 2014; Rosinski-Chupin et al., 2013; Verner-
Jeffreys et al., 2017).  
 
The aquatic isolates analysed herein extend the known host range of GBS ST-261 to rays 
and marine finfish and expand the environmental distribution from freshwater to marine 
habitats, in addition to those previously reported (Bowater et al., 2018; Bowater et al., 2012; 
Delamare-Deboutteville et al., 2015). Group B Streptococcus strains isolated from humans 
and terrestrial animals in Queensland and Northern Territory, Australia, were also 
sequenced and have larger genomes of 2,072,596 bp comprising 2,067 genes on average, 
suggesting that recent possible local transfer from terrestrial origin to Australian fish is highly 
unlikely, although probable transfer between humans and fish has been reported for ST-7 
GBS elsewhere (Evans et al., 2002; Evans et al., 2009; Liu et al., 2013). Non-human 
mammalian strains from Australia sequenced in this study QMA0300 and QMA0303 belong 
to ST-1 serotype V, and QMA0306 belong to ST-67 serotype III, whereas human isolates, 
QMA0355 and QMA0357, and crocodile strain QMA0336 belong to ST-23 serotype Ia. 
Indeed, the high sequence identity between the human ST-23 serotype Ia isolates and those 
from farm-raised crocodiles supports the idea of potable human transfer to these animals, 
as previously implied (Bishop et al., 2007). 
 
To identify the possible origin of the ST-261 isolates from marine fish in Australia, a 
phylogenetic tree was constructed by maximum likelihood from 29,689 non-recombinant 
core genome SNPs and short indel positions derived by alignment of whole genome 
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sequences of 25 Queensland fish isolates, 9 Honduras isolates, 6 Queensland terrestrial 
isolates and 42 genomes from public databases (Fig. 2.1A). Two distinct groups were 
resolved, the first comprising entirely of aquatic isolates (including serotype Ib isolates from 
ST-552, ST-260 and ST-261), while the second major group comprised various isolates of 
terrestrial origin and some fish isolates from ST-7 serotype Ia that may have infected fish 
via transfer from terrestrial sources (Fig. 2.1A). The serotype Ib aquatic group branched into 
three distinct lineages based on ST (Fig. 2.1A). One lineage comprised all Honduras strains 
of ST-260, which were derived from a lineage comprising ST-552 isolates from Brazil (Fig. 
2.1A). This is supportive of previous observations in which an extended typing system based 
on MLST, virulence genes and serotype indicated geographic endemism within fish isolates 
from differing regions of Brazil (Godoy et al., 2013a). The isolates belonging to ST-261 from 
USA, Israel, Ghana, China and Queensland clustered together (Fig. 2.1A). The second 
major division, containing serotype Ia fish strains along with terrestrial isolates, was more 
complex, but isolates largely clustered in line with serotype and ST (Fig. 2.1A). The aquatic 
serotype Ia isolates clustered with human isolates of ST-7 (Fig. 2.1A). These fish isolates 
have acquired a 10kb GI, putatively from S. anginosus, in contrast to their human ST-7 
serotype Ia relatives (Liu et al., 2013). Lineage 10 comprised serotype III ST-17 human 
isolates (Fig. 2.1A). Serotype Ia strains were divided among several additional ST groups, 
where three Australian serotype Ia ST-23 strains (QMA0336, QMA0355 and QMA0357) 
isolated from humans and a saltwater crocodile clustered together with strains of serotype 
III ST-23 (NEM316) and serotype IV ST-452 (NGBS572), also of human origin (Fig. 2.1A). 
This lineage appears to be derived from NEM316 which is a frequent cause of late-onset 
disease in human infants (Herbert et al., 2005). A further serotype Ia isolate was located in 
ST-103 and clustered together with two strains of serotype V ST-609 and ST-617 isolated 
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from camels (Fig. 2.1A) (Fischer et al., 2013). Two newly sequenced Australian terrestrial 
strains, QMA0300 isolated from a dog and QMA0303 isolated from a cat clustered with other 
serotype V ST-1 strains isolated from humans, cattle and dog hosts (Fig. 2.1A). This lineage 
also contained NGBS061 serotype IV ST-495 and GBS-M002 serotype VI ST-1 (Fig. 2.1A). 
ST-1 emerged as a significant cause of infection and disease in humans during the 1990s, 
but was recently inferred to have evolved from strains causing mastitis in cattle in the 1970s 
(Flores et al., 2015). Moreover, QMA0306 ST-1 serotype V from cattle in Queensland was 
closely related to SA111 ST-61 serotype II, which represents a host-adapted lineage of S. 
agalactiae that is dominant in cattle in Europe (Fig. 2.1A) (Almeida et al., 2016).  
 
Our phylogeny based on whole genome SNPs does not support recent direct transfer of 
GBS from Australian human clinical or terrestrial animal sources to marine fish and stingrays, 
in spite of close proximity of many of the wild fish cases to human habitation (Bowater et al., 
2012). Consequently, we refined our analyses to the ST-261 aquatic host-adapted lineage 
to attempt to infer possible route of introduction and subsequent evolution in Australian 
marine fish. A consensus minimum spanning tree based on a distance matrix comprised of 
all core genome SNPs derived from alignment of the ST-261 serotype Ib strains revealed a 
likely original introduction via tilapia from Israel, with only 63 core genome SNPs separating 
an Australian stingray isolate from the type strain of S. difficile (re-assigned as S. agalactiae 
serotype Ib) (Vandamme et al., 1997), isolated from tilapia in Israel in 1988 (Fig. 2.1B) (Eldar 
et al., 1994). Tilapia were imported on a number of occasions during the 1970s and 1980s 
from Israel into North Queensland around Cairns and Townsville, and a number of strains 
and hybrids have since colonised rivers and creeks throughout Queensland (Mather and 
Arthington, 1991). Globally, the aquatic ST-261 lineage appears to have been transferred 
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through human movements of tilapia for aquaculture and other purposes over the last 
several decades. The US and Chinese tilapia isolates also appear to derive from the early 
ND2-22 isolate, as do recent isolates from tilapia in Ghana (Fig. 2.1B). Indeed, phylogenetic 
analysis by maximum likelihood of draft whole genome alignments suggest that the 
Ghanaian and Chinese isolates share a recent common ancestor that is derived from ND2-
22, with only 60 SNPs separating ND2-22 and the Ghanaian strains (Verner-Jeffreys et al., 
2017). We identified only 36 core genome SNPs separating the Ghanaian isolates from 
ND2-22 but this reflects the smaller core genome in our study as a result of the high number 
of GBS isolates analysed (40 in the present study compared with 9 in the previous study) 
(Verner-Jeffreys et al., 2017).  
 
The minimum spanning tree implicates continued adaptation of the ST-261 lineage post-
introduction and suggests that grouper (marine Teleostei family) may have been infected 
via estuary stingrays (Dasyatidae family) (Fig. 2.1B). Stingrays are occasional prey for adult 
giant Queensland grouper and stingray barbs have been found in the gut of grouper post-
mortem (Bowater, unpublished observation). ST-261 GBS has also caused mortality in 
captive stingrays in South East Queensland, translocated from Cairns in North Queensland 
(Bowater et al., 2018).  
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Figure 2.1. A) Maximum likelihood phylogeny of 82 S. agalactiae strains. The tree was inferred from 
alignment of 6,050 non-recombinant core genome SNPs. Branch length was adjusted for 
ascertainment bias using Felsenstein’s correction implemented in RAxML (Stamatakis, 2014). Nodes 
are supported by 1,000 bootstrap replicates. The tree was rooted using S. pyogenes M1 GAS 
(accession number: NC_002737.2) as an outgroup. B) Minimum spanning tree showing relationship 
amongst ST-261 serotype Ib GBS isolates based on a distance matrix derived from non-recombinant 
core genome SNP alignment. The consensus network was computed in MST-Gold (Salipante and Hall, 
2011).  
 83 
2.3.2. The S. agalactiae pan-genome comprises a small core of protein-coding genes and 
is open 
To further elucidate adaptation amongst the fish pathogenic GBS types a pan-genome was 
built from 39 complete genomes retrieved from GenBank and using our curated ST-261 
grouper isolate QMA0271 as a high-quality reference seed genome. The resulting pan-
genome was 4,074,275 bp (Fig. 2.2A). All-vs-all BLAST analysis of the genomes 
implemented in BRIG clearly indicated the substantial reduction in genome size among the 
fish pathogenic ST-261 cohort, as previously reported for a limited number of ST-261 
isolates (Rosinski-Chupin et al., 2013). Here, we find that ST-260 and ST-552 fish-
pathogenic sequence types within serotype Ib are similarly reduced and that conservation 
amongst the serotype Ib strains is high (Fig. 2.2A). In total 4,603 protein-coding genes were 
predicted in S. agalactiae pan-genome using Roary (Fig. 2.2B), which is consistent with 
previous research (Liu et al., 2013). The number of core genes was 1,440 (representing 
35% of the pan-genome), while previous studies reported 1,202 to 1,267 genes in the pan-
genome (He et al., 2017; Liu et al., 2013). These differences may result from the methods 
being used to examine the pan-genome, the difference in sequences number being used to 
create the pan-genome, and finally, the use of draft sequences in the analysis (Liu et al., 
2013). A majority of protein-coding genes found in the pan-genome belonged to both the 
dispensable and strain-specific genes. This could be a result of the inclusion of a high 
number of serotype Ib strain sequences, which were all significantly smaller (approx. 1.8 
Mbp) than those of other isolates. Liu et al. (2013) demonstrated that removing Ib piscine 
isolates from their analysis resulted in an increase in the number of core genes. 
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Frequency analysis of IGRs in S. agalactiae pan-genome showed that the number of IGRs 
shared across all strains was smaller than core protein-coding genes, whereas strain-
specific IGRs were much higher than protein-coding strain-specific genes (Fig. 2.2C). 
Intergenic regions analysis with Piggy excludes IGRs that are less than 30 bp, which may 
result in fewer IGRs than protein-coding genes in core regions (Thorpe et al., 2017). Most 
IGRs identified in the pan-genome belonged to either core genes or strain-specific genes 
(Fig. 2.2C), in line with previous findings in Staphylococcus aureus ST-22 and Escherichia 
coli ST-131 where similar distributions of IGRs were detected (Thorpe et al., 2017). The 
gradients of the accumulation curves for both protein-coding genes and IGRs are still 
strongly positive; therefore the S. agalactiae pan-genome remains open. 
 
To determine whether strain-specific IGR sequences may be derived from genes (or 
pseudogenes) that have undergone erosion, we queried the gene sequences used to 
construct the pangenome by BLASTn using 1,539 strain-specific representative IGR 
sequence clusters (output from Piggy). A total of 1,862 hits were retrieved from 683/1,539 
representative IGR sequence clusters supportive of the gene origins of many IGRs. 
Overrepresentation of sequences from the QMA0271 reference genome among the hits 
(309/1,862 from 39 genomes employed in the pan-genome) was expected, as it was 
employed as the seed for the pan-genome assembly. Of the 241 unique hits among genes 
from QMA0271, 39 hits fell in genes that we annotated as pseudogenes. Pseudogenes are 
predicted to be rapidly lost from the genome, evidenced by the lack of conserved 
pseudogenes across multiple strains of the same species (Kuo and Ochman, 2010; Lerat 
and Ochman, 2005). The relatively high presence of pseudogenes or remnants thereof 
within the serotype Ib ST-261 QMA0271 is supportive of ongoing adaptation of this lineage 
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to the aquatic host and habitat (Rosinski-Chupin et al., 2013). As pseudogenes are often 
not annotated as such in database assemblies (Lerat and Ochman, 2004, 2005), further 
manual inspection of the 849 unique BLAST hits was performed in Excel and by reference 
to the pan-genome. Pseudogenes may arise through frameshift SNPs, resulting in early 
termination or interruption by insertion elements (Lerat and Ochman, 2004), and 239 of the 
849 unique BLAST hits were identified as insertion element transposases and a further four 
as or phage/prophage proteins, suggesting possible gene disruptions by insertion.  
Hypothetical proteins comprised 215 of the 849 unique sequences identified by BLAST of 
strain-specific IGR through the pan-genome, while genes annotated as transcriptional 
regulators comprised 48 sequences. These results lend preliminary support to the 
hypothesis that much of the IGR of bacteria comprises gene remnants and is worthy of in-
depth exploration. 
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Figure 2.2. The pan-genome of S. agalactiae. A) BLASTN-based sequence comparison of 82 S. 
agalactiae genomes against the S. agalactiae pan-genome as reference constructed with BRIG 0.95 
(Alikhan et al., 2011). Rings from the innermost to the outermost show GC content and GC skew of the 
pan-genome reference, then sequence similarity of each of the 82 strains listed in the legend, from top 
to bottom rings are coloured according to origin with fish isolates belonging to serotype Ib ST-261, 
ST-260 and ST-552 in blue, fish strains belonging to serotype Ia in purple and terrestrial strains in red. 
The outermost ring (black) represents the reference pan-genome. B) Proportion of protein-coding 
genes in the core, soft core, shell and cloud of the pan-genome of 82 S. agalactiae isolates were 
determined with Roary. C) Histogram indicates the frequency of genes (protein-coding) in red and IGRs 
(non-protein-coding intergenic regions) in blue-green from 82 S. agalactiae genomes analysed by 
Piggy (Thorpe et al., 2017). 
 
2.3.3. Aquatic serotype Ib have a reduced repertoire of virulence factors  
Almost all genes classed as adhesins, involved in immune evasion and host invasion, and 
most of the toxin-related genes found in terrestrial isolates were absent from serotype Ib 
aquatic isolates (Fig. 2.3). Rosinski-Chupin et al. (2013) reported ~60% of the virulence 
genes found in human strains were present in a serotype Ib GBS strain from fish. We found 
that CAMP factor gene cfa/cfb was present in all strains including serotype Ib ST-260, 261 
and 552 isolates, but CAMP reaction was previously reported to be negative for ST-260 and 
261 strains (Evans et al., 2008; Rosinski-Chupin et al., 2013). These authors identified that 
CAMP factor gene in ST-261 is disrupted while the gene in ST-260 is unaltered but the level 
of gene expression may be too low to detected by the test (Rosinski-Chupin et al., 2013). 
Most of the genes in cyl locus have been lost from Ib piscine strains and only cylB, an ABC 
ATP binding cassette transporter was present in ST-260 and 552 (Fig. 2.3). The cyl locus is 
responsible for hemolytic activity and production of pigment via co-transcription of cylF and 
cylL (Spellerberg et al., 2000). In ST-261, the cyl gene cluster is replaced by a GI resulting 
in loss of hemolytic activity (Rosinski-Chupin et al., 2013). Of particular relevance to 
virulence and antigenic diversity, transmembrane immunoglobulin A-binding C protein beta-
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antigen cba was absent in all aquatic isolates (Fig. 2.3). This gene has been reported in type 
Ib and Ia GBS previously (Nagano et al., 2002), and is implicated in virulence in neonates 
and is up regulated in GBS serotype Ia strain A909 in response to human serum (Nagano 
et al., 2002; Yang et al., 2010, 2011). In contrast, capsule-related genes were largely 
conserved and associated with serotype (Fig. 2.3), supporting the major role of capsule in 
virulence of fish pathogenic streptococci (Delannoy et al., 2016; Locke et al., 2007).  
 
Although serotype Ib aquatic isolates have lost the majority of virulence factors found in 
terrestrial isolates, most contained six sequences that were identified as probable adhesins 
by homology (Fig. 2.3). These ST-261 adhesins (named 0337, 0626, 0856, 1185, 1196 and 
1648 based on position in the annotated ST-261 genome from QMA0271) were fully 
conserved amongst aquatic serotype Ib ST-261 (Fig. 2.3). Moreover, ST-261 adhesin 0856 
was only present in ST-261 and two serotype II isolates, GBS1-NY and SA111 strains (Fig. 
2.3). ST-261 adhesins 1185 and 1648 were shown to be unique to aquatic serotype Ib 
isolates, being absent from Ia fish isolates and all terrestrial strains (Fig. 2.3). The analysis 
indicated that ST-261 adhesins 0337, 0626 and 1196 were well conserved across most of 
the isolates regardless of origin but 1196 was the only adhesin-like gene present in all strains 
analysed (Fig. 2.3). Some terrestrial strains, such as QMA0355, 0357, 0336 and NGBS572 
lacked adhesin 0337 (Fig. 2.3). 
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Figure 2.3. Virulence gene presence and absence in S. agalactiae. Genes were identified from VFDB to 
create a S. agalactiae database for comparison of 82 strains by BLAST using SeqFindr with default 
settings (95% identity cut off). 
 
As CPS is a requirement for full virulence in several fish pathogenic streptococci (Delannoy 
et al., 2016; Locke et al., 2007) and the major antigen in GBS (Pasnik et al., 2005; Seib et 
al., 2012; Yao et al., 2013), further analysis of the serotype Ib cps operon was conducted. 
Within the serotype Ib lineage, the capsular polysaccharide operon was well conserved (Fig. 
2.4). However, QMA0281 from grouper had a deletion at position 341 in cpsB, 
encompassing cpsC, cpsD and cpsE (Fig. 2.4), resulting in a chimeric ORF. Moreover, an 
insertion in a TA repeat at position 557 in cpsH resulted in an early stop codon marginally 
reducing gene size (Fig. 2.4). QMA0368 had a TT insertion at nucleotide position 745 in 
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cpsE resulting in insertion of an early stop codon and truncation of the gene (Fig. 2.4). 
Deletion of this region that includes the priming glycosyl transferase for capsular 
biosynthesis results in loss of capsule, attenuated virulence and modified pathology in the 
fish pathogen S. iniae (Millard et al., 2012). Buoyant density analysis in Percoll indicated 
that QMA0281 is also deficient in capsule (not shown). cps operon SNPs amongst the 
Australian serotype Ib isolates were rare (Fig. 2.4). Indeed only 1 SNP neuA separated 
QMA0271 from the 1988 tilapia isolate from Israel suggesting very little evolution of the cps 
operon since introduction of the lineage (Fig. 2.4). This may reflect a well-adapted capsule 
for colonization naïve hosts, as the Australian isolates were from wild fish and captive 
stingrays recently after capture and transport, thus placing little selective pressure for novel 
capsular sequence types. Immunity in fish drives evolution of novel capsular sequence types 
in S. iniae but these reported cases were all in high intensity aquaculture with occasional 
use of autogenous vaccination and opportunity for development of cps-specific immunity 
(Millard et al., 2012). This may explain the relatively high number of SNPs in genes encoding 
sugar and sialic acid modifying enzymes amongst the isolates from tilapia farmed in 
Honduras relative to the other isolates examined, as autogenous vaccination is occasionally 
used on farms where isolates were sourced and may apply selective pressure favoring 
modified CPS. 
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Figure 2.4. The capsular polysaccharide (CPS) operon of the ST-261 lineage. The operon was identified 
in Genbank files manually and then compared by BLAST using EasyFig (Sullivan et al., 2011).  
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2.4. Conclusions 
The clade of aquatic S. agalactiae serotype Ib including ST-260, ST-261 and ST-552 is a 
highly adapted fish pathogen with a substantially reduced genome compared to all other 
serotypes from terrestrial mammalian, reptile and fish hosts. These variants were originally 
identified as S. difficile due to their impoverished growth on laboratory media and hence 
difficulty of isolation from diseased fish (Eldar et al., 1994). Isolates from fish that were 
previously identified as S. difficile were assigned to serotype Ib GBS a few years later 
(Vandamme et al., 1997) but the recent discovery that serotype Ib isolates have substantially 
smaller genomes than those of other GBS serotypes (Rosinski-Chupin et al., 2013) explains 
the marked phenotypic difference that merited early phenotypic assignation of these strains 
to a separate species. Other serotypes have been isolated from fish, notably serotype Ia 
and serotype III, but these seem to arise from terrestrial transfer rather than being retained 
amongst the aquatic host population (Evans et al., 2008). In contrast, serotype Ib has only 
been isolated from fish and stingrays, appears to be well-adapted and is likely to have been 
transferred internationally via trade in domesticated tilapia, evidenced here by the very close 
relationship (only a handful of SNPs) between a strain isolated from tilapia in 1988 in Israel 
and those found in fish and stingrays in Australia since 2008, and in tilapia in the USA, China 
and Ghana. The ST-261 lineage in Australia likely arrived with several introductions of tilapia 
in the 1970s and 1980s. Tilapia are classed as a noxious pest in Australia and import was 
banned, but not before several lines became established throughout tropical and subtropical 
freshwater habitats in Queensland (Mather and Arthington, 1991). Although ST-261 
serotype Ib GBS has not been isolated from farm fish in Queensland in spite of proximity of 
freshwater farms to tilapia-infested creeks, this clade of GBS is a substantial problem in 
farmed tilapia globally. The cohort of putative adhesins identified here to be conserved 
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through all fish pathogenic serotypes (including Ia and III in addition to Ib) may be promising 
candidates for cost-effective cross-serotype protective vaccines for aquaculture and are 
worthy of future research.
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Chapter 3: Regulation and antigenicity of conserved ST-261 adhesins in 
Streptococcus agalactiae 
 
Abstract 
Streptococcus agalactiae (group B Streptococcus; GBS) causes disease in warm water fish 
resulting in mass mortalities globally. Previously, we assembled the pan-genome of GBS 
and identified that three out of six adhesins found in the sequence type 261 (ST-261) clonal 
complex (CC) are conserved in all GBS isolates while two are only present in serotype Ib 
fish strains and one is specific to ST-261. We characterised three ST-261 adhesins 
(adhesin_0337, 0626 and 1196) conserved in all strains and one specific to serotype Ib 
piscine strains (adhesin_1648) in silico. General domain analysis revealed that 
adhesin_0337 and 0626 have two binding domain structures in their sequences while known 
binding domain structures were not identified in adhesin_1196 and 1648 suggesting 
adheisn_0337 and 0626 might play important roles in pathogenicity in fish. The expression 
of genes encoding the ST-261 adhesins and CpsE (the initiating glycosyltransferase for 
capsular polysaccharide expression) varied inversely, dependent upon the culture condition 
suggesting co-regulation. Serum antibodies against adhesin_0337, 0626 and mixture of 
adhesin_0337, 0626 and 1196 derived from tilapia reacted to the vaccine antigens. While 
the level of antibody against adhesin_1196 by itself was low, the adhesin was recognised 
by tilapia when it was mixed with other adhesins, 0373 and 0626. Although culture conditions 
affect the expression of ST-261 adhesins, the level of ST-261 adhesins detected in whole 
cells by enzyme linked immunosorbent assay (ELISA) and Western blot did not seem to 
reflect gene expression. This may be due to post-transcriptional processing causing a 
disconnect between gene and protein expression. In conclusion, given the antigenicity of 
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adhesin_0373 and 0626 and their ubiquitous conservation amongst GBS, these ST-261 
adhesins appear to be good vaccine candidates. A vaccination and challenge model trial in 
fish is warranted. 
 
3.1. Introduction 
Streptococcus agalactiae or group B streptococcus (GBS) is an opportunistic pathogen of 
humans and animals. In humans, the bacterium colonises mucosal surfaces as a 
commensal organism, but may cause meningitis and septicaemia in neonates (Brochet et 
al., 2006; Edwards and Gonik, 2013; Six et al., 2015). In warm water fish, GBS is a significant 
cause of disease with infections reported in a diverse range of farmed and wild fish species 
globally (Bowater et al., 2012; Evans et al., 2008; Jafar et al., 2008; Mian et al., 2009). The 
economic loss caused by GBS disease outbreaks are substantial, especially in tilapia 
(Oreochromis spp.) aquaculture, resulting in estimated 40 million USD loss annually (Mian 
et al., 2009; Sun et al., 2016; Verner-Jeffreys et al., 2017). Hence, controlling disease is 
critical for the expansion of aquaculture, and vaccination of stock is the most effective way 
to control and prevent disease outbreaks on fish farms (Håstein et al., 2005; Lafferty et al., 
2015; Nur-Nazifah et al., 2014). However, there are at least 10 major capsular serotypes of 
GBS (Paoletti and Madoff, 2002; Slotved et al., 2007; Yao et al., 2013). While vaccination 
against one serotype confers protection against the same serotype, the vaccine does not 
cross-protect against other serotypes (Bachrach et al., 2001; Paoletti and Madoff, 2002). 
Consequently, serotype specificity resulting from variation in the highly immunogenic 
capsular polysaccharide (CPS) antigens represents a particular problem in controlling 
Streptococcal infections by vaccination in both humans and animals. 
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The rapid advance of whole genome sequencing and bioinformatics have allowed relatively 
rapid identification of the most conserved surface and secreted proteins amongst strains of 
a bacterial species which can then be shortlisted as potential targets for vaccination, an 
approach termed reverse vaccinology (Rappuoli, 2001). This reverse vaccinology approach 
was first applied to develop a vaccine against Neisseria meningitidis, Group B 
meningococcus (MenB) (Pizza et al., 2000; Rappuoli, 2001). Subsequently, Maione et al. 
(2005) developed the first universal vaccine candidate against multiple GBS serotypes in 
human using the reverse vaccinology based on a pan-genome derived from eight different 
GBS serotypes (Maione et al., 2005; Nuccitelli et al., 2015). The concept of the pan-genome 
was first described by Tettelin et al. (2005) and states that the gene repertoire of a bacterial 
species could be fully described by their pan-genome, which consists of the core genome 
or genes shared among all strains within a species, and the accessory genome comprising 
those genes that are unique or shared between several strains only. Exploring only the core 
genome to find effective vaccine candidates may identify candidate antigens that are 
represented in all major serotypes, but presents the risk of missing some important antigens 
present in the accessory genome (Nuccitelli et al., 2015). The universal vaccine against 
human GBS contains four surface proteins, one was found in the core gnome and three 
proteins were identified from the accessory genome (Maione et al., 2005).  
 
We sequenced the genomes of GBS isolates from wild and captive fish, along with 
collocated terrestrial farm, domestic animal and human clinical isolates in Australia and 
assembled a pan-genome based on these strains along with complete genome sequences 
of GBS available in the NCBI database (Kawasaki et al., 2018). The pan-genome analysis 
revealed that, although serotype Ib piscine strains have lost approximately 60% of their 
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virulence factor repertoire compared with terrestrial conspecific and serotype Ia piscine 
strains, a number of virulence factors including hyaluronate lyase (exoenzyme), CPS and 
six surface protein, which were identified as adhesins, are conserved (Kawasaki et al., 2018). 
Bacterial adhesins mediate adherence to host surfaces (tissues, cells, and extracellular 
matrix), and may play a critical role in invasive infection (Nobbs et al., 2009). Streptococcal 
bacteria can express numerous adhesins that allow interaction with a diverse array of host 
components by binding to specific receptors on the host cell, which allow colonisation of 
target host tissue without being eliminated by mucocilliary defense (Henningham et al., 
2013; Nobbs et al., 2015; Nobbs et al., 2009; Raynes et al., 2018; Walker et al., 2014). Due 
to their role in attachment to invariant host receptors, adhesins are highly conserved and 
are thus excellent candidates for protective vaccines. Indeed, vaccination with specific 
adhesins from S. pneumoniae conferred protection in mice, and the resulting IgG reduced 
bacterial attachment to human epithelial cells supporting the high potential for recombinant 
protein vaccines based on these adhesins (Gianfaldoni et al., 2007; Khan and Pichichero, 
2012). Also, a combination of three pilus components provided significant protection against 
GBS clinical isolates regardless the CPS serotype (Margarit et al., 2009). Margarit et al. 
(2009) found that at least one of the three pilus islands were conserved among the all clinical 
isolates used in their study. Previously, we have shown that all GBS sequence type (ST) 
261 strains carry the six adhesins (ST-261 adhesins), but only three of them are conserved 
within all strains including terrestrial isolates, while one is exclusive to ST-261 and two are 
specific to serotype Ib piscine strains (Kawasaki et al., 2018). Therefore, in this study, we 
focus on four ST-261 adhesins, three which are conserved in all strains and one which is 
specific to serotype Ib fish strains. 
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In aquaculture, cost effectiveness is critical for vaccine development since the fish require a 
higher antigen dose than terrestrial animals to induce high protection, and the target species 
are of relatively low monetary value (Sommerset et al., 2014). In contrast to purified 
recombinant proteins, inactivated whole-cell vaccines are inexpensive to produce by simple 
fermentation (Ulmer et al., 2006). However, growth conditions are critical because major 
antigenic proteins may not by expressed at high levels under “normal” culture (Colquhoun 
et al., 2002). For instance, the bacterin against Vibrio salmonicida confers better protection 
in Atlantic salmon when bacteria were grown at 10˚C, rather than 22˚C (Colquhoun et al., 
2002). This is likely to be very important in whole-cell vaccines against Streptococcus where 
potential cross-protective protein antigens against heterologous serotypes may not be 
expressed at sufficiently high levels to overcome the immunodominance of the CPS (Aviles 
et al., 2013). Therefore, in this study, we characterised ST-261 adhesins in silico and 
determined culture conditions that regulate their expressions relative to capsule. Also, to 
examine if fish can recognise the adhesin, recombinant adhesins were produced and 
injected to fish to measure the antibody response in order to determine whether a 
vaccination and live challenge model can be justified.  
 
3.2. Materials and methods 
3.2.1. Bacterial strains and routine culture 
Two serotype Ib, ST-261 strains of GBS, QMA0271, originally isolated from the heart of 
giant catfish (Netuma thalassina) in 2009 and QMA0285 which was isolated from the head 
kidney of giant Queensland grouper (Epinephelus lanceolatus) in 2008, and one serotype 
Ia, QMA0357 human strain that was isolated from female genital in Townsville hospital in 
2011 were used in this study. They were recovered from frozen stock (-80ºC) and grown on 
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Columbia agar containing 5% sheep blood (Oxoid) or in Todd-Hewitt broth (THB) at 28ºC 
unless otherwise stated. For QMA0357, the bacterial culture was incubated at 37ºC. TOP10 
Escherichia coli DH5-α (Invitrogen) was used for cloning and E. coli Rosetta 2(DE3) 
(Novagen) was used for recombinant protein expression. Lysogeny Broth (LB) agar or 
Terrific broth (TB) supplemented with ampicillin (50 µg/mL) when selection was required 
were used to culture TOP10 E. coli DH5-α. To culture E. coli Rosetta 2(DE3), both ampicillin 
(50 µg/mL) and chloramphenicol (34 µg/mL) were added to LB agar or TB. Both E. coli 
strains were grown with shaking at 200 rpm at 37ºC.  
 
3.2.2. ST-261 adhesin structural characterisation 
Analysis of general domain structures of ST-261 adhesins were performed by SMART 
GENOMES (http://smart.embl-heidelberg.de/smart/set_mode.cgi?GENOMIC=1) (Letunic et 
al., 2015) and HMMER (http://www.ebi.ac.uk/Tools/hmmer/) (Finn et al., 2011). To identify 
signal peptide cleavage sites and transmembrane regions in amino acid sequence from 
QMA0271, SignalP 4.1 Server (http://www.cbs.dtu.dk/services/SignalP/)(Petersen et al., 
2011) and TMHMM Server v. 2.0 (Krogh et al., 2001) were used. 3D structure models of the 
adhesins were created by PHYRE2 
(http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index) (Lewis et al., 2013).  
 
3.2.3. Investigation of effect of culture conditions on ST-261 adhesin and CPS gene 
expression by real-time qRT-PCR 
To investigate effects of culture conditions on expression of ST-261 adhesin genes, 
overnight starter cultures of GBS strain QMA0285 in THB and TB were standardised to 
OD600 of 1.0 and used to inoculate two THB and two TB cultures (without glycerol) 
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respectively at 2% (v/v). These cultures were then grown for 12 h at 28ºC with gentle shaking. 
To determine any effect of metals on ST-261 adhesins and CPS gene expression, Mn(II)SO4 
(final concentration 5 µM) and Zn(II)SO4 (final concentration 100 µM) were added to one of 
the THB culture at 10 h 30 min post inoculation, while the other culture remained unchanged. 
To investigate the effect of increase in carbohydrate availability, glucose was added to one 
of the TB culture to a final concentration 55 mM at 11 h 30 min post-inoculation, while the 
other culture remained un-changed (Di Palo et al., 2013). After 12 h total incubation, 1.5 mL 
culture was from each of the treatments, cells were harvested by centrifugation for 5 min at 
4°C 14,103 x g, supernatants discarded and the cell pellets were snap-frozen in ethanol/dry 
ice slurry then stored at -80ºC for subsequent RNA extraction. All experiments were 
conducted with three biological replicates (ie. from three independent starter cultures per 
treatment). An identical experiment was conducted in parallel to determine growth curves 
under the treatment conditions by measurement of optical density at 595 nm every 30 min 
for 30 h in a BMG Fluostar optima instrument (BMG Labtech). 
 
The relative expressions of ST-261 adhesin genes and cpsE, a gene encoding the first 
glycosyl transferase of the capsular polysaccharide operon of GBS under the culture 
conditions above were determined by real-time quantitative reverse transcription 
polymerase chain reaction (qRT-PCR). Briefly, total RNA was extracted with Maxwell® RSC 
simplyRNA Cells Kit (Promega) following the manufacturer’s instruction. Contaminating 
gDNA was removed with the RNAse-Free DNAse set (Qiagen) and remaining RNA was 
quantified using the Qubit® Fluorometer RNA high sensitivity assay kit (Life Technologies, 
Melbourne). Complementary DNA (cDNA) was synthesised from 100 ng per sample with 
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the QuantiTect® Reverse Transcription Kit (Qiagen) in accordance with the manufacture’s 
instruction. 
 
Primers for real-time qRT-PCR were designed with Primer3 v. 0.4.0 
(http://bioinfo.ut.ee/primer3-0.4.0/) (Koressaar and Remm, 2007; Untergasser et al., 2012) 
based on ST-261 adhesins and cpsE nucleotide sequences (Table 3.1). All real-time qRT-
PCR reactions were performed in 384-well plates with reagents dispensed using an 
epMotion 5075 Robot (Eppendorf, Hamburg). The concentration of each primer was 
optimised at 0.2 µM and template cDNA at 0.2 ng were added to each reaction yielding 
100% efficiency. In each reaction there were 0.2 µL of forward primer, 0.2 µL of reverse 
primer (both from 10µM stock solutions), 5 µL of SYBRGreen Master Mix (Applied 
Biosytems), 2 µL of cDNA 0.1 ng/µL, and 2.6 µL of water. Cycling parameters were: 95 °C 
for 10 min followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min, then a final melt curve 
at 95 °C for 15 s, 60 °C for 1 min and 95 °C for 15 s in a thermocycler ABI Vii7 (Thermo 
Fisher Scientific). All temperature cycling was performed with acceleration at 1.6 °C /s. 
Initially, five reference genes (Table 3.1) were tested for stability across all treatment 
conditions in a pilot study and the most stable, adhP, was chosen using the ∆Cq method for 
inclusion in the main experiment (De Santis et al., 2011). The ∆∆Cq method was used for 
normalisation of target gene transcript abundances against a reference gene according to 
the equation [Ratio (test/calibrator) = (E/target)∆Cq / (Enormaliser)∆Cq normaliser ] (De Santis et al., 2011; 
Pfaffl, 2001; Pfaffl et al., 2002). The Relative Expression Software Tool (Pfaffl et al., 2002) 
was used to calculate the normalized relative expression quantity of each target genes for 
each conditions, and was based on the pair-wise fixed reallocation randomisation test 
(10,000 randomisations) (Pfaffl et al., 2002). The results represent the relative up- or down- 
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regulation of each gene of interest relative to the internal control between treated and 
untreated samples.  
 
3.2.4. Cloning, expression and purification of the recombinant proteins 
Since three ST-261 adhesins were identified across all GBS strains (Kawasaki et al., 2018), 
recombinant ST-261 adhesin 0337, 0626 and 1196 were produced expressed in E. coli. 
Primers were designed to amplify ST-261 adhesin sequences excluding signal peptides and 
transmembrane regions using Phusion® High-Fidelity DNA Polymerase (New England 
BioLabs) (Table 3.1). The PCR products were cleaned or purified from 2% agarose gel, if 
needed, using ISOLATE II PCR and Gel Kit (Bioline) according to the manufacturer’s 
instructions, then directionally cloned into Champion pET101 (Invitrogen), transformed into 
TOP10 E. coli DH5-α for storage, propagation and maintenance using standard procedures. 
The transformants were grown on LB agar plate containing ampicillin (50 µg/mL), then 
colonies were analysed by PCR and plasmid constructs were confirmed by Sanger 
sequencing (AGRF, Brisbane). The confirmed transformed TOP10 E. coli DH5-α were 
archived in 20% glycerol at -80ºC. The codon usage of adhesin coding sequences were 
analysed with GenScript Rare Codon Analysis Tool (http://www.genscript.com/cgi-
bin/tools/rare_codon_analysis) and the codon adaptation index was calculated. To 
overcome the codon bias, E. coli Rosetta 2(DE3) (Novagen) was chosen for recombinant 
protein expression. The vectors containing the cloned genes were purified from TOP10 E. 
coli DH5-α and then transformed into E. coli Rosetta 2(DE3) for isopropyl β-D-1-
thiogalactopyranoside (IPTG)-induced expression. For expression, overnight cultures of E. 
coli Rosetta 2(DE3) were used to inoculate 400 mL of fresh TB (10% inoculum v/v) 
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containing chloramphenicol and ampicillin and grown until OD600 = 0.4-0.6. IPTG was added 
to a final concentration of 0.5 mM and incubated for 4 h at 37ºC with shaking.  
 
The expressed recombinant protein was purified via 6x His tag at the C-terminal using Ni-
NTA affinity chromatography (Qiagen) under native conditions. Wash and eluted fractions 
were analysed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
and Western-blotting onto polyvinylidene difluoride (PVDF) membranes (Immobilon P, 
Merck), the membrane was blocked with 5% skim milk in Tris buffered saline + 0.005% 
Tween 20 (TBST) at 4ºC overnight and recombinant protein was detected in blots using a 
mouse monoclonal anti-Penta-His antibody (1:1000) supplied in the purification kit (Qiagen) 
with a secondary polyclonal anti-mouse IgG produced in goat conjugated to alkaline 
phosphatase (1:15 000) (Sigma Aldrich). Colour was developed using NBT-BCIP Liquid 
Substrate System (Sigma Aldrich). Finally, the eluted recombinant protein was quantified by 
PierceTM BCA Protein Assay Kit (Thermo Fisher Scientific) and stored in elution buffer at -
80ºC until use.  
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Table 3.1. Oligonucleotide primers used in this study. 
Experiments Gene Primer Length (bp) Nucleotide sequence (5’ to 3’) 
 
 
 
 
 
Real-time 
qRT-PCR 
Adhesin 
0337 
SA_adhe0337F_RTPCR 20 ATGAAGCGTTTGGTGGAGAC 
SA_adhe0337R_RTPCR 20 AGAGCTTGCCCCTCTTTACC 
Adhesin 
0626 
SA_adhe0626F_RTPCR 20 TGAGATGCCTAAAACTGCCC 
SA_adhe0626R_RTPCR 20 GGTGCTGTTGGTTTCGAAGT 
Adhesin 
1196 
SA_adhe1196F_RTPCR 20 CATCGCAACCCTCACCTAGT 
SA_adhe1196R_RTPCR 20 ATTCATCGCGATCCACTTCT 
Adhesin 
1648 
SA_adhe1648F_RTPCR 20 GTCTTCACAGCAGGAGCACA 
SA_adhe1648R_RTPCR 20 TAAGAGTGGACTTGCGGCTT 
cpsE SA_cpsE_F1091_RTPCR 24 CAAGCATAGATGAGTTGCCTCAAT 
SA_cpsE_R1208_RTPCR 21 CGTCGCTTCTGCGTTGAATT 
adhP 
(reference) 
SA_adhP_F59_RTPCR 20 AACGTCTTTGAGGGTTGGTG 
SA_adhP_R208_RTPCR 20 GTTTCCAAGACCACCTGCAC 
 Adhesin SA_adhe0271_0337F 19 CACCATGCCCCAACATAAA 
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Cloning 
0337 SA_adhe0271_0337R 30 ATTTTTAGATATCATAGACATTTTTT
TACC 
Adhesin 
0626 
SA_adhe0271_0626F 23 CACCATGACACCAGTAATGGCAG 
SA_adhe0271_0626R 27 TTTTTTAGCTAAGGCTGTCATAGCT
TT 
Adhesin 
1196 
SA_adhe0271_1196F 28 CACCATGACAAGTGATAAGAATAC
TGAC 
SA_adhe0271_1196F 22 TTCCTTTTTAGGCTTACTGTGG 
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3.2.5. Vaccines preparations and formulation   
Two formalin killed bacterins, which included QMA0285 grown in THB and QMA0357 grown 
in TB without glycerol, and four recombinant vaccines were prepared. Briefly, overnight GBS 
strain QMA0285 starter cultures grown in THB (OD600 = 1) was used to inoculate (2% v/v) 
fresh 50 mL THB cultures in 200 mL flasks and incubated at 28ºC with gentle swirling for 16 
h (early stationary phase). For QMA0357, overnight starter culture grown in THB was spun 
and the cells were re-suspended in fresh TB to adjust OD600 = 1. This culture was used to 
inoculate (2% v/v) fresh 50 mL TB cultures without glycerol in 200 mL flasks and incubated 
at 37ºC with gentle agitation for 8 h (early stationary phase). Bacterial cultures were spun 
for 15 min at 4ºC and 3220 x g and resuspended in the appropriate volume of supernatant 
to adjust OD600 to 1. The cultures were immediately chilled on ice and a small aliquot was 
taken from each culture before formalin addition to estimate a colony forming unit (CFU). 
Formalin solution (from stock 37%) was added to a final concentration of 0.5% v/v equivalent 
to 0.2% final concentration of formalin for 4 days at 4ºC. To check for complete inactivation 
of vaccines, 200 µL of each culture was plated onto Columbia agar containing 5% sheep 
blood (Oxoid) and plates left to incubate for up to one week at 28ºC for QMA0285 and 37ºC 
for QMA0357. Once complete inactivation of vaccines was confirmed by culture, the 
suspensions were emulsified with MONTANIDE ISA766 (Seppic, France) adjuvant at the 
ratio of 4:6 by 25 times passage through a sterile 19G needle fitted to 3 mL Luer lock syringe. 
For recombinant vaccine, the recombinant protein in elution buffer was diluted to 400 µg/mL 
and then was emulsified as descried above. Mixed recombinant vaccine, which is the 
mixture of three recombinant ST-261 adhesins, contain 133 µg/mL of each recombinant ST-
261 adhesin. As a negative control vaccine, phosphate buffered saline (PBS) was emulsified 
with the adjuvant at the same ratio (3:7). Prepared vaccines were transferred in opaque 
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screw capped 5 mL centrifuge tubes and stored at 4ºC. Stabilities of vaccines were checked 
by centrifuging subsample of each vaccine. All bacterins and recombinant vaccines used in 
the study are listed in (Table 3.2).  
 
Table 3.2. Vaccine types and antigen concentrations. 
Antigen Concentration Per tilapia 
PBS  - - 
Whole-cell, Ib  4 x 108 cfu/mL 4 x 107 cfu/mL 
Whole-cell, Ia 4 x 108 cfu/mL 4 x 107 cfu/mL 
Recombinant protein, 0337 400 µg/mL 40 µg/mL 
Recombinant protein, 0626 400 µg/mL 40 µg/mL 
Recombinant protein, 1196 400 µg/mL 40 µg/mL 
Recombinant protein, Mix 
(mixture of 3 adhesins) 
400 µg/mL (~ 133 µg/mL of 
each adhesin) 
40 µg/mL (~13 µg/mL of 
each adhesin) 
 
3.2.6. Experimental animal and husbandry 
Catching, breeding, vaccination and challenge in tilapia were performed under guidance of 
animal welfare and ethics requirements with approval by the Animal Welfare Unit, UQ 
Research and Innovation at the University of Queensland (AEC approval number: 
SBS/398/16). In addition, since tilapia, Oreochromis mossambicus, is an invasive species 
in Australia, the permission to collect, transport, possess and breed tilapia for research was 
obtained from Queensland Government Department of Agriculture and Fisheries Biosecurity 
(permit number: PRID000267). In this study, tilapias were obtained from a wild population in 
the Brisbane river catchment and treated with Vetsense Kilverm Pig and Poultry Wormer 
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(Vetsense) to remove parasites. Five tilapias were dissected for bacteriology. Then tilapias 
were transferred to a recirculating freshwater system consisting of eight 112 L circular food-
grade plastic tanks with individual aeration. The water temperature was maintained at 28˚C. 
Tilapias were fed to satiation twice a day with a commercial diet for native freshwater fish 
(Ridley Aqua Feed). Water quality was maintained by mechanical and biological filtrations. The 
quality was monitored regularly for ammonia, nitrite, nitrate, pH and water hardness. Water 
exchanges were performed as required. 
 
3.2.7. Vaccination of tilapia and serum collection 
Tilapias were anaesthetised with AQUI-S® (AQUI-S New Zealand Ltd). and vaccinated by 
intraperitoneal (IP) injection with 100 µL vaccine per tilapia by using 1 mL syringe and 23G 
needle. Cohorts of nine fish were injected per vaccine and placed in one tank. Tilapias were 
kept in the tanks for 900 degree days (32 days at 28˚C) for immunity development. Then, 
tilapias were euthanized by lethal overdose of AQUI-S® (AQUI-S New Zealand Ltd). and bled 
from the caudal vein. Blood was stored at 4˚C overnight to clot and centrifuged at 7000 x g for 
10 min to collect sera. The sera were stored at -20˚C for subsequent use. 
 
3.2.8. Detection of adhesins in whole cells under differing culture conditions by SDS-PAGE 
analysis and Western blotting 
Based on real-time qRT-PCR results, the conditions that induced either high or low 
adhesins/CPS expression were analysed by SDS-PAGE analysis. Briefly, four cultures were 
prepared under the conditions above (THB, TB, TB+glucose, TB+Mz&Zn) and cells were 
harvested from each culture after 12 h, 18 h and 24 h. The cells were pelleted by 
centrifugation and reduced by boiling for 15 min in reducing buffer containing dithiothreitol 
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(Bio-Rad). The reduced samples were resolved in 12% SDS-PAGE gels and stained with 
PierceTM Silver Stain Kit (Thermo Fisher Scientific).  
 
For Western blotting using antisera against the vaccines prepared above, GBS strain 
QMA0285 was grown in the four different media and cells were harvested after 18 h of 
incubation at 28 ºC. The cells were washed thrice in chilled 10mM Tris buffered saline (TBS) 
and were resuspended in reducing buffer containing 2-mercaptoethanol (Sigma Aldrich). 
Cells were reduced by boiling for 15 min and the samples were separated in 12% SDS-
PAGE gels. Each recombinant ST-261 adhesin and the mixture of recombinant ST-261 
adhesins were also resolved by SDS-PAGE for Western blotting to determine if they were 
recognised by tilapia serum. The proteins were transferred to Immun-Blot ® LE PVDF 
membrane (Bio-Rad) and the membranes were blocked with 1% bovine serum albumin 
(BSA) (Sigma Aldrich) dissolved in TBS containing 0.01% Tween 20 (TBST) (Sigma Aldrich) 
overnight at 4˚C. The membranes were washed thrice in TBST and cut into strips to separate 
each lane. Each membrane strip was placed in small zip-lock bag and proteins were 
detected in each blot by each anti-serum raised in tilapia (1:32 dilution in TBST). After 3 h 
incubation at room temperature, all membrane strips were washed three times in TBST and 
incubated with a secondary polyclonal anti-barramundi IgM antibody produced in sheep 
(1:1500, shown to cross-react with tilapia IgM in a dot blot) for 1 h at room temperature. 
Unbound antibodies were removed by washing membranes in TBST and a tertiary 
polyclonal anti-goat IgG (cross-reacts with sheep IgG) raised in donkey conjugated to 
alkaline phosphatase (1:15000) (Sigma Aldrich) was added and incubated for 1 h at room 
temperature. After removing unbound antibodies by washing, NBT-BCIP Liquid Substrate 
System (Sigma Aldrich) was applied to develop the colour.  
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3.2.9. Enzyme linked immunosorbent assay (ELISA) 
Antibody responses of tilapia to the recombinant adhesins were evaluated by indirect enzyme 
linked immunosorbent assay (ELISA) as described previously (Delamare-Deboutteville et al., 
2006). Briefly, four 96-well ELISA high binding plates (Greiner) were coated with each 
recombinant ST-261 adhesin diluted in carbonate bicarbonate buffer (1 µg/mL) overnight at 
4˚C. One plate was coated with mixture of recombinant ST-261 adhesins which containing 0.33 
µg/mL of each protein. Plates were washed three times in TBST and blocked with 1% BSA for 
4 h at room temperature. Plates were washed again in TBST and anti-sera diluted in TBST 
(1:32) were added and incubated for 3 h at room temperature. As a negative control, serum 
collected from tilapias which were vaccinated with PBS was added to one row of the plates. A 
secondary antibody, anti-barramundi IgG produced in sheep (1:2000, shown to cross-react 
with tilapia IgM in a dot blot) was added to wells and plates were incubated for 1 h at room 
temperature. Then, plates were incubated for 1 h at room temperature with tertiary anti-sheep 
IgG raised in donkey conjugated with alkaline phosphatase (1:15000). Before each incubation 
step with antibody, plates were rinsed thrice in TBST. Finally, plates were washed in TBST five 
times to remove unbound antibodies and then, washed twice in TBS to remove Tween 20. The 
colour was developed by p-Nitrophenyl Phosphate Liquid Substrate System (Sigma Aldrich). 
The plate was immediately placed in a Fluostar Optima luminometer (BMG Labtech) and the 
absorbance was read at 405 nm every 30 min for 3 h. 
 
3.3. Results  
3.3.1. Identification of ST-261 adhesins and their general domain structures 
The conserved domain analysis of amino acid sequences of ST-261 adhesins indicated that 
these adhesins present typical cell-wall protein characteristics with an LPXTG anchor motif 
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at the C-terminal end (Fig. 3.1) (Novick, 2000). SignalP analysis identified signal peptide 
sequences at N-terminus suggesting they are exported to the surface in a sec-dependent 
manner (Schneewind and Missiakas, 2012). The adhesins were named adhesin_0337, 
0626, 1196 and 1648 in this study based on gene number in the QMA0271 reference 
genome (NCBI accession number; CP029632).  
 
Adhesin_0337 comprises 521 amino acids with predicted molecular weight (MW) of 56.4 
kDa. Homologues of adhesin_0337 cell surface proteins were encoded by S. sanguinis 
(WP_045773392.1), S. gordonii (WP_061586219.1) and S. oligofermentans 
(WP_048764222.1) with 49%, 47% and 43% amino acid identities respectively. Analysis of 
general domain structure revealed that adhesin_0337 contained two streptococcal surface 
repeat domains (SSURE) which bind to fibronectin (Fig. 3.1) (Bumbaca et al., 2004). These 
domains were also identified in WP_045773392.1 in S. sanguinis and WP_048764222.1 in 
S. oligofermentans. Adhesin_0626 consisted of 512 amino acids with a predicted MW of 
54.4 kDa, with 46% amino acid identity with cell surface-anchored protein encoded by S. 
equi (WP_021321150.1), 43% with S. ictaluri (WP_008089095.1) and 43% with S. 
dysgalactiae (WP_022554498.1). Adhesin_0626 contained two bacterial immunoglobulin-
like 1 domains (Big-1) belonging to the intimin/invasin family (Fig. 3.1). Adhesin_1196 was 
small, with a predicted MW of 22.3 kDa, comprising 206 amino acids with no similarity to 
proteins from other streptococci species. Binding domain structures were not identified in 
adhesin_1196, but it contains a procyclic acidic repetitive protein (PARP) like sequence (Fig. 
3.1). Adhesin_1648 predicted size was 43.45 kDa and consisted of 392 amino acids. 
BLASTn analysis of adhesin_1648 with other bacterial group revealed a hypothetical protein 
encoded by Enterococcus faecalis (WP_061100550.1) with 33% amino acid similarity. 
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However, alignment scores were low (< 65). While no binding domain could be found in 
adhesin_1648 sequence, a coiled-coil structure was identified (Fig. 3.1). 
 
Fig. 3.1. General domain structures of four ST-261 adhesins, three are conserved in all GBS strains 
(adhesin_0337, 0626 and 1196) and one is specific to serotype Ib piscine strains (adhesin_1648). The 
orange box represents the signal peptide at N-terminus including YSIRK-type and unknown signal 
peptide. The green box represents the binding domains, including SSURE domain, Big-1. Grey boxes 
indicate putative domains identified with low confidence. The analysis revealed these domains most 
similar to Trypanosoma brucei PARP (Trypan_PARP) and a coiled-coil region. The blue box indicates 
transmembrane domains with LPXTG cell-wall anchor motif.  
 
3.3.2. ST-261 Adhesin and cpsE expressions are affected by culture conditions 
Streptococcus agalactia strain QMA0285 showed different growth rates when grown in 
different culture conditions (Fig. 3.2). The addition of metals (manganese and zinc) did not 
affect the growth compared to THB culture (Fig. 3.2). On the other hand, the growth rate of 
QMA0285 cultured in TB without glucose (carbohydrate limited) was reduced while the 
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Figure 5: A general representation of six adhesins domain structures and regions length. The orange 
boxes on N-terminal indicate signal peptides such as YSIRK, KxYKxGKxW and unknown signal 
peptides. The green boxes show the regions of binding domains including streptococcal surface 
repeat (SSURE) domain, Invasin/Intimin cell-adhesion (Invasin/Intimin) domain, Fibrinogen 
binding protein (Fib_BP) domain, serine-rich repeat adhesion glycoprotein (Ser_adh_Ntrm) and 
Fibrinogen binding domain (Fib_BD). The grey boxes represent the domains, which have been 
identified but with low confidence. These domains include Trypansoma brucei procyclic acid 
repetitive protein (Trypan_PARP), coiled_coil and C-terminal cell-wall surface anchor repeat 
(Ctrm_anchor) domains. The blue boxes indicate transmembrane domains. All adhesins have 
LPxTG cell-wall anchor (LPxTG) domains.  
 
2.2 Aim 2: To determine if the adhesins can induce the production of specific antibodies and 
their roles in binding host cell. 
Previous studies sh w d that the adhesins of S. agalactiae such as pili, can lead to antibody 
production and elicit opsonophagocytosis to induce bacteria elimination events such as respiratory 
burst and phagocytotic activity by immune cells [147, 149]. In addition, although the antibodies do 
not induce athoge el minatio events, the specific antibody itself to the adhesins is capable to 
prevent infection because the antibody bindss to adhesins and block the bacterial adhesion to the 
host and inhibit establishment of bacterial infection [147]. For example, the presence of specific 
antibodies to PhtD and PhtE, member of adhesin Pht family in S. pneumoniae, significantly reduced 
S. pneumoniae bin ing to human epithelial cells by blocking interaction of the PhtD and PhtE 
adhesins wit  their respective host receptors [150]. Streptococci carry multiple adhesins on the 
surface to adhere to specific host receptors [147]. Deletion of certain adhesins can result in reducing 
pathogenesis of bacteria [147]. For instance, deletion of fibrinogen-binding adhesin FbsC genes 
fbsC from S. agalactiae caused decrease in bacterial adhesion to fibrinogen [164]. This section will 
determine if the six adhesins from S. agalactiae and putative secreted and surface proteins from S. 
iniae can elicit functional antibodies in fish and their roles in adhesion will be investigated.  
 
2.2.1 Cloning and expression of adhesins in E. coli 
To determine if the adhesins can elicit antibodies in fish, candidate genes will be expressed in E.coli 
using the Champion pET101 expression system (Invitrogen) [131]. The primers will be designed to 
cut off signal sequences and transmembrame regions. To identify signal peptides and 
transmembrane regions, protein sequences of the adhesins from S. agalactiae ST-261 strain 
QMA0271 will be analyzed by SignalP 4.1 Server [165] and TMHMM Server v. 2.0 [166]. The 
adhesins sequences will be amplified by the primers (Table 3) and cloned into pET101/D-TOPO® 
vector, then expressed in E. coli BL21 Star™(DE3) by following manufacture protocol.  
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Figure 5: A general representation of six adhesins domain structures and regions length. The orange 
boxes on N-terminal indicate signal peptides such as YSIRK, KxYKxGKxW and unknown signal 
peptides. The green boxes show the regions of binding domains including streptococcal surface 
repeat (SSURE) domain, Invasin/Intimin cell-adhesion (Invasin/Intimin) domain, Fibrinogen 
binding protein (Fib_BP) domain, serine-rich repeat adhesion glycoprotein (Ser_adh_Ntrm) and 
Fibrinogen binding domain (Fib_BD). The grey box s repr ent the domains, which have been 
identified but with low confidence. These domains include Trypansoma brucei procyclic acid 
repetitive protein (Trypan_PARP), coiled_coil and C-terminal cell-wall surface anchor repeat 
(Ctrm_anchor) domains. The blue boxes indicat transmembrane domains. All adhe ins have 
LPxTG cell-wall anchor (LPxTG) domains.  
 
2.2 Aim 2: To determine if the adhesins can induce the production of specific antibodies and 
their roles in binding host cell. 
Previous studies showed that the adhesins of S. agalactiae such as pili, can lead to antibody 
production and elicit opsonophagocytosis to induce bacteria elimination events such as respiratory 
burst and phagocyt tic activity by immune c lls [147, 149]. In addition, although the antibodies do 
not induce pathogen elimination events, the specific antibody itself to the adhesins is capable to 
preve t infection because the antibody bindss to adhesins and block the bacterial adhesion to the 
host and nhibit establishment of bac erial inf ction [147]. For example, t e presence of specific 
antibodies to PhtD and PhtE, member of adhesi  Pht f mily in S. pneumoniae, significantly reduced 
S. pn umonia  bi ding to h man epithelial cells by blocking interaction of the PhtD and PhtE 
adhesins with their respective host receptors [150]. Streptococci carry multiple adhesins on the 
surface to adhere to specific host receptors [147]. Deletion of certain adhesins can result in reducing 
pathogenesis of bacteria [147]. For instance, deletion of fibrinogen-binding adhesin FbsC genes 
fbsC from S. agalactiae caused decrease in bacterial adhesion to fibrinogen [164]. This section will 
determine if the six adhesins fro  S. agalactiae nd putative secreted and surface prot ins from S. 
iniae can elicit functional antibodies in fish and their roles in adhesion will be investigated.  
 
2.2.1 Clo i g and expressio  of ad esins in E. co  
To determine if the adhesins can elicit antibodies in fish, candidate genes will be expressed in E.coli 
using the Champion pET101 expression system (Invitrogen) [131]. The primers will be designed to 
cut off signal sequences and transmembrame regions. To identify signal peptides and 
transmembrane regions, protein sequences of the adhesins from S. agalactiae ST-261 strain 
QMA0271 will be analyzed by SignalP 4.1 Server [165] and TMHMM Server v. 2.0 [166]. The 
adhesins sequences will be amplified by the primers (Table 3) and cloned into pET101/D-TOPO® 
vector, then expressed in E. coli BL21 Star™(DE3) by following manufactur  protocol.  
 
Signal.PepCde Binding.Domain Other.Domain.(insigniﬁcant) Transmembrane
 28 
Figure 5: A general eprese tation of six adhesin  dom in structures and regions length. The orange 
boxes on N-terminal indicate sig al peptides such as YSIRK, KxYKxGKxW and unknow  signal 
peptides. Th  green boxes show th  regions of bindi g domains including streptococcal surface 
repeat (SSURE) domain, Invasin/Intimin cell-adhesion (Inva /Intimin) domain, Fibrinogen 
binding protein (Fib_BP) domain, serine-r ch repeat adhesion glycopr tein (Ser_adh_Ntrm) and 
Fibrinogen bindin  domain (Fib_BD). The grey box s present th  d , which have been 
identified but with low confidence. Thes  domains include Trypansoma brucei procyclic acid 
repetitive prote n (Trypan_PARP), coiled_coil and C-terminal cell-wall surface anchor r peat 
(Ctrm_anchor) domains. The blue boxes indicate tra smembrane do ains. All adhesins h ve 
LPxTG cell-wall anchor (LPxTG) domains.  
 
2.2 Aim 2: To determine if he adhesins c n induce the produc ion of specific antibodies d 
their roles in binding host cell. 
Previous studies showed that the ad esins of S. agalactiae such as ili, can l ad to antibody 
production and elicit opsonophagocytosis to induce bacteria elimination events such as respiratory 
burst and phagocytotic ctivity by immune cells [147, 149]. In addition, although the antibodies do 
not induce pathogen elimination events, the specific antibody itself t  the adhesins is capable to 
prevent infection because the antibody bindss to adhesins and block the bacterial adhesion to t  
host and inhibit establishmen  of bact rial infe ion [147]. For example, the pres nce of specific 
antibodies to PhtD and PhtE, member of adhesin Pht family in S. pneumoniae, signific ntly redu ed 
S. pneumoni e bindi g to human pith l l c lls by blocking interaction of the PhtD and tE 
adhesins with their respective host receptor  [150]. Streptococci carry multiple adhesins on the 
surface to adhere to specific h t receptors [147]. Deletion of c rta n adhesins can result in reducing 
pathogenesis of bacteria [147]. For instance, dele ion of fibr nogen-bindin  adhesin FbsC ge es 
fbsC from S. agalactiae caused decrease in bacterial adhesion to fibrin gen [164]. This section will 
determine if the six adhesin  from S. agalactiae nd pu ative secreted and surface pr teins from S. 
iniae can elic t functional antibodies in f sh and their roles in adhesion will be nvestigat d.  
 
2.2.1 Cloning and expression of adhesi s in E. coli 
To determine if the adh sins can elic t antibod es in f sh, candidate genes will b  expressed in E.coli 
using the Champion pET101 ex ression syst m (I vitrogen) [131]. The primers will be designed to 
cut off signal sequences and transmembrame regions. To identify signal pept des and 
transmembrane r gions, prote n sequences of the adhesins from S. agalactiae ST-261 strain 
QMA0271 will be analyzed by SignalP 4.1 Server [165] and TMHMM Server v. 2.0 [166] The 
adhesins sequence  will be ampl fied by the primers (Table 3) and c oned i to pET101/D-TOPO® 
vector, then xpressed in E. coli BL21 Star™(DE3) by following manufacture proto ol.  
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Figure 5: A general representation of six adh sins domain st uctures and reg ons length. The orange
boxes on N-terminal indicate signal peptides such as YSIRK, KxYKxGKxW and unknown signa  
peptides. The green boxes show the regions of bindi g domain  including streptococcal surface 
repeat (SSURE) domain, Invasin/Intimin cell-a he ion (Invasin/Intimin) domain, Fibrinoge  
binding protein (Fib_BP) domain, serine-rich repeat adhesion glyc protein (Ser_ dh_Ntrm) and 
Fibrinogen binding domain (Fib_BD). The grey boxes represe t the domains, which have een 
identified but with low confidence. These domains include Trypansoma brucei procyclic acid 
repetitive protein (Trypan_PARP), coil d_coil and C-terminal cell-wall surface anchor repeat 
(Ctrm_anchor) domains. The blue boxes indicate transmembrane domains. All adhesins have 
LPxTG cell-wall anchor (LPxTG) domains.  
 
2.2 Aim 2: To determine if the adhesin  can indu e the production of specific a tibodi s and 
their roles in binding host cell. 
Previous studies showed that the adhesins of S. ag lactiae such as pili, can lead to ant body 
production and elicit opsonophagocytosis to induce bacteria elimination events such as respiratory 
burst and phagocytotic activity by immune cells [147, 149]. In addition, although the antibodies do 
not induce pathogen elimination events, the specific antibody itself to the adhesins is capable to 
prevent infection because the antibody bi dss t  a hesin  d block t  acterial adhesion to t  
host and inhibit establishment of bacte ial infec ion [147]. For xample, the presen e of sp c fic
antibodies to PhtD and PhtE, member of adhesin Pht family in S. pn umoniae, sig ifi a tly r du  
S. pneumoniae binding to human epithelial cells by blocking interaction of the PhtD and PhtE 
adhesins with their respective host receptors [150]. Streptococci carry multiple adhesins on the 
surface to adhere to specific host receptors [147]. Deletion of certain adhesins can result in reducing 
pathogenesis of bacteria [147]. For instance, deletion of fibrinogen-binding adhesin FbsC genes 
fbsC from S. agalactiae caused decrease in bacterial adhesion to fibrinogen [164]. This section will 
determine if the six adhesins from S. agalactiae and putative secreted and surface proteins from S. 
iniae can elicit functional antibodies in fish and their roles in adhesion will be nvestigated.  
 
2.2.1 Cloning and expression of adhesins in E. coli 
To determine if the adhesins can elicit antibodies in fish, candidate genes will be expressed in E.coli 
using the Champion pET101 expression system (Invitrogen) [131]. The primers will be designed to 
cut off signal sequences and transmembrame regions. To identify signal peptides and 
transmembrane regions, protein sequences of the adhesins from S. agalactiae ST-261 strain 
QMA0271 will be analyzed by SignalP 4.1 Server [165] and TMHMM Server v. 2.0 [166]. The 
adhesins sequences will be amplified by he prim rs (Tab 3) and cloned into pET101/D-TOPO® 
vector, then expressed in E. coli BL21 Star™(DE3) by following manufacture protocol.  
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Figure 5: A general representation of six adhesins domain structures and regions l ngth. Th  orange 
boxes on N-terminal indicate signal peptides such as YSIRK, KxYKxGKxW and nknown sign l
peptides. The green boxes show the regions of binding domains i cluding streptococcal surface 
repeat (SSURE) domain, Invasin/Intimin cell-adh sion (Invasi /I timin) domain, Fibrinogen 
binding protein (Fib_BP) domain, serine-rich repeat adhesion glycoprot in (Ser_adh_Ntrm) and 
Fibrinogen binding domain (Fib_BD). The grey boxes r prese t the domains, which ave been 
identified but with low confidence. These domains include Trypansoma brucei procycli  acid 
repetitive protein (Trypan_PARP), coiled_coil and C-ter inal cell-w ll surface anchor repeat 
(Ctrm_anchor) domains. The blue boxes indicate transmembrane domains. All adhesi  have 
LPxTG cell-wall anchor (LPxTG) domains.  
 
2.2 Aim 2: To determine if the adhesins can induce the production of specific a tib dies an  
their roles in binding host cell. 
Previous studies showed that the adhesins of S. agalactiae such as pili, can lead to antibody 
production and elicit opsonophagocytosis t  induce bacteria elimination vents suc  as respiratory 
burst and phagocytotic activity by immune cells [147, 149]. In addition, although the antibodies do 
not induce pathogen elimination events, the specific antibody itsel  to the adhesins is capable to 
prevent infection because the antibody bindss t  adhesins and bl ck the bacterial adhesion to the 
host and inhibit establishment of bacterial infection [147]. For example, the presence of specific 
antibodies to PhtD and PhtE, member of adhesi  Pht family in S. pn umoniae, sig ificantly reduced 
S. pneumoniae binding to human epithelial cells by blocking interaction of the PhtD and PhtE 
adhesins with their respective host receptors [150]. Str ptococci carry multiple a hes s on the 
surface to adhere to specific host receptors [147]. Deletion of certain adhesins can result in reducing 
pathogenesis of bacteria [147]. For instance, deletion of fibrinogen-bi ding adh sin FbsC genes 
fbsC from S. agalactiae caused decrease in bacterial adhesion to fibrin gen [164]. This section will 
determine if the six adhesins from S. agalactiae and putative secreted and surface proteins from S. 
iniae can elicit functional antibodies in fish and their roles in adhesion will be investigated.  
 
2.2.1 Cloning and expression of adhesins in E. coli 
To determine if the adhesins can elicit antibodies in fish, candidate genes will be expressed in E.coli 
using the Champion pET101 expression system (Invitrogen) [131]. The primers will be designed to 
cut off signal sequences and transmembrame regions. To identify signal peptides and 
transmembrane regions, protein eque ces of the adhesins from S. agalactiae ST-261 strain 
QMA0271 will be analyzed by SignalP 4.1 Server [165] and TMHMM Server v. 2.0 [166]. The 
adhesins sequences will be amplified by the primers (Table 3) and cloned into pET101/D-TOPO® 
vector, then expressed in E. coli BL21 Star™(DE3) by following manufacture protocol.  
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Figure 5: A general representation of six adhesins domain structures and regions length. The orange 
boxes on N-terminal indi te signal peptides such s YSIRK, KxYKxGKxW and unknown sig al 
peptides. The green boxes show the regions of binding domains including streptococcal surface 
repeat (SSURE) domain, Invasin/Intimin cell-adhesion (Invasin/Intimin) domain, Fibrinogen 
binding pro in (Fib_BP) domain, s rine-rich r p at adh sion glycoprotein (S r_adh_Ntrm) an  
Fibri ogen binding domain (Fib_BD). The grey boxes r present the domains, which have been 
identified but with low confid nce. These domains include Trypansoma brucei procyclic aci  
repetitive protei  (Trypan_PARP), coile _ il and C-termin l cell-wall surface a chor repeat 
(Ctrm_anchor) omains. The blue boxes indicate transmembrane domains. All adhesins have 
LPxTG cell-wall anchor (LPxTG) domains. 
 
2.2 Aim 2: T  determin  if the adhesins can induc  the production of specific antibodies and 
their roles in binding host cell. 
Previous studies showe  that the adh sins of . agalactiae such as pili, can lead to antibody 
production nd elicit opsono h gocyto is to induce bacteria elimination events such as respir tor  
burst and phagocytotic activity by immune cells [147, 149]. In addition, although the antibodies do 
not induce pathogen elimination events, the specific antibody itself to the adhesins is capable to 
prevent infection because he antibody bindss to adhesins an  block the bacterial adhesi n to the 
host and i hi it establishment of bacterial infection [147]. For example, the presence of specific 
antibodies to PhtD and PhtE, member of adhesin Pht family in S. pneumoniae, significantly reduced 
S. pneu o iae binding to h man pithelial cells by blocking i teraction of the P tD a d PhtE 
adhesins with their r spective host receptors [150]. Streptococci carry multiple adhesins on the 
surface to adhere to specific host receptors [147]. Deleti n of certain adhesins can result in reducing 
pathogenes s of b cteria [147]. For instance, deletion of fibrinogen-binding dhesin FbsC genes 
fbsC from S. agalactiae caused decrease in bacterial adhesion to fibrinogen [164]. T is section will 
determine if the six adhesins fro  S. agalactiae and putative secreted and surface proteins from S. 
iniae can elicit functional antibodies in fish and their roles in adhesion will be investigated.  
 
2.2.1 Cloning and expression of adhesins in E. coli 
To etermine if the adhesins can elicit antibodies in fish, candidate genes will be expressed in E.coli 
using the Cha pion pET101 expression system (Invitrogen) [131]. The primers will be desig ed to 
cut off signal sequences and transmembrame regions. To identify signal peptides and 
transmembrane regions, protein sequences of the adhesins from S. agalactiae ST-261 strain 
QMA0271 will be analyzed by SignalP 4.1 Server [165] and TMHMM Server v. 2.0 [166]. The 
adhesins sequences will be amplified by the primers (Table 3) and cloned into pET101/D-TOPO® 
vector, then expressed in E. coli BL21 Star™(DE3) by following manufacture protocol.  
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Figure 5: A general represe tation f six adhesins domain structures and regions length. The orange 
boxes on N-terminal indicate signal peptides such as YSIRK, KxYKxGKxW and unknown signal 
pepti es. he green boxes show the regions of binding domains including streptococcal surface 
repeat (SSURE) domain, Invasin/Intimin c ll-ad esion (Invasi /Intimin) domain, Fibrinog  
bin ing protein (Fib_BP) do ain, serine-rich repeat adhesion glycoprotein (Ser_adh_Ntrm) and 
Fibrinogen bi ding o (Fib_BD). The grey boxes represent th  ains, which hav been 
identified but with low co fidence. These domains i clude Trypansoma brucei pr cyclic acid 
repetitive protein (Trypan_PARP), coiled_coil and C-terminal cell-wall surface anchor repeat 
(Ctrm_anchor) domains. The blue boxes indicate transmembrane d mains. All adh s ns have 
LPxTG cell-wall anchor (LPxTG) domains.  
 
2.2 Aim 2: To determine if the adhesins can induce the production of specific antibodies and 
their roles in bi ding host cell. 
Previous stu ies showed that the adhesins of S. agalactiae such s ili, can lead to antibody 
production and elicit opsonophagocyt sis to induce bacteria elimination eve ts such as re piratory 
burst and phagocytotic activity by im une cells [147, 149]. In addition, lthough the antibodies do 
not ind c pathogen elimi tio  event , the specific antibody its lf to the adhesins is capable to 
prevent infection because the antibody bindss to adhesins and block the bacterial adhesion to the 
host and inhibit establ shment of bacteri l infection [147]. For xample, the presence of specific 
antibodies to PhtD and PhtE, member of adhesin Pht family in S. pneumoniae, significantly reduced 
S. pneumoniae binding t  human epithelial cells by blocking interaction of the PhtD and PhtE 
adhesins with th ir respective host receptors [150]. Streptococci c rry multiple adhesins on t  
surface to a here to specific h st rec ptors [147]. D letion of certain adhesins can result in reducing 
pathogen sis f bacteria [147]. For instance, deletion of fibrinogen-binding adhesin FbsC genes 
fbsC from S. agalactiae caused decrease in bacterial adhesion to fibrinogen [164]. This section will 
determine if  si  adhesins from S. agalactiae and putative secreted and surface proteins from S. 
iniae can elicit functional antibodies in fish and their roles in adhesion will be investigated.  
 
2.2.1 Cloning and expression of adhesin  in E. coli 
To determine if t  adhesins can elicit antibodies in fish, candidate genes will be expressed in E.coli 
using the Champion pET101 expression system (Invitrogen) [131]. The primers will be designed to 
cut off signal sequences and transmembrame regions. To identify signal peptides and 
t ansmembrane regio s, protein sequences of the adhesins from S. agalactiae ST-261 strain 
QMA0271 will be analyzed by SignalP 4.1 Server [165] and TMHMM Server v. 2.0 [166]. The 
adhesins sequences will be amplified by the primers (Table 3) and cloned into pET101/D-TOPO® 
vector, then expressed in E. coli BL21 Star™(DE3) by following manufacture protocol.  
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Figure 5: A gener l represe tation of ix adhesins domain structures a  regions len th. The orange 
boxes on N-t rminal indicat  ignal peptides such as SIRK, KxYKxGKxW a d u known signal 
p pt d s. The green b x s show the regio s of binding do ains including streptococcal surface 
repeat (SSURE) domain, Inv sin/Intimin cell-adhesion (Invasin/Intim n) domain, Fibrinogen 
bindi g protein (Fib_BP) doma n, s rin -ric  repeat adhesi n glycoprotein (Ser_adh_Ntrm) and 
Fibrin gen binding dom in (Fib_BD). Th  gr y boxes represent the domains, w ich have been 
identified but ith low confid nce. These domains include Trypansoma brucei procyclic acid 
rep titive protein (Trypan_PARP), coiled_coil a d C-terminal cell-wall surfac  anchor repeat 
(Ctrm_anchor) domains. Th  blue boxes i d cate transme brane d ma s. All hesins have 
LPxTG ell-wall anchor (LPxTG) domains.  
 
2.2 Aim 2: To de ermine f the dhe ins can induce he production of specific tibodies and 
th ir roles i  binding host cell. 
Previous stu ies showed that the adhesins of S. agalactiae such as pili, can l a  to antibody 
production nd elic t opsonophago ytosis to induce bact ria eliminatio  events such a respiratory 
burst and phagocytotic activity by immun  cells [147, 149]. In addition, although the antibodies do 
no induce pathogen elim nation ev nts, the specific antib dy itself to the a hesins is capable to 
prevent infection because the antibody bindss to adhesins and block the bacterial adhesion to the 
ost and inhibit tablishm nt of act rial infecti n [147]. For example, the presence of specific 
antibodies to PhtD and PhtE, member of adhesin Pht family in S. pneumoni e, signifi antly reduced 
S. pneumoniae bi ding to uman pithelial cells by blocking interaction of the PhtD and PhtE 
adhesins with their re pective host receptors [150]. Streptococci carry multipl  ad sins on the 
surface to adhe t  sp ific host receptors [147]. D let on of certain adhesins can result in reducing 
pathogenesis of bacteria [147]. For insta ce, deletion of f brinogen-binding adhesin FbsC genes 
fbsC from S. galactiae c used decr ase in bacterial adhesi n to fibrinogen [164]. This section will 
determine if the ix adhesins from S. galac iae and pu tive secreted and surface proteins from S. 
n ae n elicit functional antibodies in fish a d their roles in adh s on w ll b  investigated.  
 
2.2.1 Cloning and expression of adhesins in E. coli 
To et rmin  f the adhesins can el cit antibodies in fish, candidate genes will be expressed in E.coli 
using the Champion pET101 expressio system (Invitrogen) [131]. The primer  will be designed to 
cut off sign l sequences and transmembrame reg ons. To identify s gnal peptides and 
transmembrane reg on , protein sequences of the adhesins from S. agalactiae ST-261 strain 
QMA0271 will be analyzed by SignalP 4.1 Server [165] and TMHMM Server v. 2.0 [166]. The 
adhesins sequences will be amplified by the primers (Table 3) a d cloned into pET101/D-TOPO® 
v ctor, then expressed in E. coli BL21 Star™(DE3) by following manufacture protocol.  
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Figure 5: A g neral representation of six adhesins domain structur s nd regions l gth. The orange 
boxes n N-termi al indicate signal peptides such as YSIRK, KxYKxGKxW and u know  si nal 
peptides. Th  green b xes show th  regions of binding dom in including treptococcal surf e 
repeat (SSURE) domain, Invasin/Intimin ell-adh sion (I v sin/Intim ) domain, Fi rinoge  
binding protein (Fib_BP) domain, serine-rich re eat adhesion glycopr t in (Ser_adh_N m) and 
Fibrinogen binding domain (Fib_BD). The grey b x  represe t the domai s, which have been 
identified but with low confidence. These domains inclu  Trypans ma bruce  procyclic i  
rep titive protein (Trypan_PARP), coiled_coil and C-terminal cell-wall surface a chor r pe t 
(Ctrm_anchor) do ains. The blue boxes indicate transme bran  domains. All dh ins have 
LPxTG cell-wall anchor (LPxTG) domains.  
 
2.2 Aim 2: To determine if the adhesins can induce t e produ tion of specific antibodies a  
their roles in binding host cell. 
Previous studies showed that the adhesins of S. agalactiae such as pili, can lead to antibody 
production and elicit opsonophagocytosis to induce bacteria elimin tion events such as respiratory 
burst and phagocytotic activity by immune cells [147, 149]. In addition, although the a tibodies do 
not induce pa hogen elimination events, the specific antibody its lf to the a hesins is c pable to 
prevent infection because the antibody bindss to adhesins and block the bacterial adhesion to the 
host and inhibit establishment of bacterial infection [147]. For example, the presence of specific 
antibodies to PhtD and PhtE, member of adhesin Pht family in S. eumonia , significantly educed 
S. pneumoniae binding to human epith lial cells by bl cking interaction f the PhtD and PhtE 
adhesins with their respective host receptors [150]. Strep ococci carry mult ple a h ins on the 
surface to adhere to specific host receptors [147]. Deletion of rtain adhesins can result in reducing 
pathogenesis of bacteria [147]. F r instance, d letion of fibrinogen-binding adhesin FbsC genes 
fbsC from S. agalacti e caused de ease in bacterial adhesion to fibrinogen [164]. This section will 
determine if the six adhesins from S. agalactiae and putative secreted and surface proteins from S. 
iniae can elicit functional antibodies in fish and their roles in adhesion will be investigated.  
 
2.2.1 Cloning and expression of adhesins in E. coli 
To determine if the adhesins can elicit antibodies in fish, candidate genes will be expressed in E.coli 
using the Champion pET101 expression system (Invitrogen) [131]. The primers will be designed to 
cut off si nal equences a d transmembrame regions. To ide tify signal peptides and 
transmembrane regions, protein sequences of the adhesins from S. agalactiae ST-261 st ain 
QMA0271 will be analyzed by SignalP 4.1 Server [165] and TMHMM Server v. 2.0 [166]. The 
adhesins sequences will be amplified by the primers (Table 3) and cloned into pET101/D-TOPO® 
vector, then expressed in E. coli BL21 Star™(DE3) by following manufacture protocol.  
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gure 5: A general representat o  of six adhesins d main structures and regio  length. The or nge
boxes on N-terminal indi ate sig al peptid s such as YSIRK, KxYKxGKxW and unknown signal
peptides. The green boxes show th  regions of binding dom i  including streptoco cal surface
repeat (SSURE) domain, Invasi /Intimin cell- dhesion (Invasin/Inti in) domain, Fibrinog
binding protein (Fib_BP) do ain, serine-rich repeat adhesion glycoprotein (Ser_ h_Ntrm) and 
Fibrinogen binding domain (Fib_BD). The grey boxes represent the domains, which have been 
d ntified but with low confide ce. These d mains include Trypansoma bru i procycli  acid
repe itiv prot in (Trypan_PARP), oi e _coil a d C-t rmin l cell-w l s rfa  anchor r peat
(Ctrm_anchor) domains. The blue boxes indicate transmembrane domains. All adhesins have 
LPxTG cell-wall anchor (LPxTG) domains.  
 
2.2 Aim 2: To determine if the adhesins can induce the production of specific antibodies and 
their roles in binding hos  cell. 
Pr vious s udi show d that the adhes ns of S. agalactiae such as pili, can lead to antibody 
pr ductio  and elicit opsonophagocytosis to induce bacteria elimination events such as respiratory 
burst and phagocytot c activity by immun  c lls [147, 149]. In addi ion, although t  antibodies do 
n t i duce pathogen eli nation even s, the specific antibody its lf to the adhesins is ca able to
prevent infectio  because the antibody bindss to adhesins and block the bacterial adhesion to the 
host and inhibit e tablishment of bacterial infection [147]. For example, the presenc  of specific 
antibodies to PhtD and PhtE, member of a hesi  Pht family in S. pneumoniae, significantly reduced 
S. pneumoniae binding to uman epithelial c lls by blocking interaction of the PhtD and PhtE 
adhesins with th ir respective host receptors [150]. Streptococci carry multiple adhesins on the 
surface to adhere t  specific host receptors [147]. Deletion of certain adhesins can result in reducing 
pathogenesis of bacteria [147]. F r instance, deletion of fibrinogen-binding adhesin FbsC gen s
fbsC from S. agalactiae caused decr ase in bacterial adhesion to fibrinogen [164]. This section will 
deter ine if the six adhesins f om S. agalactiae a d putative secreted a d surface proteins from S. 
iniae c n l cit functional antibodi s in fish and th ir les in adhesion will be investigated.  
 
2.2.1 Cloning and xpressi n of adhesins in E. co i 
To determine if the adhesins can elicit antibodies in fish, candidate genes will be expressed in E.coli 
using the Cha pion pET101 expression system (Invitrogen) [131]. The primers will be designed to 
cut off signal sequences and transmembrame regions. To iden ify signal peptides and 
transmembrane regions, protein sequences of the adhesins from S. agalactiae ST-261 strain 
QMA0271 will be nalyze  by SignalP 4.1 Server [165] and TMHMM Server v. 2.0 [166]. The 
adhesins sequences will be amplified by the primers (Table 3) and cloned into pET101/D-TOPO® 
v ctor, then ex ressed n E. coli BL21 Star™ DE3) by follow ng manufacture protocol.  
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Figure 5: A general representation of six adhesins domain structures and regi ns length. he orange 
boxes on N-terminal indicate signal peptides such as YSIRK, KxYKxGKxW a d unk own signal 
peptides. The green boxes sho  the regions of binding domains including streptoco cal surface 
repeat (SSURE) domain, Invasin/Intimin cell-adhesion (Invasin/I timin) omain, Fibrinogen 
binding protein (Fib_BP) domain, serine-rich repeat adhesion glycoprotein (Ser_adh_Ntrm) and 
Fibrinogen binding domain (Fib_BD). The grey boxes represent the domains, which ave been 
identifi d but with l w confidence. These domains includ  Trypansoma brucei procyclic acid 
repetitive protein (T ypan_PARP), coiled_coil and C-terminal cell-wall surface anchor repeat 
(Ctrm_anchor) domains. The blue boxes indicate transmembrane domains. All adhesins have 
LPxTG cell-wall anchor (LPxTG) domains.  
 
2.2 Aim 2: To determ e if the adh ins ca  induce the production f sp cific antib dies nd 
their roles in binding hos cell. 
Previous studies s wed that the adhes ns of S. ag lacti e such as pil , can lead to antibody 
production and elicit opsonophagocytosis to induce bacteri  elimi ati n events such as respirato y 
burst and phagocytotic activity by immu e cells [147, 149]. In addition, although th  antibo ies do 
not induce pathogen elimination events, th  specific antibody it el  to the adhesins is capab e to 
prevent infection becaus he a tibody bindss to adhesins and block the bacterial dhesion to the 
host and inhibit est blishm t of bacterial infection [147]. For examp e, the pr se ce of spec fic 
antibodi  to PhtD and PhtE, member of adhesin Pht family in S. p eumoniae, sign ficantly redu d 
S. pneumoniae binding to human epithelial cells by blocking inter ction f th  PhtD P tE 
adhesins with their respective host receptors [150]. Streptococci carry multipl  adhesins o  the 
surface to adhere to specific host receptors [147]. Deletion o  certain adhesins c n result in red cing 
pathogenesis of bacteria [147]. For instance, deletion of fibrinogen-binding adh si  FbsC genes 
fbsC from S. agalactiae caused decrease in bacterial adhesio  to fibri ogen [164]. This sectio will 
determine if the six adhesins fro  S. agalactiae an  putative ecreted and surface proteins from S. 
iniae can licit fun tional antibodies in fish and their roles in adhesi  will be i v t gat d.  
 
2.2.1 Cloning and expression of adhesins in E. coli
To determine if the adhesins can li it antibodies in fish, candidate genes will be xpresse i  E.coli 
using the Champion pET101 expression system (Invitrogen) [131]. The pri rs will b  design d t  
cut off signal sequences and transmembrame regions. To identify signal peptides and
transmembrane regions, protein sequences of the adhesins from S. agalactiae ST-261 strain 
QMA0271 will be analyzed by SignalP 4.1 Server [165] and TMHMM Serv r v. 2.0 [166]. The 
adhesins sequences will be amplified by the primers (Table 3) and cloned into pET101/D-TOPO® 
vector, then expressed in E. coli BL21 Star™(DE3) by following manufacture protocol.  
 
Signal.PepCde Binding.Domain Other.Domain.(insigniﬁcant) Tra smembra eLPxTG
29 109 158 190
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gure 5: A general represe tatio  of six adhesins domain structures and regio  length. The orange
boxes on N-term nal indicate sig al peptid s such as YSIRK, KxYKxGKxW and unknown sign l 
p tid s. T e gr en box s sh w th  regions of bi ding mains inclu ing streptococcal surface
repeat (SSURE) domain, Invasin/Intimin cell-adhesion (Invas n/Inti in) domain, Fibrinogen
bindi g protein (Fib_BP) domain, serine-rich repeat adhesion glycoprotein (Ser_adh_Ntrm) and 
Fibrinogen binding domain (Fib_BD). The grey boxes represent the domains, whic  have been
identified but with l w confidence. These omains nclud  Trypansoma brucei procyclic acid 
repetitive protein (Trypan_PARP), coiled_coil and C-terminal cell-wall surface anchor repeat 
(C rm_an h ) omains. The blue b xes indicate transmembra  domains. All adhesins have 
LPxTG cell-wall anchor (LPxTG) domains.  
 
2.2 Aim 2: To determine if the adhesins can induce he pr duction of specific antibodies nd 
their roles in binding host cell. 
Previous studies sh wed that the adhe ins of S. agalactiae uch as pili, can lead to an ibody 
production d elicit psonophagocytosis t  induce bacteria eliminatio  events such as respiratory 
b rst and phagoc to ic activity by immune cells [147, 149]. In addition, although the antibodies do 
not induce pathogen eli i ation events, the specific a tibody itself to the adhesi s is capable to 
preve t infection becaus  he antibo y bindss to adhesins and block the bacterial adhesion to the 
host and inhibit establishment f bacterial infection [147]. For example, the presence of specific 
antibodies to PhtD an  PhtE, member of adhesi  Pht family in S. pneumoniae, significantly reduced 
S. pneumoniae binding to human e ithelial cells by block ng interaction of the PhtD and PhtE 
adhesins with their respect ve h st receptors [150]. Streptococci arry multiple adhesins on the 
s rface to adhere t  spe ific host rece tors [147]. Deletion of certain adhesins can result in reducing 
pathogenesis of bacteri  [147]. For inst nce, deletion f fibrinogen-bi ding adh sin FbsC gene  
fbsC from S. agala tiae caused e rease in bac ial adhesion o fibrinoge  [164]. This section will 
d t r i e i  he s x adhesins from S. agalactiae and putative secr ted and surface prot i s from S. 
iniae can elicit func io al anti odies in fish a d their roles in adh ion will be investigated.  
 
2.2.1 Cloning and expression of adhesins in E. coli 
To determine if the adhesins can elicit antibodies in fish, candidate genes will be expressed in E.coli 
using the Cha pion pET101 expression system (Invitrogen) [131]. The primers will be designed to 
cut off signal s quenc s and transmem ram  regions. To identify signal peptides and 
transmembrane regions, protein sequences of the adhesins from S. agalactiae ST-261 strain 
QMA0271 will be nalyze  by SignalP 4.1 S rv r [165] and TMHMM Server v. 2.0 [166]. The 
adhesins s quences will be ampl fied y th  primers (Table 3) and cloned into pET101/D-TOPO® 
vector, then expressed in E. coli BL21 Star™(DE3) b  following manufacture protocol.  
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1 41
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Figure 5: A general r pr sentation of six dhesins dom in structures a  r gio s length. The orange 
boxes on N-terminal indicat  signal ep i s ch as YSIRK, KxYKxGKxW a d u know signal 
peptides. The green boxes show the regions of bin ing domain i c uding strepto occal surface
repeat (SSURE) d main, Invasin/Int min cell-adhes on (Invasin/Intimin) domain, Fibri ogen 
bin ing protein (Fib_BP) domain, serine-rich repeat adh sio glycoprotein (Ser_adh_Ntrm) and 
Fibrinogen binding do ain (Fib_BD). The grey boxes repre e t the domains, which have been 
identified but wi h low confid nc . Thes  do ins include Trypan oma brucei p ocyclic cid
repe itive protein (Trypan_ ARP), coiled_coil and C-terminal cell-wall urface an or repeat 
(Ctrm_anchor) domains. The bl e boxes indicate tr ns embra e d main . All adhesins ave 
LPxTG cell-wall ancho  (LPxTG) omains.  
 
2.2 Aim 2: To determine i  th  adhesins c n ind c  the production of specific ant odies and 
their roles in binding host cell. 
Previous studies showed that the adhesins of S. agalactiae uch as pili, can le d to a tibody 
production and elici  opsonophagocytosis to indu e bacteria elimi ation eve ts such as respiratory 
burst and phagocy otic act vity by i mune ells [147, 149]. In addition, alth ugh the antibodies do 
not nduce pathogen elimination events, the specific a t body its lf to the adhesins is capabl  to 
prevent infection because the ant body bi dss to a hesins and block  bact r al adh sion to th  
host and inhibit establishment of bact ria  infe ti  [147]. For example, t  presenc of specific 
ant bodies to PhtD and PhtE, m mber of adhesin Pht family in S. pneumoniae, s gnific tly reduced 
S. pneumoniae binding to human epithelial cells by blocking interaction of the PhtD and PhtE 
adhesins with their respect ve host re eptors [150]. Strep ococci carry multiple hesi s on the
surface to adhere to specific host receptors [147]. D letion of certain adhesins can result in reduc g 
pathogenesis of bacteria [147]. For instance, deletion of fibrinogen-binding adhe in FbsC genes 
fbsC from S. agalactiae caused de r ase in b c rial adhesion t  fib i ogen [164]. This ection will 
determine if the six adhesins from S. ag tiae and putativ  ecr ted and surface proteins from S. 
iniae can elicit functional antibodies in fish and their roles in adhesion will be investigated.  
 
2.2.  Cloning and expression of adhesi s in E. coli 
To determine if the adhesins can elicit antibodi s in fish, c ndidate genes will be xpressed in E.coli 
using the Champion pET101 expression system (Invitrog n) [131]. The primers will be d signed to 
cut off signal sequences and transmembrame regions. To identify signal peptides and 
transmembrane regions, protein sequ nces of the adhesins from S. agalactiae ST-261 strain 
QMA0271 will be an lyzed by ig alP 4.1 S rv r [165] and TMHMM Serv r v. 2.0 [166]. The 
adhesins sequences will be amplified by the primers (Table 3) and cloned into pET101/D-TOPO® 
vector, then expressed in E. coli BL21 Star™(DE3) by following manufacture protocol.  
 
Signal.PepCde Bindin .Domain Other.Domain.(insigniﬁcan ) TransmembraneCoiled_coil
246 276
 28 
Figure 5: A gen ral representatio  of six adhesins domain st uctur s a d regi ns le gth. The or ng
boxes on N-terminal in icate signal peptides such as YSIRK, KxYKxGK W a d unknow  signal 
peptides. The green boxes show the regions of bindi g domains including streptococcal surface 
repeat (SSURE) domain, Invasin/Intimin cell-adh sion (Inva in/Intimin) dom in, Fibrinogen 
binding protein (Fib_BP) domain, serine-rich r p at adhesio  glyco rotein (Ser_adh_Ntrm) d 
Fibrinogen binding domain (Fib_BD). The grey xes repr ent he do ai s, which h v  been
identified but with low confid n . These domains i clu e Trypans  br cei procyclic a id 
repetitive protein (Trypan_PARP), coiled_coil and C-t rmi al cell-w ll surf ce anchor repe t 
(Ctrm_a chor) domains. The blue b xes indicate transm mbr ne do ains. All av  
LPxTG cell-wall anchor (LPxTG) dom ins.  
 
2.2 Aim 2: T  determine if the adhesins can induce the production of specific antibodi s and 
their roles in binding host cell. 
Previous studies showed that th  dhesins of S. agalactiae such as pili, can lead to antibody 
production and elicit opsonophagocytosis to induce bacteria elimination events such as respira ory 
burst and phagocytotic activity by im une cells [147, 149]. In addition, lthough the tibodies do 
not induce pathogen elimination events, the specific antibody its lf to the ad esins is capable to 
prevent infection because the antibody bindss to adhesins and block the bacteria  adhesio to the 
host and inhibit establishment of bacterial infection [147]. For example, the presence of spe ific
antibodies to PhtD and PhtE, member of ad sin Pht family in S. pne moni e, significantly re uc d 
S. pneumoniae b nding to human epithelial cells by blocking i teraction of the PhtD and PhtE
adhesins with their respective host receptors [150]. Strep ococci carry multiple adhesins  the 
surface to adhere to specific host receptors [147]. Del tion of certain adhesins can re ult in reducing 
pathogenesis of bacteria [147]. For instance, deletion of fibrin gen-binding adhesin FbsC genes 
fbsC from S. agalactiae caused decrease in bacterial adhesio  to fibrinogen [164]. This sectio  will 
determine if the six adhesins from S. agal ctiae and putative secreted and surfac  prot in  rom S.
iniae can elicit functional antibo ies in fish and their roles in adhesion will be investigated.  
 
2.2.1 Cloning and expression of dhesins n E. coli
To determine if the adhesi s can elicit antibodies in fish, candidate genes will be expressed in E. oli 
using the Champion pET101 expression system (Invitrogen) [131]. The primers will be designed to 
cut off signal sequences and transmembrame regions. To identify signal peptides and 
transmembrane regions, protein sequences of the adhesins from S. agalactiae ST-261 strain 
QMA0271 will be analyzed by SignalP 4.1 Server [165] and TMHMM Server v. 2.0 [166]. The 
adhesins sequences will be amplified by the primers (Table 3) and cloned into pET101/D-TOPO® 
vector, then expressed in E. coli BL21 Star™(DE3) by following manufacture protocol.  
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Figure 5: A general representatio  of six adhesins domain st uctures and regions length. The orange 
boxes on N-terminal indicate signal peptides such as YSIRK, KxYKxGKxW and unknown signal 
peptides. The green boxes sh w the regions of binding domains including treptococcal surface 
repeat (SSURE) domain, Invasin/Intimin cell-adhesion (Invasin/Intimin) domain, Fibrinogen 
binding protei  (Fib_BP) domain, serin -rich repeat adhesion g ycoprot in (Ser_adh_Ntrm) and 
Fibrinoge  binding domain (Fib_BD). The r y boxes represent the domains, which ave been 
identified but with low confidence. These dom ins include Tryp nsoma brucei procyclic cid 
repetitive pro ein (Trypan_PARP), coiled_c il and C-terminal cell-wall surface anch r repeat 
(Ctrm_anchor) domains. The blue boxes indicate transmembrane domains. All adhesins have 
LPxTG cell-wall anchor (LPxTG) domains.  
 
2.2 Aim 2: To determine if the adhesins can in uce the production of specific antibo ies and 
their roles in binding host cell. 
Previous studies showed that the adhesins of S. agalactiae such as pili, can lead to antibody 
production and elicit opsonophagocytosis to induce bacteria elimination events suc  as respiratory 
burst and phagocytotic activity by immune cells [147, 149]. In addition, although the antibodies do 
not in uce pathogen elimination events, he sp c fi  antibody itself to the adhesins is capable to 
prevent infection because e antibody bindss to adhesins and block the bacterial adhesion to the 
host and inhibit establishment of bacterial infection [147]. For ex mple, the presence of specific 
antibodies to PhtD nd PhtE, ember of adhesin Pht family in S. pn umoniae, significantly reduced 
S. pneumoniae bi ding to hu an epithelial cells by blocking interaction of the PhtD and PhtE 
adhesins with their respectiv  host receptors [150]. Streptococci c rry multiple adhesins on the 
surface to adhere to specific host receptors [147]. Deletion of certain adhesins c n result in reducing 
pathogenesis of bacteria [147]. For i stance, deletion of fibrinog n-binding adh sin Fb C genes 
fbsC from S. agalactiae caused decrease in bacterial adhesion to f ri ogen [164]. This section will 
determine if the six adhesins from S. agalactiae and putative secreted and surface proteins from S. 
iniae can elicit functional antibodies in fish and their role  in adhesi n will be investigated.  
 
2.2.1 Cloning and expression of adhesins in E. coli 
To determine if the adhesins can elicit antibodies in fish, candidate genes will be expressed in E.coli 
using the Champion pET101 expression system (Invitrogen) [131]. T e primers will be designed to 
cut off signal sequences and transmembrame regions. To identify signal peptides and 
transmembrane regions, protein sequences of the adhesins from S. agalactiae ST-261 strain 
QMA0271 will be analyze  by SignalP 4.1 Server [165] and TMHMM Server v. 2.0 [166]. The 
adhesins sequences will be amplified by the primers (Table 3) and cloned into pET101/D-TOPO® 
vector, then expressed in E. coli BL21 Star™(DE3) by following manufacture protocol.  
 
Signal.PepCde Binding.Domain Other.Domain.(insigniﬁcant) Transmembrane
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addition of glucose increased the growth (Fig. 3.2). In addition, while bacteria reached 
stationary phase in THB, THB with metals and TB cultures after 24 h, the stationary phase 
for QMA0285 grown in TB with glucose was not observed after 30 h of incubation (Fig. 3.2). 
 
The effect of changing the culture environment on expression of cpsE and ST-261 adhesin 
genes was investigated by real-time qRT-PCR. Carbohydrate limitation (growth in TB) 
increased relative expression of ST-261 adhesins whilst decreasing expression of cpsE 
compared to culture in THB (Fig. 3.3). The expression of adhesin_0337, 0626 and 1648 
were up-regulated by 12.5 (p < 0.005), 4.8 (p < 0.05) and 9.2-fold (p < 0.05) respectively 
when grown in TB compared to THB (Table 3.3). Addition of glucose to TB culture increased 
both ST-261 adhesins and cpsE expression relative to expression in THB (Fig. 3.3). 
However, only adhesin_0337 and 1648 were increased significantly, which adhesin_0337 
was upregulated by 12.4-fold (p < 0.05) and adhesin _1648 were increased by 9.2-fold 
compared to the reference condition. Relative expression of ST-261 adhesins and cpsE was 
lower than in THB when metals were added to THB culture during mid exponential growth 
(Fig. 3.3), with 8.4-fold (p < 0.005) decrease in expression of adhesin_0626, a 2.7-fold (p = 
0.005) decrease in expression of adhesin_1196, a 5.6-fold (p < 0.005) decrease in 
expression of adhesin_1648 and a 13-fold (p < 0.005) decrease in cpsE expression (Table 
3.3). 
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Fig. 3.2. Growth of S. agalactiae strain QMA0285 in different culture media. Bacteria was grown in four 
different cultures 1/ THB (in Red), 2/ THB + 5 µM Mn(II)SO4 and 100 µM Zn(II)SO4 (THB + Mn&Zn in Blue), 
3/ TB without glucose (TB in Green) and 4/ TB + 55 mM glucose (TB + Glu in Pink). 
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Fig. 3.3. Relative expression of GBS QMA0285 adhesins and cpsE genes under three different culture 
conditions. Up- or down-regulations of genes are shown relative to expression in Todd-Hewitt broth 
(THB) during exponential growth. A) Expression ratio of adhesin_0337 (Log2). B) Expression ratio of 
adhesin_0626 (Log2). C) Expression ratio of adhesin_1196 (Log2). D) Expression ratio of adhesin_1648 
(Log2). E) Expression ratio of cpsE (Log2). * p < 0.05, ** p < 0.01, *** p < 0.001 (n = 9).  
 
Table 3.3.  Relative expression of QMA0285 adhesins and CpsE genes under three different culture 
conditions. Up- or down- regulation of genes relative to the expression in bacteria cultured in Todd-
Hewitt broth (THB) during exponential growth.  
note 1: the values in red indicate statistically significant up-regulation of the genes. 
note 2: the value in blue show statistically significant down-regulation of the genes. 
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Conditions adhesin_0337 adhesin_0626 adhesin_1196 adhesin_1648 CpsE 
TB w/o glycerol 12.483 4.773 3.998 8.614 -1.46 
TB + glucose 12.422 5.638 5.135 9.215 1.008 
THB +Mn & Zn -2.078 -8.395 -2.701 -5.580 -13.0 
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3.3.3. Serum antibody against recombinant ST-261 adhesins reacted with the vaccine 
antigens except for antisera against adhesin_1196 
In order to determine whether tilapia responded to vaccination with recombinant ST-261 
adhesins and to raise specific antibody for downstream analyses, specific antibodies in 
serum collected from vaccinated tilapia were quantified by indirect ELISA against 
recombinant ST-261 adhesins. ELISA results revealed that tilapia vaccinated with 
recombinant adhesin_0337 and mixture of three recombinant ST-261 adhesins had 
significantly higher level of specific serum antibodies compared to PBS vaccinated fish 
serum (p < 0.005), followed by the fish received recombinant adhesin_0626 (p < 0.01) (Fig. 
3.4A-B and D). However, ELISA detected low level of serum antibody in tilapia injected 
recombinant adhesin_1196, with absorbance not significantly different from PBS negative 
control fish (p > 0.1).  
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Fig. 3.4. Tilapia serum antibody responses to vaccine antigen measured by indirect ELISA. The 
response of serum antibody against recombinant adhesin was compared with the response of serum 
antibody from tilapia injected with PBS. A) The responses of serum antibodies against recombinant 
adhesin_0337 and PBS. B) The responses of serum antibodies against recombinant adhesin_0626 and 
PBS. C) The responses of serum antibodies against recombinant adhesin_1196 and PBS. D) The 
responses of serum antibodies against mixture of the three adhesins and PBS. ** p < 0.05; *** p < 0.005.  
 
3.3.4. Changes in the protein profile of QMA0285 cultured in different conditions after 18 h  
To determine whether changes in ST-261 adhesin gene expression correlated with changes 
in proteins in the culture, total proteins extracted from QMA0285 were compared between 
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different culture conditions and time points by SDS-PAGE. There were no apparent 
differences in the protein profiles of QMA0285 in samples taken after 12 h (Fig. 3.5). 
However, after 18 h of incubation, proteins with relative mobilities of 56 kDa, 54 kDa and 43 
kDa were observed in TB and TB with glucose cultures at 18 h and were also more abundant 
than in THB and THB with metals (Fig. 3.5). The apparent concentrations of these proteins 
remained high relative to other proteins in the TB and TB + glucose culture medium after 24 
h (Fig. 3.5). ` 
 
 
Fig. 3.5. Silver stained SDS-PAGE of whole cell proteins of GBS strain QMA0285 grown under different 
conditions. Cells were grown in four different conditions including 1/ THB, 2/ THB + 5 µM Mn(II)SO4 and 
100 µM Zn(II)SO4 (MnZn), 3/ TB without glycerol (TB) and 4/ TB + 55 mM glucose (TB Glu). Cells were 
harvested at 12 h, 18 h and 24 h time points and reduced by boiling for 15 min in reducing buffer 
containing DTT. Five µL of reduced samples were resolved by 12% SDS-PAGE gel and stained by 
Silver-stain. Predicted molecular masses of four adhesins are: 1) adhesin_0337 is 56.4 kDa, 2) 
adhesin_0626 is 54.4 kDa, 3) adhesin_1196 is 22.3 kDa and 4) adhesin_1648 is 43.45 kDa. Lane M 
contains broad range protein marker (New England Biolabs). 
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Sera of vaccinated tilapia were used in Western blotting to identify the antigens which were 
recognised in the whole protein profiles from GBS strain QMA0285 grown under the four 
experimental culture conditions (Fig. 3.6). Regardless of different culture conditions and 
antiserum, a major antigen with molecular mass of ~35 kDa was detected (Fig. 3.6A-D). 
From bacteria grown in THB and THB with metals, other less immunoreactive bands (~70, 
57 and 40 kDa) were identified by all antisera (Fig. 3.6A-B). However, bacteria grown in TB 
without glycerol and TB with glucose expressed fewer antigens that were detected by serum 
compared to bacteria grown in THB and THB with additional Mn and Zn (Fig. 3.6C-D). An 
immunoreactive band (~55 kDa) was detected on the membrane strips incubated with 
antiserum against recombinant adhesins_0626 when the bacteria were cultured in THB, 
THB with metals and TB without glycerol, but not when bacteria were grown under high 
glucose condition (Fig. 3.6A-D). Although antisera against recombinant ST-261 adhesins 
(adhesin_0337, 1196 and mix) detected vaccine antigen (Fig. 3.6E), the bands were not 
observed in the whole cell lysates by Western blot (Fig. 3.6A-D). 
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Fig. 3.6. Immunoblot profiles of whole cell of GBS strain QMA0285 grown in four different culture 
conditions, reacted with antisera from vaccinated tilapia. Lane M is the protein marker (New England 
Biolabs) and label on top of each lane is showing the antiserum used to incubate the membrane strips. 
A) THB grown QMA0285 antigens, B) THB + 5 µM Mn(II)SO4 and 100 µM Zn(II)SO4 (MnZn) grown 
QMA0285 antigens, C) TB without glycerol grown QMA0285 antigen, D) TB + 55 mM glucose grown 
QMA0285 antigens and E) recombinant adhesin_0337 (56.4 kDa), 0626 (54.4 kDa), 1196 (22.3 kDa) and 
mixture of the three adhesins detected by antisera from tilapia that were with each recombinant 
vaccine.  
 
3.4. Discussion 
Reverse vaccinology using pan-genomes gives unprecedented ability to identify highly 
conserved surface and secreted epitopes across very diverse lineages of pathogens in silico, 
therefore, has potential to identify universal protein antigens amongst highly variable 
pathogens such as GBS (Maione et al., 2005; Rappuoli, 2001). From pan-genome analysis, 
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six novel surface proteins, including three putative adhesins specific to serotype Ib piscine 
strains, one is specific to ST-261 isolate, and three adhesins identified in all GBS strains in 
the pan-genome (Kawasaki et al., 2018). Due to their critical roles in early stages of infection, 
adhesins are considered as good vaccine candidate antigens (Nobbs et al., 2009; Raynes 
et al., 2018). Therefore, in this study, we investigated four of ST-261 adhesins, one that is 
specific to serotype Ib piscine strains and three that are conserved among all strains, in 
order to assess if they would be good candidate antigens for the development of a cross-
protective vaccine against multiple serotypes. All the identified ST-261 adhesins display a 
signal peptide sequence at the N-terminus and a LPXTG anchor motif at the C-terminal 
suggesting that they are cell-wall anchored proteins (Novick, 2000; Schneewind and 
Missiakas, 2012; Siegel et al., 2017). Two ST-261 adhesins, adhesin_0337 and 0626, 
exhibit domain repeats in their amino acid sequences, characteristic of adhesins in 
streptococci (Nobbs et al., 2015). The two SSURE domains, which were found in 
adhesin_0337, are known to bind to fibronectin (Bumbaca et al., 2004) suggesting that 
adhesin_0337 may play a role in attachment to fish extracellular matrix proteins. Bacterial 
immunoglobulin-like (Ig) 1 domain identified in adhesin_0626 is also present in pathogenic 
E. coli intimin and Yersinia pseudotuberculosis invasin, both belonging to a family of 
bacterial adhesion molecules that play an important role in pathogenicity (Hamburger et al., 
1999; Luo et al., 2000). Since no homologous sequences of adhesin_1196 were found in 
the database, this protein may only be present in GBS. The present study did not reveal the 
binding domain of adhesin_1648 but found a coiled-coil region with no known function.  
 
In order to infect its host, bacteria must cope with the stress resulting from rapid 
environmental changes and host conditions, for example the availability of nutrients like 
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metal ions and carbohydrates (Claverys et al., 2000; McIver et al., 1995). The ability to adapt 
to these changes is critical, especially for pathogens that have a wide range of niches such 
as invasive Streptococci (Claverys et al., 2000; Tettelin et al., 2005). Group B Streptococcus 
is able to regulate the expression of multiple virulence factors during the course of infection 
to best fit the changing micro-environments of the host (Di Palo et al., 2013; Rajagopal, 
2009). For instance, to initiate bacterial attachment during early stage of infection, 
streptococci decrease CPS production in order to maximize the exposure of their adhesins 
to host cells (Rajagopal, 2009).  
 
In the present study, ST-261 adhesins and cpsE genes were down-regulated in QMA0285 
under elevated metal ion concentrations (addition of manganese and zinc) compared with 
expression during exponential phase in THB. Manganese and zinc are important metal ions 
for bacteria as micronutrients and their availabilities fluctuate amongst host tissue micro-
environments (Jacobsen et al., 2011; McDevitt et al., 2011). These metal ions have 
previously been associated with the regulation of Streptococcal virulence factors (Brown et 
al., 2016; Eijkelkamp et al., 2015; Kadioglu et al., 2008; McDevitt et al., 2011). In S. 
pneumoniae, the expression of pneumococcal histidine triad (Pht) proteins, which are 
involved in adhesion to human epithelial cells, are repressed by AdcR repressor in the 
presence of zinc (Kallio et al., 2014; Shafeeq et al., 2011). Zinc is also an important metal 
ion involved in innate immune defenses; indeed in response to bacterial infection, the host 
is capable of increasing the zinc concentration in its tissue (Cheryl-lynn et al., 2015). Under 
high zinc condition, S. pneumoniae’s manganese uptake via pneumococcal surface antigen 
A (PsaA) is inhibited since zinc binds competitively to PsaA, resulting increased 
susceptibility to oxidative stress (McDevitt et al., 2011). Manganese is a crucial metal ion in 
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S. pneumoniae, indeed it is required in the production of capsule (CpsB) and also involved 
in reactive oxygen species detoxification, thus manganese limitation results in reduction of 
capsule and increased susceptibility to oxidative stress (Jacobsen et al., 2011; Morona et 
al., 2002). Zinc stress can interrupt the enzymatic activity of phosphoglucomutase, leading 
to the reduction of capsule biosynthesis in S. pyogenes (Cheryl-lynn et al., 2015). Although 
the regulatory mechanisms of ST-261 adhesin expression and those involved in CPS 
expression have not been investigated in the current study, down-regulations of four ST-
261 adhesins and cpsE genes from GBS strain QMA0285 may be caused by high zinc 
concentration affecting regulatory system.  
 
In the host environment, the availabilities of carbon sources such as carbohydrates are 
highly variable (Paixão et al., 2015). Since carbohydrates are important for bacterial growth, 
pathogens must deal with fluctuating amounts of carbohydrates to survive in specific host 
niches, often by regulating protein production including adhesins and CPS (Di Palo et al., 
2013; Paixão et al., 2015). The expression of ST-261 adhesins by GBS strain QMA0285 
grown in carbohydrate-limited TB culture and high glucose TB culture was equally up-
regulated compared with expression when grown in THB. When free-sugar availability is 
low, bacteria must acquire carbon from other sources such as glycoproteins (Burnaugh et 
al., 2008; Shelburne et al., 2008). When S. pneumonia, is grown in media containing only 
human α-1 acid glycoprotein or yeast extract as a carbon source it is capable of growth, 
albeit reduced compared with media containing free sugars (Burnaugh et al., 2008). In our 
study, the growth of QMA0285 was reduced in carbohydrate limited TB culture (Fig. 3.2) but 
the bacteria still grew suggesting that bacteria are using yeast extract in TB culture medium 
as a carbon source. Therefore, although free carbohydrates were limited, the amount of 
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carbon seems to be sufficient for QMA0285 to yield similar levels of ST-261 adhesins gene 
expression with cells grown in high glucose TB, suggesting expression of these proteins is 
critical even under carbon limitation. Previous studies on GBS serotype V strain 2603V/R 
suggested that under high glucose conditions, genes coding for virulence factors such as 
adhesin BibA were down-regulated (Di Palo et al., 2013), in contrast with our findings. 
Invasive streptococci may respond to environmental cues via two-component regulatory 
systems such as the capsule synthesis regulator CovRS; CovRS in GBS is responsible for 
regulating genes encoding virulence factors (Di Palo et al., 2013; Lamy et al., 2004), 
including BibA in GBS strain 2603V/R, and CovRS act as a repressor under high glucose 
condition leading to the down-regulation of the BibA gene (Di Palo et al., 2013). However, 
the regulatory control of CovRS is strain-specific (Lembo et al., 2010; Rajagopal, 2009), 
therefore, in piscine ST-261 GBS strain QMA0285, CovRS may either induce ST-261 
adhesins expression in the presence of high glucose concentration or different regulatory 
systems not yet described in this lineage may be involved in the control of ST-261 adhesin 
expressions.  
 
Enzyme Linked Immunosorbent Assay results revealed that tilapia develop a specific 
antibody response to recombinant adhesin_0337, 0626 and mixture of three recombinant 
ST-261 adhesins but the level of antibody against recombinant adhesin_1196 was not 
different from negative control (Fig. 3.4C). In addition, Western blotting analysis indicated 
immunoreactive band of adhesin_1196 incubated with antiserum against adhesin_1196 was 
weaker than the band of adhesin_1196 on the membrane strip incubated with antiserum 
against mixture of three adhesins (Fig. 3.6E). The antigens’ immunogenicities can be varied 
depending on their characteristics including solubility, chemical nature and molecular size 
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(Roberts, 2012). Roberts (2012) suggested proteins with high molecular weight are more 
immunogenic than smaller peptides. Recombinant adhesin_1196 is smaller than other ST-
261 adhesin with molecular mass of 22.3 kDa so it may be less immunogenic. Also, rainbow 
trout (Oncorhynchus mykiss) elicit antibody against Flavobacterium psychrophilum proteins 
with molecular mass between 35 to 45 kDa and 65 to 200 kDa (LaFrentz et al., 2004). 
However, other studies on this bacterium showed that an 18 kDa protein was highly 
immunogenic in rainbow trout (Dumetz et al., 2006; Sudheesh et al., 2007). Therefore, 
adhesin_1196 should be big enough to be recognised by fish. To understand lower 
antigenicity of this adhesin, other characteristics such as chemical natures of the adhesin 
need to be examined. Perhaps conjugating this adhesin with a carrier protein like keyhole 
limpet hemocyanin may help to elicit a T-dependent response to the adhesin in tilapia.  
In the present study, we investigated the regulation of ST-261 adhesins and cpsE in 
response to different culture conditions to identify the best environmental condition for ST-
261 adhesins expression. However, although ST-261 adhesins and cpsE expression were 
suppressed under metal-supplemented culture condition and up-regulated under the high 
glucose, the Western-blotting analysis results did not resolve differences from control culture 
condition (THB). This may be due to the lack of correlation between mRNA abundances and 
protein concentration as post-transcriptional, translational and degradation regulation 
contribute to expressed protein concentration as much as transcription (Vogel and Marcotte, 
2012). In our study, despite the significant change in gene regulation, the differences of ST-
261 adhesins and cps expressed on GBS might not be detectable due to the effects of post-
transcriptional processes.  
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In conclusion, given the antigenicity of adhesin_0373 and 0626, these ST-261 adhesins 
would be good vaccine candidate. In addition, although the level of specific antibody 
response to adhesin_1196 was low, the adhesin was recognised by tilapia when it was 
mixed with other adhesins, 0373 and 0626. A vaccination and challenge model trial in fish 
is warranted. In this study, we only investigated the characteristics of ST-261 adhesins by 
analysing general domain structures. However, the roles of these ST-261 adhesisns in 
relation to pathogenicity in fish are unknown. Therefore, further work might focus on roles of 
ST-261 adhesins using knockout mutants to investigate pathogenicity in an in vivo fish 
model. Moreover, capability of adhesin-specific antibodies to block binding to host tissue 
and subsequent infection might be investigated in primary fish cell cultures and passive 
immunisation studies respectively (Khan and Pichichero, 2012; Raynes et al., 2018; 
Wizemann et al., 1999).
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Chapter 4: Recombinant ST-261 adhesins from Streptococcus agalactiae are not 
effective as an injectable vaccine against Streptococcosis in tilapia (Oreochromis 
mossambicus) 
 
Abstract 
Effective vaccinations have underpinned disease control in the aquaculture industry for 
more than a decade. However, despite the successes, some bacterial fish pathogens are 
hard to control by vaccination due to high strain diversity. Streptococcus agalactiae (Group 
B Streptococcus; GBS) expresses a polysaccharide capsule which is the major protective 
antigen in vaccines, but there are multiple serotypes that infect fish. Using a pan-genome 
reverse vaccinology approach, ST-261 adhesins were identified as conserved, surface 
located potential vaccine candidates that are immunogenic in tilapia. Here, we evaluated 
the efficacies of recombinant ST-261 adhesins as injectable vaccines in tilapia, Oreochromis 
mossambicus, in a challenge experiment. Tilapia were vaccinated intraperitoneally (IP) with 
whole-cell vaccines prepared from GBS serotype Ib strain (QMA0285) or Ia strain 
(QMA0357), recombinant ST-261 adhesins (0337, 0626 and 1196), and a mixture of the 
recombinant proteins. After 900 degree days following immunisation, fish were challenged 
by IP injection with GBS serotype Ib isolate (QMA0285) and mortalities were monitored. The 
challenge resulted in relative percentage of survival (RPS) of 81.6% in fish vaccinated with 
serotype Ib whole-cell vaccine followed by RPS of 24.92% in tilapia injected with serotype 
Ia whole-cell vaccine. All recombinant ST-261 adhesin vaccines (0337, 0626, 1196 and mix) 
resulted in RPS of less than 15%. This lack of protection by recombinant vaccines may be 
due to capsular polysaccharide (CPS), which is the dominant antigen, masking other 
antigens including the adhesins. It may also be that adhesins are not expressed during the 
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critical stages of proliferation in the host. Future work should elucidate the role of these ST-
261 adhesins in pathogenicity in fish, including and where and when they are expressed on 
GBS during the infection.  
 
4.1. Introduction 
Aquaculture is the fastest-growing primary production sector in the world (Defoirdt et al., 
2011; FAO, 2016). Production has been increasing dramatically in the last five decades and, 
in 2014, aquaculture production for human consumption overtook the wild catch fisheries for 
the first time (FAO, 2016). Contribution of aquaculture to sustainable food security is 
significant but it also plays important roles in development of economic, social and 
environmental sectors (Assefa and Abunna, 2018; FAO, 2016). Expansion of the 
aquaculture industry is essential to accommodate the increased demand for seafood, 
however, there are also constraints for the industry, especially disease (Assefa and Abunna, 
2018; Bondad-Reantaso et al., 2005; Defoirdt et al., 2011; Stentiford et al., 2017). The global 
losses caused by disease are estimated at six billion US dollars every year and the impacts 
of disease are more remarkable in developing countries (Assefa and Abunna, 2018). Under 
farm conditions, disease-causing agents, such as bacteria, can reach higher densities than 
in the wild and hosts are more likely to be exposed to pathogens (Defoirdt et al., 2011). 
Since total eradication of pathogen from the farming system is not feasible, other means of 
control are important to further expansion of the aquaculture industry (Assefa and Abunna, 
2018; Defoirdt et al., 2011; Millard et al., 2012). Control with antibiotics facilitates acquisition 
of antibiotic resistance by pathogens (Assefa and Abunna, 2018; Defoirdt et al., 2011), which 
can be dispersed in the environment around farming sites and increase the risk of horizontal 
resistance gene transfer to other serious pathogens (Barlow, 2009; Cabello et al., 2013; 
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Kümmerer, 2009) with consequent risk to human health (Cabello et al., 2013). Therefore, 
the use of antibiotics is under strict regulation in aquaculture and has been reduced 
substantially (Assefa and Abunna, 2018). Vaccines have played an important role in the 
reduction of antibiotic use for disease control and prevention in the aquaculture industry 
(Håstein et al., 2005; Sommerset et al., 2014). In Norway, since the introduction of functional 
vaccines against bacterial pathogens during the early 1990s, the production of salmonids 
has increased more than tenfold while the use of antibiotics has been almost eliminated 
(Gudding, 2014; Håstein et al., 2005). Currently a number of vaccines have been developed 
against bacterial pathogens, such as Aeromonas salmonicida, various Vibrio spp., 
Francisella spp., Yersinia spp. and Streptococcus spp. (Barnes et al., 2016; Håstein et al., 
2005; Munang’andu, 2018). However, some bacterial fish pathogens are still hard to control 
by vaccination.  
 
Streptococcus agalactiae or Group B Streptococcus (GBS) is an important pathogen not 
only in human and domestic animals but also in farmed and wild fish in warm-water regions 
throughout the world (Delamare-Deboutteville et al., 2015; Evans et al., 2002). The impact 
caused by GBS outbreaks is significant, especially in tilapia (Oreochromis spp.) production 
(Li et al., 2016). Whole-cell vaccines against GBS that provide excellent protection in tilapia 
species have been produced (Eldar et al., 1995b; Evans et al., 2004). For example, a 
commercial vaccine against S. agalactiae biotype II (serotype Ib), AQUAVAC® Strep Sa, 
has been developed by Merck Animal Health Inc., and is available in a number of countries 
where it has approval for use. However, GBS whole-cell vaccines are only efficient against 
the homologous serotype and do not give protection against different serotypes (Bachrach 
et al., 2001; Paoletti and Madoff, 2002). Group B Streptococcus serotypes are determined 
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by capsular polysaccharide (CPS), which is present in most encapsulated Gram-positive 
bacteria, and is the major antigen recognized during antibody-mediated adaptive immunity 
(Paoletti and Madoff, 2002). To date, there are 10 different GBS serotypes and each 
serotype elicits only type-specific antibody production (Maione et al., 2005; Paoletti and 
Madoff, 2002; Slotved et al., 2007; Yao et al., 2013). Moreover, CPS is highly polymorphic 
and, under the strong selective pressure of vaccination and fish immunity, re-emergence of 
novel serotypes can occur (Bachrach et al., 2001; Millard et al., 2012). Currently, three 
different serotypes including Ia, Ib and III are known to cause disease in wild and farmed 
fish (Kawasaki et al., 2018). Therefore, in order to develop more cost-effective cross-
protective vaccines, identification of highly conserved surface protein antigens across 
different CPS serotypes is critical (Baiano and Barnes, 2009; Maione et al., 2005).  
 
Conventional approaches to vaccine development tend to focus on the dominant antigens 
so they are not effective if the pathogen’s major antigens are highly variable, such as CPS 
in Streptococcus (Johri et al., 2006; Rappuoli, 2001). In the era of next-generation 
sequencing, prediction of all potential vaccine candidate antigens in a bacterial species and 
identifying the most conserved antigens among all strains are possible (Rappuoli, 2001). 
This approach is called reverse vaccinology (Rappuoli, 2001). Reverse vaccinology 
identifies potential antigens by examining the pan-genome of the pathogen to determine all 
open reading frame (ORFs) encoding proteins (Johri et al., 2006). The identified ORFs are 
analysed in silico to identify surface-located and secreted proteins; protein antigens most 
likely to be accessible to the host immune system. Finally, the antigens are tested and their 
efficacies determined in vaccine trials in animal model (Johri et al., 2006). The first universal 
vaccine against GBS human isolates, which confers protection against serotypes Ia, Ib, II, 
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III, V and VIII, was developed by applying the reverse vaccinology approach based on a 
GBS pan-genome including eight genome sequences of GBS strains (Maione et al., 2005).  
 
In the present study, we have employed a reverse vaccinology approach based on a pan-
genome from 82 GBS isolates (Kawasaki et al., 2018). Several identified surface proteins 
were characterised as adhesins, and three of them were conserved in most of the strains 
including terrestrial isolates (Kawasaki et al., 2018). Recombinant adhesins, alone and as 
mixtures, were found stimulate antibody production in tilapia by enzyme linked 
immunosorbent assay (ELISA) and Western blot (Chapter 3). To determine if these adhesins 
confer protection against GBS, recombinant vaccines were tested in a tilapia challenge 
model. We also identified the optimal culture conditions for adhesins expression (Chapter 
3). To determine if these adhesins can confer protection against GBS, their efficacies were 
examined by a tilapia challenge model. In the previous chapter, we identified the optimal 
condition for adhesins expressions (Chapter 3). Therefore, a whole-cell vaccine was 
produced from GBS serotype Ia grown under these optimum conditions to evaluate cross-
protection against challenge with the heterologous serotype Ib.   
 
4.2. Materials and methods 
4.2.1. Ethics and biosecurity statements 
Catching, breeding, vaccination and challenge in tilapia were performed under guidance of 
animal welfare and ethics requirements with approval by the Animal Welfare Unit UQ 
Research and Innovation in the University of Queensland (AEC approval number: 
SBS/398/16). In addition, since tilapia, Oreochromis mossambicus, is an invasive pest 
species in Australia, permission to collect, transport, possess and breed tilapia for research 
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purposes was obtained from Queensland Government Department of Agriculture and 
Fisheries Biosecurity Act 2014 (permit number: PRID000267).  
 
4.2.2. Tilapia breeding  
The sex of wild tilapia was determined by observing genital papilla and the animals were 
placed into a recirculating fresh water system consisting of two glass aquaria. Two male and 
six female fish were placed into each glass tank and fed twice a day with a commercial diet 
for native freshwater fish (Ridley Aqua Feed). Water temperature was maintained at 28˚C 
and quality was monitored regularly for ammonia, nitrite, nitrate, pH and water hardness. 
Water exchanges were performed as required. Tilapia reproductive and breeding behaviors 
were monitored and the eggs were collected from their mouth and transferred to a ZET-55 Fish 
Egg Incubator (Ziss Tumbler). Fish larvae were grown for two weeks in the incubator and 
transferred to separate floating cages to protect them from adult fish. When the fish larvae 
reached approximately 2 to 3 cm, they were transferred to 112 L food-grade plastic tanks with 
canister filter (Eheim) and grown for three months for the challenge experiment.  
 
4.2.3. Bacterial strains and culture conditions 
For the challenge experiment, GBS serotype Ib ST-261 strain QMA0285, isolated from giant 
Queensland grouper, Epinephelus lanceolatus, in 2010 was used (Delamare-Deboutteville 
et al., 2015). For cross-serotype ELISA, GBS serotype Ia, strain QMA357 isolated from 
female genital in Townsville hospital in 2011 was used. The isolates were maintained as 
frozen stock in Todd-Hewitt broth (THB) containing 20% glycerol at -80˚C and recovered 
from the stock on Columbia sheep blood agar (5%) (Oxoid) at 28˚C. One colony was picked 
up and used to inoculate fresh THB and incubated at 28 ˚C with gentle agitation overnight 
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for bacterial suspension. For the strain QMA0357, the plate and THB culture were incubated 
at 37˚C. 
 
4.2.4. Pre-challenge 
A pre-challenged with GBS to evaluate the virulence of the challenging strain and to 
determine the concentration of inoculum for challenge experiment was performed. Briefly, 
GBS strain QMA0285 was grown in THB overnight and the bacterial suspension was spun 
at 3220 x g to remove culture media. The pellet was resuspended in phosphate buffered 
saline (PBS) to OD600 = 1, then serially diluted tenfold and plated onto agar plate THB + 
1.5% bacterial culture agar to estimate colony-forming units (CFU) post-hoc. The bacterial 
suspension was diluted 10-fold, 100-fold, 1000-fold and 104-fold in PBS as inoculums. 
Sixteen tilapias were tagged individually by PIT tag (BTS-ID, Sweden) and were injected 
intraperitoneally with 100 µL of each inoculum, four fish per dose. Challenged fish were 
placed in a tank at 28°C and monitored continuously. Fish showing signs of infection were 
humanely killed according to a score sheet and counted as mortality. Fish were aseptically 
dissected (eye, kidney and brain) for bacteriology. The identity of isolated bacteria was 
confirmed by polymerase chain reaction (PCR) using the 16S primers (Table 4.1) (Amann 
et al., 1995).  
 
Table 4.1. Oligonucleotide primers used in this study. 
Gene Primer Length (bp) Nucleotide sequence (5’ to 3’) 
16S rRNA 
29F 20 AGAGTTTGATCCTGGCTCAG 
1492R 18 GGTTACCTTGTTACGACT 
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GBS 
23S rRNA 
AgaF 31 AACAGCCTCGTATTTAAAATGATAGATTAAC 
AdyR 23 TCCTACCATGACACTAATGTGTC 
 
4.2.5. Vaccinations and challenge fish 
Six vaccines were tested in this trial (Table 4.2). Preparation of whole cell and recombinant 
vaccines are described in Chapter 3. In total, 525 tilapias (O. mossambicus) of 
approximately 15 ± 5 g were starved for 12 h to reduce the risk of damaging gut by 
intraperitoneal (IP) injection. Fish were divided into seven groups of 75, anaesthetised with 
AQUI-S® (AQUI-S New Zealand Ltd.) and injected intraperitoneally with 100 µL of vaccine. 
One group was injected with 100 µL of PBS mixed with adjuvant as a negative control vaccine. 
Immediately after vaccination, each group of tilapias was placed into recirculating fresh water 
and left to recover from injection.  
 
Table 4.2. Vaccine types and antigen concentrations. 
Antigen Concentration Per tilapia 
PBS  - - 
Whole-cell, Ib  4 x 108 cfu/mL 4 x 107 cfu/mL 
Whole-cell, Ia 4 x 108 cfu/mL 4 x 107 cfu/mL 
Recombinant protein, 0337 400 µg/mL 40 µg/mL 
Recombinant protein, 0626 400 µg/mL 40 µg/mL 
Recombinant protein, 1196 400 µg/mL 40 µg/mL 
Recombinant protein, Mix 
(mixture of 3 adhesins) 
400 µg/mL (~ 133 µg/mL of 
each adhesin) 
40 µg/mL (~13 µg/mL of 
each adhesin) 
 
 135 
Nine hundred degree days (32 days at 28˚C) post-vaccination, tilapia were anaesthetised with 
AQUI-S® and identified individually using PIT tags. Tagged fish were challenged by IP injection 
with 100 µL of inoculum under anaesthesia with triplicate cohorts of 25 fish per treatment. Each 
group of 25 challenged tilapias was placed into one of three replicates 800 L tanks with 
individual FX4 High Performance Canister Filter (Fluval®) such that each complete experiment 
comprising all treatment and control groups was contained within each of three replicate trial 
tanks. The challenge inoculum was prepared from overnight culture of QMA0285 serotype Ib 
in THB culture. Cells were harvested at 3220 x g for 20 min at 4˚C and resuspended in PBS 
to adjust to an OD600 of 1. The pre-challenge result (data not shown) indicated that tilapia 
challenged with 1.01 x 106 CFU/mL (1.0 x 105 cfu/fish) resulted in 100% mortality after seven 
days. Therefore, the bacterial suspension was diluted 100-fold, which was determined to be 
equivalent to 1.01 x 106 CFU/mL. A subsample of the challenge inoculum was taken to 
determine challenge CFU post hoc. 
 
Challenged tilapias were continuously monitored. Moribund fish were humanely euthanised 
and counted as mortality in accordance with animal welfare requirement. Mortalities were 
recorded several times every day and four mortalities from each vaccine group from each 
tank were sampled aseptically from the eye, kidney and brain onto 5% sheep blood agar 
(Oxoid). The fish were observed for a total of three weeks after which trials were terminated, 
and all survivors were euthanized. The identity of isolated bacteria was confirmed by PCR 
using the AgaF/AdyR primers set (Kawata et al., 2004) as previously described (Table 4.1). 
The efficacy of each vaccine was determined by calculating the relative percentage survival 
(RPS) for each vaccine group according to Amend (1981) using PBS: adjuvant negative 
control group as the reference for control mortality.  
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4.2.6. Enzyme linked immunosorbent assay (ELISA) 
In order to determine the serum antibody response against GBS, collected anti-sera 
(Chapter 3) were subjected to indirect enzyme linked immunosorbent assay (ELISA) as 
previously described (Delamare-Deboutteville et al., 2006). Cross-reactivity of anti-sera 
against heterologous serotype (Ia) was also tested by using serotype Ia GBS strain QMA0357 
as antigen. Enzyme linked immunosorbent assay high binding 96-well plates (Microlon, 
Greiner) were coated with formalin fixed GBS strain QMA0285 or QMA0357 diluted in 
carbonate bicarbonate buffer and incubated overnight at 4˚C, then washed with Tris buffered 
saline (TBS) containing 0.005% of Tween-20 (TBST) (Sigma Aldrich). The plates were blocked 
with 1% bovine serum albumin (Sigma Aldrich) in TBST for 3 h at room temperature and 
washed thrice in TBST. Anti-sera were applied at 1:32 dilution in TBST in triplicate and 
incubated for 3 h at room temperature, following the incubation with secondary anti-
barramundi IgM produced in sheep (1:2000) (shown to cross-react with tilapia IgM in a dot 
blot) and tertiary anti-goat antibodies raised in donkey conjugated with alkaline phosphatase 
(1:15000) for 1 h each at room temperature. The plates were washed three times with TBST 
between the incubations with antibodies. After the incubation with tertiary antibody, the 
plates were washed thrice in TBST and twice in TBS. To develop the colour, p-Nitrophenyl 
Phosphate Liquid Substrate System (Sigma Aldrich) was added to the wells and the 
absorbance was read at 405 nm every 30 min for 3 h at room temperature by using Fluostar 
Optima luminometer (BMG Labtech). 
 
4.3. Results 
4.3.1. Homologous whole-cell vaccine protects against challenge, but heterologous whole-
cell and recombinant adhesin vaccines are not protective 
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Mortalities commenced after 6 h of challenge and reached 20 to 50% at 24 h post injection 
except for Ib vaccinated group (Fig. 4.1A). The groups that were vaccinated with PBS: 
adjuvant, adhesin_0337, adhesin_0626, adhesin_1196 and mixture of adhesins showed 
rapid rise in mortalities within 24 h of challenge and continued for 12 days (Fig. 4.1A). After 
12 days, only small number of fish was observed as dead and mortality did not occur 15 
days post challenge in these groups (Fig. 4.1A). Ia whole cell vaccinated tilapia group 
indicated slower mortality than PBS: adjuvant group. The mortality reached 20.3% at 24 h 
post injection and gradually increased to 59.7% at day 10 (Fig. 4.1A). Few tilapias 
vaccinated with Ib were found as dead for four days after challenge but mortality stopped at 
day 5 (Fig. 4.1A).  
 
Mean mortalities of PBS: adjuvant group and recombinant adhesin vaccines groups were 
not significantly different from each other (86.7% for PBS: adjuvant group, 80% for 
adhesin_0337 group, 93.3% for adhesin_0626 group, 86.7% for adhesin_1196 group and 
81.3% for adhesins mix group). Tilapia vaccinated with whole cell GBS had significantly 
lower mortality than PBS: adjuvant group with groups vaccinated with Ib whole cell 
(homologous) having mean mortality 16 % (p < 0.0001, n = 3) while groups receiving Ia 
whole cell (heterologous) vaccine had mean mortality of 64.7% (p < 0.05, n = 3) at day 21. 
Relative percentage survival was calculated for each treatment based on the mortality of 
PBS: adjuvant group. The group vaccinated with Ib whole cell showed significantly higher 
RPS (81.6%) (p < 0.0001) compared to other treatments while all recombinant vaccines 
groups represented lower than 15% RPS (Fig. 4.1B). The RPS of serotype Ia whole-cell-
vaccinated tilapias (24.92%) was lower than homologous vaccine group; however, it was 
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significantly higher than the fish receiving adhesin_0626 and adhesin_1196 recombinant 
vaccines (p < 0.05) (Fig. 4.1B).  
 
 
Fig. 4.1. Cumulative mortality and relative percent survival of vaccinated tilapia after the challenge with 
GBS serotype Ib strain QMA0285. A) Mean cumulative mortality (%) of each vaccinated tilapia group. 
B) Relative percent survival (RPS) was calculated for each vaccine group based on PBS negative 
control group. **** p < 0.0001; *** p < 0.005; ** p < 0.01; * p < 0.05.  
 
4.3.2. Homologous and cross-reactive serum antibody responses of tilapia to GBS serotype 
Ib and Ia 
Sera were collected from six fish per treatment group 900 degree days after the vaccinations 
and the serum antibody reactivity to GBS whole cell was determined by ELISA. Specific 
antibody in sera from fish vaccinated with any of the antigens was not significantly different 
from sera from adjuvant control fish against serotype Ib whole cell antigen in the ELISA (p 
> 0.05, n = 6) (Fig. 4.2A). To identify serotype cross-reactivity, GBS serotype Ia was also 
used as coating antigen in the ELISA (Fig. 4.2B). Once again, specific antibody in sera 
collected from tilapia vaccinated with serotype Ib and Ia whole cell vaccines did not differ 
significantly from PBS: adjuvant negative control serum. In contrast fish vaccinated with 
recombinant adhesins had significantly higher specific antibody against serotype Ia whole 
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cells compared to negative control (adhesin_0626: p < 0.005, adhesin_0337, 1196 and mix: 
p < 0.01) (Fig. 4.2B).  
 
 
Fig. 4.2. Cross reactivity of serum antibodies from vaccinated fish from each treatment group against 
GBS whole cells by indirect ELISA. A) Serum antibody cross-reactivity against GBS serotype Ib whole-
cell coating antigen. B) Serum antibody response to GBS serotype Ia whole-cell coating antigen. 
Significant difference from PBS: adjuvant negative control *** p < 0.005; ** p < 0.01; * p < 0.05, (n = 6 
fish per treatment).  
 
4.4. Discussion 
Adhesins are surface proteins which mediate bacterial attachment to the host cells to initiate 
infection and are well conserved across species due to their central role in infection (Nobbs 
et al., 2009). Therefore, they are often important antigen candidates for vaccine 
development (Henningham et al., 2013; Khan and Pichichero, 2012; Margarit et al., 2009; 
Nobbs et al., 2009). The adhesins investigated in this study were confirmed to elicit specific 
antibody production (Chapter 3). In spite of this, none of recombinant adhesins conferred 
protection against challenge in tilapia, although two adhesins (adhesin_0337 and 0626) 
were capable of eliciting cross-specific antibody against serotype Ia, but not Ib whole cells. 
Lack of protection against infection in spite of detectable specific antibody has been reported 
previously in both human and fish vaccines (Aviles et al., 2013; Sandin et al., 2006). This 
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can occur if the antibody binds a non-protective epitope (Sandin et al., 2006). For example, 
the amino-terminal hypervariable region of S. pyogenes M5 protein is a protective epitope 
since antibody that bind to this region is opsonic, while the semi-variable B-repeat region 
and conserved C-repeat region of the M5 protein are non-protective epitopes because 
antibodies binding these regions are not opsonic (Sandin et al., 2006). In the M5 protein, 
the B-repeat binds to fibrinogen and C-repeat region binds to human serum albumin, 
therefore, under physiological conditions, fibrinogen and albumin bind to the regions 
blocking antibody binding (Sandin et al., 2006). Here, the two adhesins that elicited high 
specific antibody response contain a fibronectin-binding repeat, Streptococcal surface 
repeat domain (SSURE) (adhesin_0337) and bacterial Ig-like domain 1 (Big-1) 
(adhesin_0626) (Chapter 3). It is possible therefore, that antibody binding in vivo might be 
blocked by binding of host proteins and this requires further investigation. Antibody binding 
to B-repeat region of S. pyogenes M5 protein is significantly reduced in the presence of 
fibrinogen at physiological concentration (Sandin et al., 2006). However, in the present study 
none of serum antibodies bound serotype Ib QMA0285 whole-cells even though the host 
proteins were almost absent. 
 
The accessibility of antigen is important to confer protection so surface exposed proteins 
are ideal target for vaccine development (Grandi, 2010; Maione et al., 2005). Although 
antigens might be found across all strains, the accessibility of antigens to antibody may vary 
amongst the strains (Maione et al., 2005). For instance, the surface accessibility of Sip 
protein in GBS varies from isolate to isolate, depending on the presence of CPS (Maione et 
al., 2005). In the present study, ST-261 serotype Ib strain QMA285 was used for challenge 
in tilapia. Although isolates belonging to ST-261 have a substantially reduced repertoire of 
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virulence factors (Rosinski-Chupin et al., 2013), all strains have conserved most of the 
capsular operon (Kawasaki et al., 2018) and express CPS as determined by buoyant density 
assay (Delamare Deboutteville, 2014). Although not experimentally demonstrated in fish 
pathogenic GBS, CPS is a critical virulence factor in other fish pathogenic streptococci such 
as, S. iniae (Locke et al., 2007; Rosinski-Chupin et al., 2013). Consequently, CPS may 
completely mask adhesins during systemic infection in the blood. Moreover, gene reduction 
associated with adaptation of the ST-261 lineage to fish has depleted the repertoire of 
transcriptional regulators (serotype Ib fish strains carry eight two-component systems 
compared to 21 in human strains) (Rosinski-Chupin et al., 2013). This may cause 
deregulation of virulence gene expression (Rosinski-Chupin et al., 2013), therefore, our 
challenge strain QMA0285 might express large amounts of CPS during infection. In contrast, 
whole cell ELISA against GBS serotype Ia QMA0357 from humans detected cross-reacting 
antibody in serum from fish vaccinated with recombinant adhesins, which suggests this 
strain might express less CPS compared to QMA0285 enabling binding of antibody to 
exposed adhesins. 
 
Pathogens regulate expression of surface proteins and virulence factors to adapt to 
changing environment in the host. Consequently, organization of surface proteins fluctuates 
during the course of infection (Grandi, 2010; Rajagopal, 2009). Streptococcus species, such 
as GBS and S. iniae are known to infect fish through a number of routes (Agnew and Barnes, 
2007; Delamare-Deboutteville et al., 2015; Iregui et al., 2016). Group B Streptococcus 
infection of fish via injection, immersion and oral routes have been experimentally 
demonstrated but highest mortality is by injection challenge (Delamare-Deboutteville et al., 
2015; Iregui et al., 2016). However, Iregui et al. (2016) suggest that the gastrointestinal 
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epithelium is the most important natural route of infection and CPS was not detected when 
GBS adhered to the gastrointestinal epithelium of red tilapia, Oreochromis spp. (Iregui et al., 
2016). In our study, tilapias were challenged with GBS via intraperitoneal injection, 
bypassing the environment where genes required for attachment may be induced. An 
important follow up study should determine when these adhesins are expressed in ST-261 
and other fish pathogenic lineages during more natural cohabitation infections.  
 
In the present study, only the whole-cell killed vaccine was protective, and the only against 
the homologous capsular serotype. In contrast, the whole-cell vaccine comprising the 
heterologous serotype Ia only marginally decreased mortality against Ib challenge 
compared to adjuvant-only controls, although the difference was statistically significant. 
Serotype Ia whole-cell vaccine was grown under carbohydrate limited condition, the 
optimum condition for adhesin expression and suppression of CPS expression as 
determined by real-time qRT-PCR (Chapter 3), but the protection was still poor. This may 
result from immunodominance by the CPS antigen. Fish adaptive immunity and immune 
memory recognises and responds overwhelmingly to bacterial carbohydrate antigens with 
lipopolysaccharide (LPS) and CPS being the dominant protective antigens in vaccines 
against Yersina ruckeri LPS (Welch and LaPatra, 2016), Vibrio anguillarum LPS (Boesen et 
al., 1999), Lactococcus garvieae CPS (Barnes and Ellis, 2004; Barnes et al., 2002) and S. 
iniae (Millard et al., 2012). Even though there may be a primary response to purified 
recombinant adhesins or those expressed in the optimized killed Ia culture, it may be that 
the critical secondary response is not successfully initiated during infection as the fish 
response is fully consumed in dealing with the polysaccharides of the capsule. 
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Group B Streptococcus serotype Ib whole-cell vaccine provided excellent protection against 
homologous serotype challenge but no specific antibody was detected in serum immediately 
prior to challenge. This may be because the peak primary antibody response in vaccinated 
fish was missed and protection was derived from secondary antibody response activated on 
infection during challenge. However, high antibody levels were elicited by the recombinant 
proteins (Chapter 3), but no protection was evident. This apparent paradox might be 
explained by the differing nature and kinetics of the immune response of fish to particulate 
and soluble antigens (Dos Santos et al., 2001). Primary antibody response to soluble T-
dependent DNP in sea bass is substantially higher and faster (18-24 days) than the 
response to particulate Photobacterium damselae or Vibrio bacterins and the response 
declines quickly from the peak (Dos Santos et al., 2001). In the present study the sera were 
collected four weeks post-immunisation, which may coincide with peak response to soluble 
recombinant proteins but may not be optimal for primary response against killed cells (Dos 
Santos et al., 2001).  
 
The adhesins identified in my previous research (Kawasaki et al., 2018) are conserved 
across almost all lineage of GBS, even against a background of substantial genetic change 
as lineages become host adapted (Kawasaki et al., 2018; Rosinski-Chupin et al., 2013). 
This suggests they are under strong selection and essential for GBS survival. Further work 
is required to fully elucidate their role in infection in fish and when and where they are 
expressed by GBS. It may be possible to adapt antigen delivery and presentation to improve 
cross-protection based on a very limited repertoire of conserved surface proteins across the 
diversity of S. agalactiae sequence types.
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Chapter 5: General Discussion 
Emerging infectious diseases have been a significant constraint to aquaculture expansion 
with global economic and social impacts (Adam and Gunn, 2017; Stentiford et al., 2017). 
Under the aquaculture condition, disease causing agents such as bacteria, viruses and 
parasites can be present at a high density and transmit among host animals rapidly since 
the animals are often maintained at high densities of monospecies populations (Defoirdt et 
al., 2011; Kennedy et al., 2016). In addition, poor environmental conditions including low 
oxygen level and low water qualities in aquaculture system can increase host susceptibility 
(Defoirdt et al., 2011; Murray and Peeler, 2005). Moreover, increase of global seafood 
trading and transport can lead to disease transmission between countries resulting in 
introduction of new pathogens into naïve aquaculture systems and environments around 
farms (Dadar et al., 2017; Stentiford et al., 2017). The negative impacts of infectious disease 
is not only the economic losses, but also increases in antibiotics use, which raises the risk 
of developing antibiotic resistance with potential threats to human health if serious 
pathogens acquire the resulting resistance by horizontal gene transfer or simply by their 
presence in the environment or products in which the antibiotics were used (Barlow, 2009; 
Cabello et al., 2013; Dadar et al., 2017).  
 
Vaccination in aquaculture has successfully reduced the use of antibiotics while increasing 
production by protecting fish against pathogens (Gudding, 2014; Håstein et al., 2005; 
Sommerset et al., 2014). Today, many commercial vaccines against bacterial pathogens 
are available to aquaculture producers in several countries (Barnes et al., 2016; Håstein et 
al., 2005; Munang’andu, 2018). However, vaccines are not a perfect solution to all bacterial 
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diseases and some bacterial pathogens, like Streptococcus, present challenges to effective 
long-term protective vaccines. 
 
Outbreaks of GBS cause significant impacts, especially in tilapia (Oreochromis spp.) 
productions in Asia, Middle East, North America, Latin America and Africa (Brum et al., 
2017; Li et al., 2016; Liu et al., 2016; Verner-Jeffreys et al., 2017) and, although many 
outbreaks are caused by fish-specific clonal complexes (Kawasaki et al., 2018), there are 
increasing numbers of cases of human pathogenic variants isolated from diseased fish 
presenting a potential biosafety hazard (Liu et al., 2016). Aquaculture production of tilapia 
is second highest in the world after carp production and is still increasing (FAO, 2018) so 
mitigating disease risk is critical in tilapia farming (Liu et al., 2016). Whole-cell inactivated 
vaccines against GBS provide good protection for tilapia from GBS infection (Eldar et al., 
1995b; Evans et al., 2004; Liu et al., 2016). However, due to the variations of capsular 
polysaccharide (CPS), which is the dominant antigen of GBS, whole-cell killed vaccine 
usually provide effective protection only against homologous CPS serotype but are not 
protective for heterologous GBS infection (Liu et al., 2016; Paoletti and Madoff, 2002). In 
addition, CPS is highly polymorphic so strong selective pressure exerted by vaccines can 
cause capsular switching to facilitate GBS to escape vaccine coverage (Bellais et al., 2012). 
Therefore, to overcome the serotype specificity problem, the identification of antigens that 
are well conserved across the different serotype strains is likely to be a good strategy for 
developing cost effective cross-protective vaccine (Baiano and Barnes, 2009; Maione et al., 
2005).  
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In this study, I applied pan-genome reverse vaccinology to develop a potential multi-
serotype cross-protective GBS vaccine for tilapia, Oreochromis mossambicus. I generated 
a pan-genome for GBS from 82 genomes, including representatives from wild marine fish 
isolates, stingray isolates, terrestrial isolates and human isolates in Australia, farmed tilapia 
isolates in Honduras and genomes available NCBI database (Kawasaki et al., 2018). Pan-
genome analysis revealed that remarkable genome reduction occurred in serotype Ib fish 
pathogenic strains compared to serotype Ia fish pathogenic strains and terrestrial isolates 
(Kawasaki et al., 2018; Rosinski-Chupin et al., 2013). Also, Ib fish strains have lost most of 
virulence factors including many adhesins, genes associated with immune evasion, cellular 
invasion and toxin production (Kawasaki et al., 2018). However, some virulence factors are 
conserved across most of the isolates, and these include CPS and a limited repertoire of 
putative adhesins which I named the ST-261 adhesins as they are the only surface 
associated virulence factors preserved in the aquatic-adapted 261 GBS sequence type (ST) 
(Kawasaki et al., 2018). Although some ST-261 adhesins are only present in serotype Ib 
fish strains or specific to ST-261 isolates, three ST-261 adhesins, 0337, 0626, and 1196 are 
conserved in most of the strains (Kawasaki et al., 2018).  
 
Adhesins are important virulence factors that mediate bacterial attachment to the host 
surface and colonisation (Kouki et al., 2011; Nobbs et al., 2009; Raynes et al., 2018). Due 
to their role, adhesins are usually located on the cell surface, which can be easily targeted 
by the host immune system (Raynes et al., 2018). In this study, the efficacies of three ST-
261 adhesins, which are conserved in most of the strains, as vaccines against GBS were 
evaluated in a tilapia disease challenge model. However, although two recombinant ST-261 
adhesins, 0337 and 0626, and mixture of three recombinant ST-261 adhesins were capable 
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of inducing antibody production, they were not protective for tilapia against GBS serotype Ib 
challenge (Chapter 3 and 4). Adhesins are considered as good vaccine candidates not only 
because they are located on bacterial surface where antibody can access, but also their 
degree of conservation across different isolates (Kouki et al., 2011; Krachler and Orth, 2013). 
This means adhesins should be under the strong immunological pressure. However, 
although some sequence variations in the adhesins can occur, their biological functions 
must still be conserved (Kouki et al., 2011; Moschioni et al., 2010). For instance, RrgA, 
which is a subunit of pilus 1 in S. pneumoniae and responsible for bacterial adhesion by 
pilus 1, has two major variants (clades I and II) but the two variants were both capable of 
binding to epithelial cells at a similar level (Barocchi et al., 2006; Moschioni et al., 2010; 
Nelson et al., 2007). In addition, the two RrgA variants were antigenically cross-reactive in 
vitro and also cross-protective in a murine model passive immunisation experiment with 
RrgA clade I rabbit antiserum (Moschioni et al., 2010). Different levels of diversification 
observed across antibody binding targets in bacteria can be elucidated from the functional 
constraints on variations of the bacterial proteins (Croucher et al., 2017). Bacterial 
adherence to the host cell surface requires specific ligand-receptor interactions (Berne et 
al., 2015). When pathogens encounter the host cells, they initially attach to the surfaces via 
non-specific interactions involved the bacterial and host surfaces physiochemical properties 
(Krachler and Orth, 2013; Tuson and Weibel, 2013). These interactions are weak and 
reversible so pathogens are still allowed to move and examine the host cell surfaces (Berne 
et al., 2015; Krachler and Orth, 2013; Tuson and Weibel, 2013). Once pathogens are on the 
host surface, they trigger strong and irreversible adherence mediated by specific ligand-
receptor interactions, such as bacterial adhesin-host cell surface receptor pairing (Berne et 
al., 2015; Krachler and Orth, 2013; Tuson and Weibel, 2013). Due to this specific interaction, 
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any changes in adhesins can significantly affect the ability of bacteria to adhere to the host 
cells, which can negatively impact on bacterial fitness in the host (Krachler and Orth, 2013). 
Therefore, ST-261 adhesins may similarly be subjected to a strong functional constraint that 
explains their high level of conservation.  
 
It has been proposed that the vaccines targeting adhesins are less likely to lead to bacterial 
resistance (Krachler and Orth, 2013; Ofek et al., 2003). When anti-adhesin antibodies bind 
to the bacterial surface epitopes, they can also block the critical step of bacterial infection, 
attachment to the host surface and colonisation, by interrupting specific ligand-receptor 
interactions so that bacterial infection may be prevented (Klemm et al., 2010; Krachler and 
Orth, 2013; Ofek et al., 2003; Wizemann et al., 1999). However, inhibiting bacterial 
adherence does not affect on bacterial viability and growth, like antibiotics, so it would not 
exert selective pressure on pathogens (Cozens and Read, 2012; Krachler and Orth, 2013). 
A counter argument to this, of course is that blocking adhesion may render bacteria less fit 
within the host and consequently reduce the transmission and success, thereby conferring 
advantage to variants that are not impeded. 
 
Sequence type 261 adhesins were not protective for tilapia against GBS challenge, perhaps 
implicating that these adhesins may not be under strong immunologic pressure during 
infection consistent with their high conservation across the all GBS isolates. Many bacterial 
species are capable of expression of various adhesins during the different stages of infection 
and in different environments (Klemm et al., 2010; Ofek et al., 2003). Although GBS serotype 
Ib fish isolates only possess ST-261 adhesins, GBS serotype Ia isolates from both fish and 
terrestrial animals conserve additional adhesins (Kawasaki et al., 2018). This may implicate 
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these alternative adhesins in the colonisation of mammals, but it may also be possible that 
these isolates may express these additional adhesins rather than ST-261 adhesins during 
the infection of tilapia. In my research, I did not examine if the three conserved ST-261 
adhesins were expressed during infection in tilapia. The tilapias were challenged by 
intraperitoneal injection (IP) which is likely different from natural routes of infection, in which 
GBS enter tilapia via gastrointestinal epithelium from the oral route and attach to the 
epithelium cell surface and colonise (Iregui et al., 2016). Consequently, the route of infection 
employed may bypass the adhesion stage during which adhesins might be critical to 
invasion of the gut epithelium. Instead, GBS might express different factors when they are 
injected to tilapia abdominal cavity. This may explain why the adhesins were not protective 
against GBS in the present model. However, I cannot elucidate if adhesins are conserved 
well because of low immunologic pressure to adapt or because of functional constraint, since 
I did not determine if the ST-261 adhesins are expressed on the bacterial surface during 
infection under natural conditions. Therefore, further works are needed to elucidate the role 
of ST-261 adhesins during the infection and if the adhesins are important for GBS 
pathogenesis in fish. In order to clarify the question, the future study may employ ST-261 
adhesin-knockout mutants and test their pathogenesis in tilapia challenge model. Also, the 
levels of the adhesin expression during the infection should be investigated. Moreover, 
although the genes of the antigens are conserved and expressed by all isolates, accessibility 
of antigen can be vary between the isolates (Maione et al., 2005). For example, Sip protein 
is conserved in core genome of GBS and even though it is expressed on the bacterial 
surface, with the accessibility dependent on the presence of CPS (Maione et al., 2005). If 
the ST-261 adhesins were expressed on the surface but were not accessible, this might 
explain why the antigens were not protective which cause less immunological pressure. 
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Indeed, CPS and ST261-adhesins seem to be inversely co-regulated under different growth 
conditions (Chapter 3) suggesting some form of interdependent phase control during the 
infection lifecycle of these strains. Better understanding of antigen expression and 
accessibility is needed for efficient vaccine development because although the presence of 
gene for the antigen is a critical factor for antigen selection, the antigen expression in vivo 
and their accessibility are equally critical to elicit effective protection.  
 
Currently, commercial aquaculture vaccines are available for farmed fish including salmonid 
fish, European seabass, seabream, Japanese flounder, yellow tail, Atlantic cod, grouper, 
catfish, carps and tilapia (Assefa and Abunna, 2018; Brudeseth et al., 2013; Muktar et al., 
2016; Sommerset et al., 2014). Vaccination has played critical role in the success of 
salmonid farming industries in terms of production growth and antibiotic reduction, 
particularly in Norway (Brudeseth et al., 2013; Sommerset et al., 2014). Today, commercial 
vaccines are licensed and available for more than 40 countries (Brudeseth et al., 2013). 
However, although vaccines are widely used to protect farmed salmonid fish and marine 
fish in Europe, North America, Middle East, Chile, Japan and Korea, it is not the case for 
freshwater fish aquaculture in some countries (Brudeseth et al., 2013). Tropical and warm-
temperate freshwater fish, such as carp, catfish and tilapia, are mainly farmed in China, 
Southeast Asia, Africa and South America and growth in production is very high but use of 
vaccines is very limited (Brudeseth et al., 2013; Opiyo et al., 2018; Wamala et al., 2018). 
For example, commercial injectable vaccines against GBS are available for tilapia farmers 
in Brazil, Costa Rica and Indonesia but many farmers in tilapia aquaculture still relying on 
husbandry techniques to prevent disease rather than vaccination (Aftabuddin et al., 2016; 
Brudeseth et al., 2013; Chitmanat et al., 2016; Yanong, 2011). When disease outbreaks 
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occur, antibiotics are mainly used to treat fish (Aftabuddin et al., 2016; Chitmanat et al., 
2016; Yanong, 2011). Manual vaccination is labor intensive and requires good fish handling 
skills which can cause high stress (Brudeseth et al., 2013). Since most warm freshwater fish 
like tilapia are low value species injection vaccines, or even immersion vaccines, may seem 
too expensive, especially for small farms (Brudeseth et al., 2013; Sommerset et al., 2014). 
In addition, pathogens like GBS may be hard to control by generic vaccines as a result of 
the immunodominance of the CPS on the infecting strains in fish. Furthermore, vaccines 
that target CPS exert selective pressure leading to capsular serotype switching and 
consequent vaccine failure and/or emergence of novel serotypes not covered by the 
vaccines in use (Bachrach et al., 2001; Bellais et al., 2012). In Brazil, GBS serotype Ib is the 
major causative agent of disease outbreaks in tilapia industries so commercial vaccine, 
AQUAVAC® Strep Sa (MDS Animal Health), are used to protect fish in some farms 
(Chideroli et al., 2017). However, in 2016, outbreak caused by GBS serotype III occurred in 
the farms, some of whom had vaccinated fish (Chideroli et al., 2017). Although AQUAVAC® 
Strep Sa (MDS Animal Health) is reported to provide excellent protection for tilapia against 
GBS biotype II (serotype Ib), the vaccine efficacy is evidently reduced by the emergence of 
new serotypes. The ideal vaccine for aquaculture has to meet strict standards including 
safety of use, provision of long-term immunity preventing mortality for the life of the fish, 
must also be cheap to produce, license and register (Grisez and Tan, 2005; Muktar et al., 
2016; Sommerset et al., 2014). Development of generic vaccines that meet these standards 
for tropical and subtropical freshwater aquacultures might be very difficult, particularly given 
the existing serotypic diversity and extensive pan-genome that still remains open indicating 
potential for discovery of further diversity over time.  
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To develop effective vaccines against the pathogens with broad diversities, autogenous 
vaccines, which are custom vaccines prepared from the pathogens isolated directly from the 
farm and applied only on the farm, could be one of the solutions to control diseases in warm 
water fish aquacultures (Hoelzer et al., 2018; Millard et al., 2012; Toranzo et al., 2009). 
Autogenous vaccines are usually deployed at small or medium scale and under restricted 
permit that reduces registration costs (Arsenakis et al., 2018; Brudeseth et al., 2013). 
Autogenous vaccines have been used in terrestrial agriculture including cattle, swine and 
poultry where they have successfully reduced antibiotic use (Arsenakis et al., 2018; Baums 
et al., 2010; Li et al., 2017; Reeves et al., 2013). For instance, exudative epidermitis caused 
by Staphylococcus hyicus is a common skin disease in pigs and autogenous vaccine against 
S. hyicus reduce morbidity and mortality rate while the amount of metaphylactic antimicrobial 
treatment has been reduced (Arsenakis et al., 2018). In aquaculture, autogenous vaccines 
have been used widely in both cold and warm water fish (Gudmundsdóttir et al., 1997; 
Millard et al., 2012) and have been effective against Aeromonous salmonicida spp. 
achromogenes and Yersinia ruckeri in salmonid fish (Barnes et al., 2016; Gudmundsdóttir 
et al., 1997; Ormsby et al., 2016) and against Streptococcus iniae in barramundi and GBS 
in stingrays (Bowater et al., 2018; Millard et al., 2012). Autogenous vaccines are also known 
as emergency vaccine, which can be used under the circumstances where fully licensed 
vaccines are not available, not effective or the causative agent is not covered (Hoelzer et 
al., 2018). The process of developing autogenous vaccines is much shorter than developing 
generic vaccines so the vaccine could be very effective against pathogens like 
Streptococcus that evolve rapidly because even emerging novel serotypes can be 
incorporated in a short period of time.  
 
 153 
Although there are considerable advantages of autogenous vaccines in rapidly developing, 
margin industries such as warm water aquaculture, there are some disadvantages. One of 
the problems is that autogenous vaccine needs to be regularly updated with different strains 
from the vaccine population or vaccine escape strains that may be circulating in the 
environment (Arsenakis et al., 2018). In order to solve this problem, careful surveillance and 
frequent diagnosis to determine the emergence of infectious disease in real-time is the key 
for effective autogenous vaccine development. These services are often not widely available 
in developing economies and lack of diagnostics has been attributed as one contributing 
factor in misdiagnosis and misuse of antibiotics in tilapia aquaculture in Vietnam and 
aquaculture in general (Boerlage et al., 2017; Henriksson et al., 2017). Whilst tools such as 
next generation sequencing technologies and bioinformatics can provide rapid and low cost 
genomic and metagenomic data that allow more accurate surveillance and detection of 
causative agents of disease (Barnes et al., 2016; Brynildsrud et al., 2014; Gardy and Loman, 
2018; Gulla et al., 2018; Kawasaki et al., 2018), the establishment of readily available basic 
diagnostic and strain collection capability locally in aquaculture growth areas is a first priority. 
Once established, pathogenomics can increase understanding of the evolution of pathogen 
strains and the mechanism of shifting from microbiome to pathobiome which can be used to 
predict occurrence of disease outbreaks (Vayssier-Taussat et al., 2014). Moreover, a highly 
portable pocket-sized sequencer, MinIONTM from Oxford Nanopore has potential to enable 
sequencing to be performed almost anywhere without establishment of expensive 
sequencing facilities (Bayliss et al., 2017; Gardy and Loman, 2018; Jain et al., 2016). 
MinION has been used in field situations for sequencing Ebola and Zika virus epidemic 
(Gardy and Loman, 2018). By applying MinIONTM, it is possible to sequence pathogens 
causing disease outbreaks on the farms where a sequencing facility is not accessible 
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(Bayliss et al., 2017). Therefore, rapid surveillance and diagnosis supported by 
pathogenomics are likely to enable accurate and timely formulation of autogenous vaccines 
in response to changes in the pathobiome and emergence of novel strains once basic 
routine pathological sampling is established locally.  
 
Pathogenomics provides not only useful information for surveillance but also the evidence 
to justify expansion of the epidemiological unit that defines and limits autogenous vaccine 
use. Autogenous vaccines can only be used on the farm where the vaccine strain is isolated 
(Hoelzer et al., 2018; Millard et al., 2012). The same vaccine formulation cannot be used for 
animals that are not within the same epidemiological unit although the same isolate may be 
causing disease in different farms (Pesticides and Authority, 2014). Generally, each farm, 
flock or herd is considered as a separate epidemiological unit but the definition can vary 
(Hoelzer et al., 2018; Landman et al., 2014; Pesticides and Authority, 2014). Developing 
and manufacturing costs are diluted over a number of vaccine doses so producing smaller 
amount of vaccine can lead to higher per-unit production cost (Plotkin et al., 2017). As a 
consequence, an autogenous vaccine produced for a single small farm may not be 
affordable even though registration costs are low. However, when disease is caused by the 
same pathogenic strain over several farms, they should be defined as the same 
epidemiological unit so that the same vaccine formulation can be used in all of those farms 
decreasing the cost per dose. The expansion of the epidemiological unit for autogenous 
vaccine use provides economy of scale towards affordable solutions for smaller farmers. 
Evidence provided by timely pathogenomics will facilitate this process. In conclusion, 
affordable autogenous vaccines would bestow benefit onto the famers in lower income 
countries where the aquaculture growth is rapid and antibiotics are still the main measure to 
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treat infectious disease (Brudeseth et al., 2013; Sommerset et al., 2014). The work in this 
thesis reveals some of the challenges and potential solutions for such vaccines. With global 
antimicrobial use in animal production far exceeding use in human medicine (Van Boeckel 
et al., 2017), and considering the “one health” philosophy linking human health with 
production animal and environmental health (Kaplan and Echols, 2009) that is driving 
towards reduction of antimicrobial use in agriculture (Robinson et al., 2016), it is critical that 
affordable disease prevention methods such as guided autogenous vaccination are 
promoted in the world’s fastest growing food production sector.
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